Invesitagating the role of the guanine nucleotide exchange factor P-Rex1 in cell invasion by Lawn, Samuel Oliver
 
 
 
 
 
 
 
Investigating the role of the guanine nucleotide 
exchange factor P-Rex1 in cell invasion 
 
 
 
 
 
Samuel Oliver Lawn 
 
 
 
A thesis submitted to the University of Glasgow for the degree of 
Doctor of Philosophy 
 
 
 
 
 
October 2008 
 
 
 
 
 
Beatson Institute for Cancer Research 
Garscube Estate 
Switchback Road 
Glasgow G61 1BD 
 
 
 
 
Abstract 
 
Cell invasion is a critical step in cancer metastasis. Rho family GTPases are 
key regulators of cell motility, regulating the form and function of the actin 
cytoskeleton. P-Rex1, a Rac guanine nucleotide exchange factor (GEF), was 
previously identified in this lab in a transcriptional screen for mediators of 
cell invasion. A number of GEFs have been shown to regulate the invasive 
phenotype of tumours and cancer cell lines, leading to the hypothesis that P-
Rex1 is an invasion promoting gene. 
 
We show that overexpression of P-Rex1 induces dramatic morphological 
changes in fibroblasts characterised by extensive membrane ruffling and 
lamellipodia formation. P-Rex1 modulates the 2D migration of fibroblasts and 
potently stimulates their in vitro invasion. These phenotypes are dependent 
on Rac1, PI3 kinase and GPCR signalling and can be stimulated by growth 
factor mediated accumulation of PIP3. 
 
P-Rex1 expression is shown to be upregulated in a number of melanoma 
derived cell lines compared to normal human melanocytes. Ectopic 
overexpression of P-Rex1 enhances the membrane ruffling and invasion of 
melanoma derived cell lines, while in some cell lines, limiting its expression 
by RNAi reduces both serum stimulated ruffling and invasion.  
 
The P-Rex1-/- mouse is shown here to have a previously uncharacterised 
pigmentation phenotype, consistent with a defect in melanocyte precursor 
migration. This phenotype is not overcome by crossing on to a melanoma 
model driven by expression of activated N-RasQ61k and loss of the INK4a locus. 
While it seems that P-Rex1 deficiency does not affect melanoma initiation, 
studies are ongoing to determine whether it has a role in metastastic 
progression. Data also suggests that P-Rex1 has an unexpected role in 
lymphoma development. 
 
This work further characterises the regulation and function of P-Rex1, adding 
to our understanding of how RhoGTPase GEFs function in cancer. 
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1 Introduction 
 
Invasion and metastasis are hallmarks of cancer and are the cause of 90 % of 
deaths from solid tumours (Hanahan and Weinberg 2000). A thorough 
understanding of metastasis would likely allow for the development of 
therapeutics and diagnostic tools to improve the treatment of cancer.  
A feature thought to be common to many metastatic tumour cells is an enhanced 
ability to actively invade through surrounding tissue. One family of proteins with 
a long established role in the regulation of cell morphology, motility and 
invasion are the Rho GTPases (Hall 2005). The precise role of Rho GTPases and 
their regulators such as Guanine Nucleotide Exchange Factors (GEFs), in tumour 
cell invasion is not fully understood and so presents itself as an area of active 
research with potential therapeutic implications. 
Previous work in this lab has sought to identify genes downstream of the 
transcription factor AP-1 that are important in regulating cell invasion (Lamb, 
Hennigan et al. 1997; Ozanne, McGarry et al. 2000; Spence, Johnston et al. 
2000; McGarry, Winnie et al. 2004). Microarray analysis of human immortalised 
fibroblasts that have been made invasive by expression of the v-Fos or H-RasV12 
oncogenes has identified a number of upregulated and downregulated genes that 
are hypothesised to be positive and negative mediators of invasion, respectively 
(Scott, Vass et al. 2004). One such upregulated gene is P-Rex1, a Rac GEF 
originally identified in neutrophils as promoting reactive oxygen species 
generation and cell motility. 
The aims of this investigation are to determine whether P-Rex1 functions as an 
invasion promoting gene, both within the fibroblast model of invasion described, 
and within the context of tumour derived cell lines and mouse tumour models. 
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1.1 Cancer Metastasis 
1.1.1 The course of metastasis 
Most models describe tumourigenesis as an evolutionary process in which 
accumulating genetic mutations and epigenetic events confer a selective growth 
advantage on cells to the point that they constitute a tumour (Hanahan and 
Weinberg 2000). The spread of cancer, metastasis, is thought to be an extension 
of this process whereby only a selection of tumour cells are capable of initiating 
a new site of growth in the body (Fig. 1.1) (Gupta and Massague 2006). The most 
universal features of metastasis are the detachment and invasion of cells from a 
primary tumour to intravasate into the circulatory systems, survival and 
extravasation to a new site and subsequent growth and development. While 
numerous theories exist to explain metastasis, most agree that it is a 
multifaceted process that requires the modification of the tumour cells 
themselves and a change in their physiological context. Tumour cell intrinsic 
alterations include changes in adhesion, motility, sensitivity to chemotactic 
growth factors, proteolysis of the extracellular matrix and resistance to anoikis. 
Extrinsic factors influencing the nature of metastasis include the tumour 
vasculature, extracellular matrix composition and presence and activity of 
residing stromal cells and infiltrating immune cells. These intrinsic and extrinsic 
features are rarely fixed and separate entities and will instead impact on each 
other during tumour development. Some of the properties driving tumour spread 
also promote the initiation and development of primary tumours e.g. a capacity 
for self-renewal and resistance to apoptosis. Other characteristics of metastatic 
cells, such as modified adhesiveness and enhanced motility act primarily to 
advance the spread of the disease and not in primary tumour initiation. The 
progression of a tumour from a benign to metastatic state is often depicted as a 
linear process, but is likely to proceed in a stochastic fashion with cells acquiring 
new properties in a non-determined order.  
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Figure 1.1 – Basic early steps of metastasis 
 
Metastasis is a highly complex process. Depicted is a basic 
summary of the invasive progression of a solid epithelial tumour, 
involving loss of differentiation, enhanced proliferation and the active 
migration of a subset of cancer cells escaping the primary tumour 
through the surrounding matrix and stromal cells, and finally 
intravasating into the bloodstream. In order to colonise a new site, 
cells need to survive the hostile physical and immune environment of 
the circulation and extravasate into a new tissue. 
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Many aspects of metastasis are not fully understood, such as when and how 
frequent is the escape of cells into the circulation, what is the efficiency of 
these cells embedding in a new location, what controls the dormancy period 
between metastatic colonisation and development, what is the stem cell nature 
of cells leading to successful metastases, and how permanent is the metastatic 
phenotype? Cancer is a generic term for over 200 hundred different diseases and 
it seems likely that each will utilise varying mechanisms to spread from a 
primary site.  
 
1.1.2 Cell invasion 
1.1.2.1 Invasion occurs in multiple contexts 
Cell invasion can be regarded as the pronounced movement of cells through a 
tissue. Invasion occurs at multiple stages of metastasis – during the movement of 
cells into the immediate surrounding tissue, through a basement membrane, into 
and out of a blood or lymphatic vessel, and into the tissue of the secondary site. 
It is, however, a process not restricted to tumour progression, but occurs in a 
number of developmental and physiological contexts. Furthermore, direct 
parallels can often be made between the molecular mechanisms of invasion 
during healthy and pathological states. For example, during human pregnancy, 
the developing blastocyst implants into the uterine wall using highly migratory 
invasive trophoblast cells, which during this time express many genes shown to 
promote tumour cell invasion, such as the transcription factor c-fos, the GTPase 
and proto-oncogene Ras, the growth factor receptor EGFR and the matrix 
metalloproteinase MMP9 (Ferretti, Bruni et al. 2007). During immune responses, 
haematopoietic cells extravasate from the bloodstream to invade in a co-
ordinated fashion to sites of infection. The cellular and biochemical similarities 
between wound healing and tumour cell invasion have been noted for some time 
and these similarities have more recently been extended to the genetic level 
(Pedersen, Leethanakul et al. 2003; Chang, Sneddon et al. 2004). During 
embryogenesis, the directed migration of highly motile neural crest cells 
involves modulation of expression of the cell-cell adhesion molecule N-Cadherin 
(Kuriyama and Mayor 2008). Such changes in cadherin mediated cell-cell 
19 
contacts also occur in many invasive tumour cells, often involving loss of E-
Cadherin. Tumour cell invasion can therefore be thought of as a scenario in 
which normal cellular behaviours occur in a mis-regulated manner and in an 
inappropriate context. 
Although the concept of a tumour cell moving through a tissue seems a simple 
one, recent research including the utilisation of novel imaging techniques (Sahai 
2007), has shown there are a myriad of diverse ways in which this could happen 
in human cancers (Friedl and Wolf 2003). 
 
1.1.2.2 A 2D model of cell movement 
The detailed investigation of tumour cell invasion mechanisms in 3D 
environments has followed decades of analysis of cell movement on 2D surfaces. 
Numerous primary cells and established cell lines, both ‘normal’ and tumour-
derived, have been used to study cell migration including neutrophils, 
macrophages, fibroblasts, epithelial cells and non-mammalian cells such as 
Dictyostelium and fish keratocytes. This research has lead to a broad model of 
cell movement that involves 4 basic steps (Fig. 1.2) (Ridley, Schwartz et al. 
2003). First, cells extend a leading edge in the direction of movement, followed 
by adhesion of this leading edge to the substrate. Finally, the cell body contracts 
to pull the cell forward and the rear of the cell detaches from the substrate. 
Despite a common use of this strategy, different cell types can have markedly 
different morphologies when viewed by timelapse microscopy moving across a 
surface and this can be explained in part by differing spatiotemporal co-
ordination of the 4 basic steps and by the relative contributions of the multitude 
of molecular mechanisms that govern cell propulsion discussed below. Some 
cells move as an ‘inchworm’, with all extension, adhesion and contraction 
occurring in distinct steps, while other cells appear to crawl along a surface as 
these steps occur rapidly and simultaneously across the lateral line of the cell. 
The speed of migration also varies enormously between different cell types. On 
2D tissue culture plastic, neutrophils move at around 5 µm/min, while 
macrophages and fibroblasts are much slower at approximately 0.5 µm/min, and 
fish keratocytes very nimble at about 20 µm/min. How the model of 2D 
migration translates into a 3D context is the subject of extensive investigation. 
20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 – Basic cell movement 
 
Cells appear to move in a multitude of ways, but there are common 
processes to all of them. Cells first extend, using lamellipodia or 
pseudopodia driven by actin polymerisation, and then make new 
adhesions to the matrix. Contraction occurs by means of actin-myosin 
filaments and dissolution of rear adhesions allows the cell body to 
move forward. Movement in 3 dimensions is likely to be a far more 
complex process and show even greater variety between cell types. 
 
 
 
 
 
21 
1.1.2.3 Actin based cell movement 
Cell movement is largely dictated by the actin cytoskeleton, a highly dynamic 
structure that together with the cell membrane and hydrostatic pressure largely 
maintains the cell’s form (Le Clainche and Carlier 2008). The protrusive force of 
leading edge extension is generated by polymerisation of globular ‘G-actin’ 
subunits into filamentous ‘F-actin’. ATP-bound actin monomers bind the ‘plus’ or 
‘barbed’ end of actin filaments and the resulting polymerisation hydrolyses the 
ATP so that the ‘minus’ or ‘pointed’ end of the filament is ADP bound (Fig. 1.3). 
Actin assembly is a system of treadmilling involving simultaneous polymerisation 
at the plus end and depolymerisation at the minus end, meaning the filament 
effectively moves forward while maintaining a constant length. The size, 
distribution and treadmilling rate of actin filaments determines their protrusive 
force, and this is regulated by proteins from a number of different families. 
These include the formins such as mDia2, and members of the Ena/VASP family, 
which both facilitate the addition of actin monomers to the plus ends of growing 
actin filaments, and the Arp2/3 complex, which promotes the formation of new 
actin filaments branching at a 70o angle from existing filaments. Other 
regulators of actin dynamics include cofilin, which acts both to enhance 
depolymerisation of the minus end of actin filaments, thus elevating the G-actin 
monomer pool for polymerisation at the plus end, and to sever F-actin filaments 
to create new sites of Arp2/3 complex promoted branches. Another protein, 
profilin, binds and incorporates monomeric actin to the growing plus ends of the 
actin filaments to which it localises. Ena/VASP proteins are thought to 
antagonise both the growth inhibitory capping of actin filaments by proteins 
such as CapZ and the branching of actin filaments by the Arp2/3 complex. This, 
like the actin nucleation enhanced by the formins, leads to elongation of the 
linear actin filaments that constitute actin stress fibres and cellular protrusions 
such as filopdia and microvilli. In contrast, Arp2/3 complex activation promotes 
the dense network of branched actin characteristic of broad protrusions termed 
lamellipodia and highly dynamic structures termed ruffles. The Arp2/3 complex 
was discovered in Acanthamoeba as a profilin binding protein (Machesky, 
Atkinson et al. 1994) and has since been shown to be positively regulated by 
interaction with WH2 domain containing proteins of the SCAR/WAVE (WAVE 1, 2, 
3) and WASP (WASP and N-WASP) families. Binding of these proteins to the 
Arp2/3 complex occurs via their CA domains (cofilin-like and acidic) and binding  
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Figure 1.3 – Actin polymerisation 
 
Simple schematic diagram of the regulation of actin polymerisation leading to 
lamellipodia formation. GEFs link extracellular signals to Rho family GTPase 
activation and downstream activation of effectors such as wave/scar and PAK, 
which act to both stimulate arp2/3 complex mediated actin polymerisation at new 
branches and to limit depolymerisation of actin at the minus end of existing 
filaments. Actin monomers undergo a rapid cycling from ADP to ATP bound forms 
that is promoted by profilin and favours recycling of actin from the minus end to the 
growing plus end of filaments. Actin polymerisation drives propulsive force against 
the plasma membrane that promotes cell movement. Blue hexagon represents the 
arp2/3 complex; green stars represent the actin severing protein cofilin. 
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of monomeric actin occurs via their V domain (verprolin-homology) and this 
facilitates Arp2/3 catalytic activity. WASP family proteins are all multi-domain 
proteins that directly or indirectly link Arp2/3 complex activity to various 
regulatory proteins such as the Rho family of small GTPases, as discussed below. 
Contraction of the cell body following extension and adhesion requires the ATP 
dependent relative movement of interacting myosin and actin filaments. Control 
of the actin cytoskeleton during cell movement by these proteins is highly co-
ordinated, but it is also quite a malleable system and attenuation of one 
mechanism of protrusion and propulsion can often result in the employment of 
another without absolute loss of cell function. 
 
1.1.2.4 Studying modes of cell invasion 
Tumour cell invasion occurs in 3 dimensions. The behaviour of cells in 3D has 
been studied within reconstituted extracellular matrices such as collagen and 
matrigel (Smalley, Lioni et al. 2006), in animal models amenable to microscopic 
visualisation such as the transparent zebrafish (Beis and Stainier 2006) and also 
deep within intact mouse tissues using advanced fluorescent microscopy 
techniques (Sidani, Wyckoff et al. 2006; Sahai 2007). One particularly prevalent 
system has been the matrigel invasion assay (Albini, Benelli et al. 2004), a 
modified version of which is used extensively in this study. Matrigel is a 
basement membrane type matrix composed of laminin, collagen IV, heparin 
sulphate proteoglycans, entactin and a range of growth factors extracted from 
the Engelbreth-Holm-Swarm (EHS) mouse sarcoma (BD Biosciences). While it 
does not recreate the comprehensive heterogeneous complement of cell types 
and matrix types that exist in intact tissues, it has been used in a variety of 
systems to better recapitulate the in vivo environment than 2D tissue culture 
plastic. For example, an immortalised human breast cell line can be cultured in 
matrigel to differentiate into acini that are highly representative of human 
tissue with regard to both cell architecture and function, to the point that they 
secrete milk proteins from their apical surface. The invasion assay used in the 
current study is summarised in Fig. 1.4. Cells are seeded on to the underside of a 
transwell filter with 8 µm diameter pores through which cells can migrate and 
then move up into the overlying matrigel plug. Despite its simplicity, an  
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Figure 1.4 – Matrigel chemoinvasion assay 
 
Representation of the ‘inverse’ invasion assay used in this investigation. 
Cells are seeded on the outer side of a transwell into which matrigel is 
placed in the transwell. Above the matrigel is added a chemoattractant and 
below the matrigel, serum free media. Cells migrate through the pores in 
the transwell and invade into the matrigel. Invading cells can be visualised 
after staining with fluorescent dyes. 
 
 
 
advantage of the system is its versatility with respect to cell visualisation and 
manipulation of experimental conditions e.g. use of different growth factors, 
chemical inhibitors, cell types and their gene expression. 
Three modes of 3D cell invasion - elongated, amoeboid and collective - have 
been described based on simple morphologies and characterised by their 
dependence on different molecular pathways and processes (Fig. 1.5) (Friedl and 
Wolf 2003). Like many biological classifications made through empirical 
observation, these 3 modes are likely to be points on a scale rather than  
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Figure 1.5 – Depiction of mesenchymal and 
amoeboid invasion 
 
Simple schematic of differing modes of individual cell invasion. These 
modes have a different degree of plasticity in different cells depending 
on the microenvironment and can be manipulated by inhibition of 
specific signalling pathways and processes. For example, inhibition of 
extracellular matrix degradation can convert mesenchymal cells to 
amoeboid cells, while inhibition of Rho signalling can convert 
amoeboid cells to mesenchymal cells. 
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absolute and distinct from each other. Elongated movement, as used by MDA-
MB-231 carcinoma cells, involves a long and narrow morphology aligned with the 
direction of motility, a dependence on Rac and Cdc42 signalling, integrin 
clustering and matrix protease activity. Rac activity is required for protrusive 
actin polymerisation and Cdc42 is important in defining polarity, largely through 
its positioning of the microtubule-organising centre (MTOC) between the nucleus 
and the leading edge. Elongated cell movement is characteristic of cells that 
have undergone epithelial to mesenchymal transition (EMT), a transcriptionally 
regulated event that occurs during development and often during tumour 
progression. Cells moving in an amoeboid mode, such as HT1080 fibrosarcoma 
and A375 melanoma cells, are rounder and more reliant on Rho and ROCK 
activity and acto-myosin contraction to remodel the cytoskeleton and propel 
them through gaps between matrix fibres without digestion (Sahai and Marshall 
2003; Wolf, Mazo et al. 2003). This is similar to the mechanism used by 
leukocytes (Friedl and Wolf 2003). Collective cell movement occurs when cell-
cell adhesions such as adherens junctions remain intact while a group of cells 
move as a single cluster or sheet.  
Although most cells possess an inherent ability to move, and under in vitro cell 
culture conditions often move with no distinct cue, many instances of tumour 
cell or physiological cell motility proceed by chemotaxis toward a source of 
extracellular ligand. Growth factors such as EGF, HGF and PDGF bind and 
activate tyrosine receptor kinases to stimulate downstream responses leading to 
Rho GTPase family activation and subsequent actin remodelling. In the case of 
tumour cells, the source of these chemotactic agents can be stationary stromal 
tissues but can also be co-migrating non-tumour cells. For example, breast 
carcinoma cells have been shown to attract macrophages with CSF-1, which in 
turn attract the tumour cells with secreted EGF (Wyckoff, Wang et al. 2004).  
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1.2 RhoGTPases 
The Rho family are members of the Ras superfamily of small GTPases, signalling 
proteins that act as molecular switches to activate various downstream effectors 
and signalling pathways (Wennerberg, Rossman et al. 2005). There are 
approximately 20 members of the Rho family that can be divided into 6 groups, 
the Rho-like, Rac-like, Cdc42-like, Rnd, RhoBTB and Miro proteins, of which 
RhoA, Rac1 and Cdc42 are the best characterised (Wherlock and Mellor 2002; 
Hall 2005).  
GTPases cycle between an inactive GDP-bound state and an active GTP-bound 
state and this is regulated by 3 classes of protein – guanine nucleotide exchange 
factors (GEFs), gtpase activating proteins (GAPs) and guanine nucleotide 
dissociation inhibitors (GDIs), Fig. 1.6. Of these, GEFs are the most intensely 
investigated and are thought to be most pertinent to the regulation of GTPase 
activity. GEFs activate GTPases by stabilising their nucleotide free form and 
allowing them to bind the GTP that is at a high intracellular concentration 
relative to GDP. GAPs enhance the intrinsic hydrolytic activity of GTP-bound 
GTPases, reducing them to the inactive GDP-bound form. GDI’s limit the 
function of GTPases by sequestering them from the active pool.  
GTP binding induces a conformational change that allows GTPases to interact 
with and activate downstream effectors. Rho GTPase activation has effects on 
many processes including cell cycle progression, reactive oxygen species 
generation, apoptosis, membrane trafficking and transcription. However, it is 
their influence on cytoskeletal rearrangements that has been most widely 
studied (Raftopoulou and Hall 2004).  
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Figure 1.6 – Regulation of GTPase activity by GEFs, 
GAPs and GDIs 
 
GTPases cycle between a GTP-bound active form and a GDP-bound inactive form. 
The formation of GTP-bound GTPases is promoted by guanine nucleotide 
exchange factors (GEFs), which catalyses the dissociation of GDP from the 
GTPase, allowing GTP to bind. GTPase activating proteins (GAPs) enhance the 
GTPase activity to return it to the inactive GDP-bound form.  A third class of 
regulatory proteins, the guanine nucleotide dissociation inhibitors (GDIs) sequester 
the GDP-bound form of GTPase making it unable to interact with GEFs. 
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1.2.1 RhoGTPases in motility, invasion and cancer 
1.2.1.1 RhoGTPases control actin dynamics 
Protein microinjection studies in the early 1990s made valuable insights into the 
role of RhoGTPases on regulation of cell morphology. Microinjection of RhoA 
protein promotes actin stress fibre formation in serum starved fibroblasts and 
conversely, serum induced stress fibre formation can be prevented inhibition of 
Rho function by treatment with C3 transferase, an exoenzyme that ADP-
ribosylates Rho (Ridley and Hall 1992). Rho-like proteins activate the formin 
mDia and Rho Kinase (ROCK), which activates LIM kinase, leading to cofilin 
inactivation. This favours actin filament stabilisation and polymerisation. 
Activated ROCK also phosphorylates myosin light chain and inactivates myosin 
light chain phosphatase to enhance contractility and provide tension that 
stimulates formation of actin stress fibres and focal adhesions. Cdc42-like 
proteins stimulate formation of filopodia (Kozma, Ahmed et al. 1995). This 
occurs by formin and Ena/Vasp activation and by direct binding to WASP, which 
promotes Arp2/3 mediated actin polymerisation. The Rac proteins, comprising 
Rac1, Rac2, Rac3 and the splice variant Rac1b, stimulate formation of 
lamellipodia and actin ruffles and endogenous ruffling can be inhibited by 
expression of the dominant negative mutant RacN17 (Ridley, Paterson et al. 
1992). Downstream effectors of Rac include the WASP family member 
Scar/WAVE, leading to Arp2/3 complex activation as described above. Unlike 
Cdc42, which directly binds WASP, Rac activates Scar/WAVE indirectly both 
through the scaffold protein IRSp53 and by dissociating it from the inhibitory 
complex of Nap125, PIR121 and Abi2. Rac also activates the serine/threonine 
kinase PAK, which modifies the cytoskeleton through its downstream effectors 
such as LIM kinase, paxillin and Nck.  
Various experimental approaches have been utilised to study Rho family GTPase 
function, including specific small molecule and protein inhibitors such as the 
Rac1 inhibitor NSC23766 and the Rho inhibitor C3 transferase; dominant negative 
forms of GTPases such as RacN17 and RhoN19 that are thought to sequester their 
respective exchange factors (Feig 1999); RNAi based inhibition of expression; 
and whole organisms and tissue specific mouse gene knockouts. 
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The Rac1 knockout mouse is embryonic lethal and developing embryos do not 
progress past E9.5, with a high incidence of apoptotic cell death in the 
mesoderm during gastrulation (Sugihara, Nakatsuji et al. 1998). Primary epiblast 
cells derived from E6.5 Rac-/- embryos do not form lamellipodia or membrane 
ruffles, but retain filopodia and display vigorous membrane blebbing and die 
after 40 hrs in culture. Tissue and cell type specific Rac knockouts have been 
generated in order to circumvent the lethality of Rac1 null mice, most notably 
with macrophages. Conditional knockout of Rac1 in macrophages reveals that 
while certain cell morphologies are dependent of Rac1, the cells are still able to 
migrate efficiently (Wells, Walmsley et al. 2004). Rac1-/- macrophages are more 
elongated, with less extensive lamellipodial extensions. Membrane ruffling is 
reduced upon Rac1 knockout and can be further inhibited by expression of 
dominant negative Cdc42N17, but in neither of these situations is ruffling in 
response to CSF-1 completely absent. Surprisingly, random cell migration and 
chemotaxis towards CSF-1 is unaffected by Rac1 knockout in macrophages. 
Simultaneous knockout of Rac1 and Rac2 in macrophages, which do not express 
Rac3, further reduces but does not entirely ablate membrane ruffling (Wheeler, 
Wells et al. 2006). Rac1/2-/- macrophages are still able to respond to CSF-1 
gradients and have increased persistence of random migration, consistent with 
experiments in fibroblasts, which have elevated persistence of movement upon 
Rac1 RNAi (Pankov, Endo et al. 2005). Interestingly, Rac1/2-/-, but not Rac2-/- 
macrophages are impaired in their ability to invade matrigel, demonstrating that 
in these cells, Rac1 acts to preferentially facilitate 3D migration rather than 2D 
migration. As discussed, 3D migration is more complex than 2D migration and the 
dependence on Rac1 for matrigel invasion may involve processes such as matrix 
degradation as well as its role in actin generated protrusive force. While Rac1 is 
ubiquitously expressed, Rac2 expression is restricted to the haematopoietic 
lineage. Rac2 knockout mice develop normally, but their neutrophils have a 
severe defect in reactive oxygen species (ROS) generation by the NADPH oxidase 
complex, reduced capacity for chemotaxis, integrin mediated cell spreading, 
and actin polymerisation (Roberts, Kim et al. 1999). These phenotypes show 
some degree of overlap with the phenotype of the P-Rex1 knockout mouse, as 
discussed later (Dong, Mo et al. 2005; Welch, Condliffe et al. 2005). The in vitro 
migratory phenotypes observed upon reducing Rac activity in neutrophils could 
be more severe than those observed in macrophages because neutrophils move 
over 10 times faster than macrophages. Rac1-/- mouse embryonic fibroblasts 
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(MEFs) also have a severe migratory and morphological phenotype, moving at 
approximately a third of the speed of wild type MEFs and rarely forming 
lamellipodia or ruffles (Vidali, Chen et al. 2006). Compared to ubiquitous Rac1 
expression, Rac3 is restricted to neural tissues and Rac3 knockout mice have no 
physiological or histological abnormalities but do have some modest behavioural 
phenotypes (Bolis, Corbetta et al. 2003; Corbetta, Gualdoni et al. 2005).  
One interesting conclusion from studying cells derived from Rac knockout mice is 
that membrane ruffling capacity does not correlate with capacity for cell 
migration, at least in 2 dimensions. The structure and regulation of membrane 
ruffles has been studied in enormous detail, but the actual function of these 
structures is still not entirely understood. With an increasing emphasis on 
describing cell movement and cell structures in 3 dimensions, it is becoming 
clear that membrane ruffles and broad lamellipodial extensions are simply not 
often observed in 3D. Instead of being directly analogous to cellular structures 
within 3D environments, membrane ruffles are perhaps more likely to be 
indicative of a certain cell process, such as protrusive force or 
pinocytosis/phagocytosis. 
A key feature of directed cell movement is cell polarity. Polarity can be forced 
upon a cell by a chemical gradient, a non-homogenous arrangement of matrix 
proteins, differing physical forces e.g. the sheer stress of the vasculature, or by 
an asymmetric distribution of cells e.g. the free edge created by a wound. To a 
varying extent, cells also possess inherent polarity. Fish keratocytes in particular 
show a remarkable aptitude for crawling along with a broad leading 
lamellipodium in a persistent direction with no external stimulus (Small, Herzog 
et al. 1995).  Extrinsic and intrinsic factors work together in a number of positive 
and negative feedback systems to promote and maintain polarity, most notably 
through the restriction of Rac mediated actin polymerisation to the leading 
egde. Rac is activated downstream of the lipid messenger PIP3 by GEFs (such as 
P-Rex1, as discussed later), but Rac activity itself can activate PI3 kinase to 
increase PIP3 levels. At least in neutrophils, this leads to a positive feedback 
loop that has been proposed to be further enhanced by PIP3 accumulation 
following actin polymerisation (Wang, Herzmark et al. 2002; Weiner, Neilsen et 
al. 2002). In another positive feedback loop, integrin engagement leads to Rac 
activation, via GEFs, which leads to lamellipodia formation and the promotion of 
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new adhesions and further integrin engagement at the leading edge (Moissoglu 
and Schwartz 2006).  
 
1.2.1.2 RhoGTPases and cancer 
Rho GTPases including Rac are key regulators of a wide array of cellular 
processes and their deregulation has been implicated in a number of aspects of 
tumourigenesis including cell survival, growth, cell cycle progression and 
invasion (Ridley 2004). Unlike Ras GTPases, the 3 isoforms of which are 
commonly mutated in human tumours, there have been almost no mutations of 
Rho GTPases associated with cancer, the exception being a rearrangement of 
the RhoH gene in non-Hodgkin’s lymphomas and multiple myeloma (Preudhomme 
wt. al 2000). Overexpression of Rho family members is a far more common 
occurrence, such as elevated levels of RhoC observed in metastatic melanoma 
and gastric carcinomas (Clark, Golub et al. 2000), RhoA in breast and testicular 
cancers (Simpson, Dugan et al. 2004), Rac1 and Rac3 in prostate and breast 
cancers (Engers, Ziegler et al. 2007) and the splice variant Rac1b in colorectal 
and breast cancers (Jordan, Brazao et al. 1999). Although many expression 
analysis studies are purely correlative, there is much supporting functional 
experimental evidence for a role of Rho GTPases and their respective GEFs in 
cancer, particularly in cell motility and invasion through their influence on the 
actin cytoskeleton (Olson and Sahai 2008). 
 
1.2.1.3 Rac GEFs in cancer, motility and invasion 
Since the discovery that the dbl oncogene product acts as a GEF for Cdc42 (Hart, 
Eva et al. 1991), numerous GEFs have been implicated in tumourigenesis. In 
particular, many GEFs for Rac have been demonstrated to modulate cell motility 
and invasion. Of these Tiam1, originally identified through a proviral insertion 
tagging screen for invasion inducing genes in T-cell lymphoma cells (Habets, 
Scholtes et al. 1994), has been most widely studied and has been shown to 
possess both pro- and anti-invasive properties. Upon overexpression, Tiam1 or 
active RacV12 induces invasion of lymphoma cells (Michiels, Habets et al. 1995) 
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and membrane ruffling and transformation of NIH3T3 fibroblasts (van Leeuwen, 
van der Kammen et al. 1995). However, overexpression of active C1199 Tiam1, 
but not inactive C580 Tiam1, in Madin-Darby canine kidney (MDCK) epithelial 
cells results in its localisation to adherens junctions, promotion of E-Cadherin 
adhesions and a subsequent inhibition of scattering in response to HGF (Hordijk, 
ten Klooster et al. 1997). This pro-adhesive, anti-migratory phenotype occurs on 
fibronectin and laminin1 matrices but not on collagen, where the effects are 
pro-migratory (Sander, van Delft et al. 1998). Tiam1 -/- mice develop normally, 
but are highly resistant to the initiation and growth of Ras-induced skin tumours 
formed by application of the carcinogen DMBA, which causes activating H-Ras 
mutations, and the tumour promoter TPA (Malliri, van der Kammen et al. 2002). 
Interestingly, the tumours that do develop in Tiam1 -/- mice have a higher 
frequency of invasive and malignant progression and the acquisition of this 
phenotype in Tiam1 +/+ mice corresponds to a reduction in Tiam1 expression. An 
in vitro study has shown that Tiam1 overexpression inhibits the migration and 
invasion of human melanoma derived cell lines by upregulating ALCAM cell 
adhesions (Uhlenbrock, Eberth et al. 2004), while a seemingly contradictory 
study shows active Tiam1 expression to promote migration and experimental 
metastasis of colon carcinoma cells (Minard, Herynk et al. 2005). This suggests 
that the effects of active Tiam1 overexpression are both cell type and matrix 
type dependent. Elevated levels of Tiam1 have been observed in breast and 
prostate cancers (Engers, Mueller et al. 2006). Other GEFs implicated in cancer 
and invasion include the Rac/Cdc42 GEF Geft, which induces foci formation and 
enhanced proliferation and migration upon overexpression in NIH3T3 fibroblasts 
(Guo, Stafford et al. 2003). The Vav family of Rac GEFs include Vav1, which like 
P-Rex1 is predominantly expressed in the haematopoietic system, and Vav2 and 
Vav3 which are more widely expressed. Vav1 expression has been implicated in 
pancreatic cancer tumourigenesis (Denicola and Tuveson 2005), Vav2 has been 
shown to promote Rac dependent motility and invasion of head and neck 
squamous cell carcinoma cells (Patel, Rosenfeldt et al. 2007) and Vav3 
modulates cell morphology and induces transformation (Zeng, Sachdev et al. 
2000). Knockdown of Vav1 or Vav2 in some melanoma cells has been shown to 
reduce Rac and Rho activation with a concomitant inhibition of invasion 
(Bartolome, Molina-Ortiz et al. 2006). Asef is a GEF with demonstrated activity 
towards Rac and Cdc42. It is activated by APC and has been shown to promote 
the migration of colorectal tumour cells but also to harbour tumour suppressive 
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growth activity in vitro (Kawasaki, Sato et al. 2003; Mitin, Betts et al. 2007). 
Dock180 is a member of a newly characterised family of GEFs that lack a DH and 
instead possess a Docker domain. It forms a bipartite Rac GEF with Elmo1 that 
promotes glioma cell invasion (Jarzynka, Hu et al. 2007). Also, the Rac/Cdc42 
GEF betaPIX has been shown to be overexpressed in breast cancer (Ahn, Chung 
et al. 2003). Given the large number of Rac GEFs and their crucial role in GTPase 
activation, it seems likely that more members of the family will be found to 
have roles in tumour cell motility. 
 
 
1.3 P-Rex1 
1.3.1 Identification and structure of P-Rex1 
Most Rho family GEFs have been identified either as oncogene products or 
through bioinformatics methods (Schmidt and Hall 2002). P-Rex1 was first 
identified as a Rac specific GEF through a biochemical screen for Rac GEF 
activity in neutrophils (Welch, Coadwell et al. 2002). Cell lysates were shown to 
have PIP3-stimulated Rac-dependent ROS formation activity and were resolved 
into fractions, and their ROS forming ability was analysed. The protein of the 
active fraction was identified by MALDI-TOF analysis and the gene was 
subsequently cloned and named PIP3-dependent Rac exchanger 1.  
P-Rex1 is a 185 kDa multidomain protein comprising the tandem DH (Dbl 
homology) and PH (pleckstrin homology) domains common to most GEFs and two 
DEP (Dishevelled, EGL-10, Pleckstrin-homology) and two PDZ (postsynaptic 
density, Discs-large, ZO-1) domains and a C-terminal domain that shows high 
homology to Inositol Polyphosphate 4-Phosphatase (IP4P). A schematic 
comparison of the domain structures of P-Rex1 and another Rac GEF, Tiam1, is 
shown in Fig. 1.7. Dbl-family GEFs are characterised by their tandem DH and PH 
domains, but outside of this region their domain structure is diverse. Regions 
within DH domains, which are approximately 200 residues in length, mediate 
binding with the switch region of GTPases and the precise structure of the DH  
35 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7 – Schematics of the domain structures of 
P-Rex1 and Tiam1 
 
Although they are a structurally diverse family, a majority of GEFs have a DH 
domain, which mediates binding to the RhoGTPases. Many also contain a PH 
domain for lipid binding. DH Dbl homology domain, PH pleckstrin homology, domain, 
CC coiled-coil domain, Ex Ex region, RBD Ras binding domain. 
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domain can confer selectivity towards specific GTPases. Despite a degree of 
diversity within the DH domains of different GEFs, their mechanism of action is 
highly conserved. Binding induces a conformational change in the GTPase that 
favours Mg2+ (a co-factor for nucleotide binding) and GDP dissociation and allows 
subsequent GTP-Mg2+ binding. DH domains are often partnered with C-terminal 
PH domains, which are approximately 100 residues in length and bind to the lipid 
products of PI3 kinase. The functions of the PH domain vary between different 
GEFs and include membrane targeting, GTPase binding, promoting protein 
interactions and facilitating regulatory events by phospholipids. P-Rex1 also 
contains two DEP domains, conserved regions of approximately 90 residues that 
are vaguely described as protein interaction domains. In addition to a proposed 
role in membrane targeting, it has been shown in yeast that the tandem DEP 
domains of an RGS protein mediate its binding to a specific GPCR in order to 
negatively regulate the receptor activity (Ballon, Flanary et al. 2006; Chen and 
Hamm 2006). At 808 residues in length, the IP4P domain constitutes 
approximately half the sequence of P-Rex1. However, it has not been 
demonstrated to possess any phosphatase activity (Hill, Krugmann et al. 2005) 
and its function is unknown beyond its recently defined role in maintaining 
intramolecular interactions important for Gβγ mediated regulation, as discussed 
later (Urano, Nakata et al. 2008). 
P-Rex1 can be synergistically activated by PIP3 and Gβγ subunits downstream of 
PI3 Kinase and GPCR, respectively (Welch, Coadwell et al. 2002). Activation of 
P-Rex1 promotes GTP loading of Rac1, Rac2 and Cdc42 in vitro (Welch, Coadwell 
et al. 2002), but is specific to Rac when expressed in cells. P-Rex1 is expressed 
at high levels in leukocytes and also in the spleen, lymph node and brain tissues. 
A homologue of P-Rex1, P-Rex2, has two splice variants (Donald, Hill et al. 2004; 
Rosenfeldt, Vazquez-Prado et al. 2004). P-Rex2a is expressed in skeletal muscle, 
small intestine and placenta, while the smaller P-Rex2b, which lacks the IP4P-
homology domain, is expressed in the heart. P-Rex2 can be stimulated to 
activate Rac by PIP3 and Gβγ subunits in the same manner as P-Rex1. 
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1.3.2 Regulation of P-Rex1 
1.3.2.1 P-Rex1 is activated by PIP3 and Gβγ subunits 
In addition to P-Rex1, there are a number of other RhoGTPase GEFs that also 
bind PIP3, including Vav, Dbl and Tiam1 and a small number that bind Gβγ 
subunits, including Dbl, Ost, Kalirin and p114 Rho-GEF (Nishida, Kaziro et al. 
1999). However, the syngergistic activation of P-Rex1 by PIP3 and Gβγ subunits is 
unique (Fig. 1.8). This syngergistic activation is especially relevant to 
neutrophils, which express PI3 kinase γ. This PI3 kinase isoform is itself 
activated by Gβγ subunits, meaning that activation of a single GPCR can elevate 
both PIP3 and Gβγ subunit levels simultaneously. The binding of PIP3 to the PH 
domain was determined by its ability to elicit Rac GEF activity in a panel of P-
Rex1 domain mutants except for one lacking the PH domain, and by a direct PIP3 
binding assay (Hill, Krugmann et al. 2005). The binding site of Gβγ subunits, 
various dimers of which bind with different affinities (Mayeenuddin, McIntire et 
al. 2006), is less clear. Cell-free in vitro Rac GTP loading assays reveal that 
removal of the PH, DEP, or PDZ domains of P-Rex1, or removal of all sequence C-
terminal from the PH domain, enhances P-Rex1’s basal level of activity, 
indicating that these domains act to suppress GEF function. Masking of the DH 
domain by the PH domain is a common autoinhibitory mechanism of GEF 
regulation (Rossman, Der et al. 2005). Point mutations in the catalytic DH 
domain at positions E56 and N238 totally abrogate P-Rex1’s activity, analogous 
to the mutations used to generate ‘GEF-dead’ Tiam1 that interrupt Rac binding 
(Worthylake, Rossman et al. 2000). All of the P-Rex1 domain mutants except for 
GEF-dead mutant respond to stimulation by Gβγ subunits, while all except the 
GEF-dead and the ΔPH mutant respond to PIP3. However, the maximal level of 
Gβγ stimulated activity is much reduced in ΔDEP, ΔPDZ and ΔIP4P mutants. 
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Figure 1.8 – Regulation of P-Rex1 
 
P-Rex1 function is positively regulated by the lipid messenger PIP3, generated by PI3 
kinase activity, and the Gβγ subunits that dissociate from the Gα subunit downstream 
of GPCR signalling. In neutrophils, which express PI3 kinase γ, activation of a single 
type of GPCR is able to elevate both Gβγ and PIP3 levels simultaneously. In other 
cell types, signalling from RTKs may also contribute 
 
 
 
 
α
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1.3.2.2 P-Rex1 activity is regulated by phosphorylation 
Most regulatory interactions of GEFs with kinases are stimulatory to their 
activity. For example, phosphorylation of Vav proteins are required for 
activation of Rac (Crespo, Schuebel et al. 1997) by relieving an autoinhibitory 
masking of the catalytic DH domain (Aghazadeh, Lowry et al. 2000). However, 
phosphorylation of P-Rex1 by the cAMP dependent kinase PKA inhibits Gβγ and 
PIP3 mediated stimulation (Mayeenuddin and Garrison 2006). 
 
1.3.3 Function of P-Rex1 
P-Rex1 constitutes 0.01 % of cytosolic protein in neutrophils and reducing P-Rex1 
expression in a neutrophil-like cell line by siRNA strongly inhibits GPCR mediated 
C5a-stimulated ROS formation (Welch, Coadwell et al. 2002). Neutrophils from 
the P-Rex1 -/- mouse show mildly and more significantly reduced levels of Rac1 
and Rac2 activation respectively, and display a reduced formation of GPCR 
stimulated ROS (Dong, Mo et al. 2005; Welch, Condliffe et al. 2005). The role of 
neutrophils is to rapidly and efficiently migrate to sites of infection to combat 
pathogenic bacteria and fungi; as such they are extremely motile cells that are 
highly sensitive to chemotactic gradients. Although it had been hypothesised 
that ablation of P-Rex1 expression would have a dramatic effect on the GPCR 
mediated chemotaxis of neutrophils, P-Rex1 -/- neutrophils have a modest 
reduction in transwell migration towards C5a and no defect at all towards fMLP. 
This is due not to a reduced capacity to sense chemotactic gradients, but rather 
an approximate 10 % reduction in cell speed towards such a gradient. In 
chemokinetic conditions where no gradient exists, cell speed is reduced by 
approximately 30 %. The morphology of neutrophils upon P-Rex1 knockout is 
largely unaffected, with a slight reduction in GPCR mediated actin 
polymerisation. As discussed above, cell movement and translocation within real 
tissues and organs is much more complex than most 2D in vitro cell based assays 
can recapitulate. It is within this whole animal context that P-Rex1 -/- 
neutrophils have the strongest phenotype, showing a 50 % reduction in their 
recruitment to sites of inflammation. Consistent with its role as a Rac GEF, 
overexpression of P-Rex1 in porcine aortic endothelial (PAE) cells induces 
40 
membrane ruffling and lamellipodia formation (Welch, Coadwell et al. 2002). 
Other than the described neutrophil phenotype, P-Rex1 knockout mice have 
been reported as developing healthily, but with a 14 % decrease in weight age 10 
weeks and a 61 % increase in peripheral neutrophil number over wild type mice 
(Welch, Condliffe et al. 2005). 
At the time of commencing this investigation, the function of P-Rex1 in other 
cell types and physiological contexts was unknown. Since that time, a number of 
studies have further described its cellular functions, especially within cell 
migration and cytoskeleton dynamics. How these studies relate to results 
presented here is discussed in Chapter 6. 
 
 
1.4 Melanoma 
During the course of the current investigation, it was observed that expression of 
P-Rex1 was consistently highly expressed in a number of melanoma derived cell 
lines, as evidenced from the online gene expression resource of the Cancer 
Genome Anatomy project (www.cgap.nci.nih.gov). This lead to an examination 
of the function of P-Rex1 in melanoma. 
 
1.4.1 Melanoma development and progression 
Cutaneous melanomas arise from melanocytes in the skin, which reside in the 
basal layer of the epidermis and hair follicles. There are 132,000 cases of 
melanoma worldwide each year and although the prognosis is good if caught 
early, diagnosis with aggressive malignant melanoma precedes an average 6 
month survival rate (Gray-Schopfer, Wellbrock et al. 2007). 
Melanoma is commonly envisaged to proceed along a stepwise path of 
progression starting with proliferation of melanocytes to become a benign 
naevus, commonly known as a mole. This spreads laterally, termed the radial 
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growth phase (RGP) and then down into the dermis and through the basement 
membrane, termed the vertical growth phase (VGP). Finally, aggressive invasion 
and vascularisation of the tumour leads to metastasis (Gaggioli and Sahai 2007). 
Mutation and deregulation of numerous genes have been implicated in melanoma 
initiation and progression. Activating mutations in B-Raf are found in 50-70 % of 
melanomas and N-Ras activating mutations are found in approximately 20 % of 
melanomas, both of which stimulate the MAP Kinase pathway to elevate pERK 
levels and promotion of cell growth, survival and motility. Akt activity is also 
commonly upregulated following either its overexpression, or through loss or 
mutation of PTEN, which normally acts to limit the PIP3 signalling generated 
downstream of PI3 kinase. Aberrant signalling from such pro-growth pathways 
can lead to senescence, a protective mechanism that is overcome by cancer 
through loss of tumour suppressors including p53 and the cdkN2A locus that 
encodes p16INK4a and p14ARF, which signal through the pRB and p53 pathways, 
respectively. Although these genes and pathways clearly have an important 
function in melanoma, their involvement in specifically promoting progression to 
the invasive stage is unclear. Invasive melanoma cells are thought to have 
altered adhesion, motility and sensitivity to chemotactic and chemokinetic 
growth factors. Much functional and expression analysis of E-cadherin in 
melanoma cell lines suggests an invasion suppressive role for this cell adhesion 
molecule in melanoma cell lines, although immunohistological evidence from 
tumour samples supporting a correlation between loss of e-cadherin and tumour 
progression is mixed.  A variety of growth factors and cytokines are thought to 
promote melanoma invasion. For example, expression of the HGF receptor c-Met 
has been positively correlated with stage of melanoma development and HGF is 
able to induce invasion of melanoma derived cell lines. 
 
1.4.2 Modelling melanoma in mice 
A number of mouse models of melanoma have been developed, driven by 
expression and deletion of different oncogenes and tumour suppressors, 
respectively, or by chemical and UV mutagenesis. Ectopic expression of HGF 
under the melanocyte specific MT-1 promoter is sufficient to cause malignant 
melanoma in mice (Otsuka, Takayama et al. 1998). The tyrosinase promoter, 
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which is specifically active in melanocytes, has been used to express mutant H-
Ras expression, resulting in melanocytes hyperproliferation (Powell, Hyman et 
al. 1995). With INK4a deficiency or activated CDK4 and UV stimulation, this leads 
to melanoma formation (Hacker, Muller et al. 2006) that is dependent on PI3 
kinase and MAP kinase signalling (Bedogni, Welford et al. 2006). Expression of 
activated N-RasQ61K under the control of the melanocyte specific tyrosinase 
promoter causes a hyperproliferative melanocyte phenotype and a on an INK4a-
deficient background causes a high penetrance of melanoma formation within 7 
months, over a third of which develop metastasis to lungs or liver (Ackermann, 
Frutschi et al. 2005). The progressive nature of this model makes it amenable to 
the study of both melanoma initiation and metastatic spread. 
 
1.4.3 Inhibitors and therapies 
Currently there are no routinely used clinical targeted therapies specifically 
designed to halt the motile invasive step of the metastatic process. One class of 
enzymatic inhibitors that showed promise in preclinical models but were 
unsuccessful in clinical trials are the matrix metalloproteinase inhibitors. 
Although MMPs are required for mesencymal invasion, application of MMP 
inhibitors results in a conversion to amoeboid invasion and this is one plausible 
explanation for their lack of efficacy, another being the choice of clinical trial 
criteria. Numerous chemical inhibitors have been developed against mediators of 
actin cytoskeleton signalling and function, such as the ROCK inhibitor Y-27632 
(Uehata, Ishizaki et al. 1997), and compounds such as migrastatin analogues are 
able to reduce Rac activation with a concomitant inhibition of in vitro tumour 
cell migration and experimental metastasis in mice (Shan, Chen et al. 2005). 
Most of these compounds remain in the domain of research tools. There are a 
number of anti-cancer compounds in clinical trials that could be envisaged to 
inhibit cell migration/invasion, but as key signalling pathways often affect 
multiple cell behaviours, migration is rarely the rational target. For example, PI3 
kinase inhibitors affect cell migration but are in clinical trials for their effects on 
the Akt/mTOR pathway that promotes cell growth and survival. Most clinical 
trial therapies to treat melanoma are currently focused on raising the immune 
response against melanoma cells, either by general elevation of the immune 
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system by treatment with Interferon or peptides such as the Toll-like receptor 
agonist 852A, or more specifically to melanoma cells by using peptides of 
melanocyte-lineage specific proteins such as MART-1, GP100 and Tyrosinase as 
antigens (www.clinicaltrials.gov). Dacarbazine, an alkylating agent, is currently 
the only chemotherapeutic drug licensed by the FDA for treatment of advanced 
melanoma, this being used as an adjuvant therapy to surgical excision 
(www.fda.gov). 
 In a clinical setting inhibition of GTPases themselves may elicit unwanted side-
effects due to their involvement in numerous and diverse cellular and 
physiological processes. Specific inhibition of their regulators such GEFs, which 
show a more restricted cell and tissue expression pattern, could be more 
advantageous targeted therapy.
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1.5 Aims 
 
There is much evidence supporting a role for Rho family GTPases and their 
respective GEFs in the regulation of cell morphology and migration. Despite a 
common ability to promote the activity of Rho-GTPases, GEFs are a structurally 
and functionally diverse family of proteins with a wide variation in tissue 
expression. How this group of proteins co-ordinate with each other and with 
other molecules to control Rho-GTPase activity is not fully understood. 
Over 70 Rho-GEFs have been identified in the human genome by bioinformatics, 
but the basic functions of many have been not been fully characterised (Rossman 
KL et al. 2005).  
Previous work in this lab has identified the Rac GEF P-Rex1 as being 
transcriptionally upregulated in human fibroblasts made invasive by expression 
of the v-Fos or H-RasV12 oncogenes. This, together with extensive literature 
implicating Rac and its GEFs in the control of migration and invasion, supports 
the investigation of the role of P-Rex1 in these processes. 
Understanding better the contribution of specific Rho-GTPases and their GEFs to 
tumour invasion should benefit the treatment of cancer patients either through 
expansion of diagnostic tools or the development of therapeutic interventions. 
The aims of this project are to examine a potential role for the Rac GEF P-Rex1 
in cell migration and invasion. 
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2 Chapter 2: Materials and Methods 
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2.1 Commonly used solutions and media 
Solution 
 
Ingredients 
Phosphate Buffered Saline (PBS) 170 mM NaCl, 3.3 mM KCl, 1.8 mM Na2HPO4, 
10.6 mM H2PO4 
 
PBS-T PBS + 0.1 % Triton X-100 
 
Tris-Buffered Saline (TBS) 10 mM Tris-HCl, pH 7.4, 150 mM NaCl 
 
TBST TBS + 0.1 % Tween-20 
 
L-Broth (LB) 1 % Bacto-tryptone, 86 mM NaCl, 0.5 % yeast 
extract 
 
LB Agar LB + 1.5 % agar 
 
Tris-EDTA (TE) 10 mM Tris-HCl, pH 8.0, 1 mM EDTA 
 
Tris-acetate-EDTA (TAE) 
 
40 mM Tris, 0.1 % glacial acetic acid, 1mM 
EDTA 
 
2 X Western Sample Buffer 100 mM Tris, pH6.8, 2 % SDS, 5 % B-
mercaptoethanol, 15 % glycerol, bromophenol 
blue 
 
Cell Lysis Buffer 50 mM Tris HCl pH 8, 150 mM NaCl, 1 % NP-
40, 0.5 % sodium deoxycholate, 0.1 % SDS 
 
5 x Sample Loading Buffer 10 % SDS, 250 mM Tris Hcl pH 6.8, 50 % 
glycerol, 500mM β-mercaptoethanol, 0.5 % 
bromophenol blue 
 
SDS Running Buffer 
 
0.1 % SDS, 192 mM glycine, 25 mM Tris  
pH 8.3 
 
Transfer Buffer (Semi-dry) 
 
48 mM Tris, 39 mM glycine, 1.3 mM SDS, 20 
% methanol 
 
Stripping Buffer 0.2 M glycine, 1 % SDS, pH 2.5 
 
Cell Lysis Buffer, GTPase assays 
 
50 mM Tris pH 7.2 at 4 oC. 150 mM NaCl, 10 
mM MgCl2, 1 % Triton X-100, 1 mM PMSF, 1 
EDTA-free complete protease inhibitor tablet 
per 50 ml 
 
Bacterial Lysis Buffer 
 
50 mM Tris pH 8 at 4 oC, 150 mM NaCl, 1 mM 
EGT, 5 mM MgCl2, 10 % glycerol, 1 mM 
PMSF, 5 µg/ml DNAaseI, 1 EDTA-free 
complete protease inhibitor tablet per 50 ml 
 
5 X DNA Loading Buffer 
 
30 % glycerol, 0.25 % bromophenol blue 
Table 1.1 – Solutions and media 
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2.2 Antibodies and dyes 
Antibody Type Dilution Source 
 
Anti-P-Rex1 Mouse monoclonal WB – 1:10 of 
supernatant; IF - 
neat 
H. Welch 
Anti-Myc Mouse monoclonal, 
9E10 
WB – 1:1000;  
IF – 1:100 
Beatson Institute 
Anti-Erk2 Mouse monoclonal WB – 1:2000 BD Transduction 
Labs 
Anti-phospho ERK 
(p44/42 Thr202/204) 
Rabbit polyclonal WB – 1:1000 Cell Signaling 
Technology 
Anti-Akt Rabbit polyclonal WB – 1:1000 Cell Signaling 
Technology 
Anti-phospho Akt 
Ser473 
Rabbit polyclonal WB – 1:1000 Cell Signaling 
Technology 
Anti-Rac1 Mouse monoclonal WB – 1:1000 Cytoskeleton Inc 
 
Anti-Rac (Rac1, 2, 3) Mouse monoclonal WB – 1:1000 BD Transduction 
Labs 
Anti-Rac2 Rabbit polyclonal WB – 1:500 Santa Cruz 
 
Anti-Cdc42 Mouse monoclonal WB – 1:500 Santa Cruz 
 
Anti-mouse IgG HRP-linked WB – 1:3000 Cell Signaling 
Technology 
Anti-rabbit IgG HRP-linked WB – 1:3000 Cell Signaling 
Technology 
Anti-mouse 
 
IgG FITC 488 
conjugated 
I.F. – 1:200 Invitrogen 
Phalloidin 
 
TRITC-conjugated I.F. – 1:500 Sigma 
Calcein AM 
 
Fluorescent cell dye 5 µM Molecular Probes 
Table 2 – Antibodies and dyes 
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2.3 Commonly used reagents 
Compound Type Source 
 
Wortmannin PI3 Kinase inhibitor Sigma 
 
LY294002 PI3 Kinase inhibitor CellSignaling Technology 
 
Pertussis toxin GPCR inhibitor Sigma 
 
NSC23766 Rac1 inhibitor Calbiochem 
 
Latrunculin A Actin polymerisation inhibitor Sigma 
 
Y-27632 Rho Kinase inhibitor Calbiochem 
 
U0126 Mek inhibitor Upstate 
 
EGF Growth factor Peprotech 
 
PDGF Growth factor Sigma 
 
HGF Growth factor Sigma 
 
LPA Growth factor Sigma 
 
Matrigel ECM BD Biosciences 
 
Table 3 – Common reagents 
2.4 DNA constructs 
Construct Type Source 
 
pLHCX Retroviral expression vector Clonetech 
pCMV3-Myc-P-Rex1 WT Transient expression vector H. Welch 
 
pCMV3-Myc-P-Rex1 iDHPH Transient expression vector H. Welch 
 
pCMV3-Myc-P-Rex1 GEF-dead Transient expression vector H. Welch 
pCMV3-Myc-P-Rex1 DEP Transient expression vector H. Welch 
 
pCMV3-Myc-P-Rex1 IP4P Transient expression vector H. Welch 
 
pcDNA3.1 Myc-Tiam1 Transient expression vector A. Malliri 
LMP Retroviral shRNA vector S. Lowe 
Table 4 – DNA constructs 
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2.5 Cell Culture 
 
2.5.1 Origin of Cell Lines 
Telomerase-immortalised human foreskin fibroblasts and the derived cells 
expressing v-Fos and HRasV12 were obtained from Brad Ozanne, Beatson Institute. 
Melanoma derived cell lines A375mm, WM266.4, CHL-1, RPMI8332, SKMEL28, 
MelIM were obtained from Gareth Inman, Beatson Institute. Primary Human 
Melanocytes were obtained from Cascade Biologics. Primary mouse melanocytes 
and mouse melanoma derived cells were established as described below. 
 
2.5.2 Maintenance of Cell Lines 
All cell lines were routinely grown in tissue culture treated 100 mm dishes 
(Falcon) at 37oC in a humidified atmosphere containing 5% CO2. All techniques 
were performed in sterile conditions. All cell lines with the exception of 
RPMI8332 melanoma cells and human primary melanocytes were cultured in 
DMEM (Gibco) supplemented with 2 mM glutamine (Gibco) and 10 % FBS (Autogen 
Bioclear). RPMI8332 melanoma cells were cultured in RPMI medium (Gibco) with 
identical supplements. Fresh media was added every 3-4 days. Cells were 
passaged when subconfluent, typically every 7 days with a 1:20 split ratio. After 
aspirating the medium and washing with PBS, 0.5 ml TE with 0.25% trypsin was 
added and after approximately 2 minutes cells were resuspended in 10 ml fresh 
medium, 1 ml of which was added to 10 ml fresh medium in a new 10 mm dish. 
Human primary melanocytes were cultured in Medium 254 with Human 
Melanocyte Growth Supplement-2, PMA free (Cascade Biologics) and split when 
subconfluent and the medium was changed every 3 days. Subculture was 
essentially as described above but with the additional step of centrifuging the 
resuspended cells after trypsinisation at 180 g for 5 minutes before seeding in 
fresh medium at 5 x 105 cells per 100 mm dish. 
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2.5.3 Storage of Cell Lines 
Cells were stored in liquid nitrogen. Cells were trypsinised as described above 
and pelleted by centrifugation. Cells were resuspended in medium supplemented 
as described but with 50 % FCS and 10 % DMSO. Resuspended cells were placed in 
cryotubes, wrapped in cotton wool and frozen at -70 oC overnight before 
transferring to liquid nitrogen. Cells were thawed by placing cryotubes in a 37 oC 
water bath. Cells were diluted in 10 ml fresh medium, pelleted by 
centrifugation, resuspended in 10 ml fresh medium and placed in a new 10 mm 
dish. 
 
2.5.4 Establishment of primary melanocyte and melanoma cell 
lines 
Melanocytes were derived from the skin of 2 day old mouse pups. Pups were 
stunned and decapitated (Owen Sansom, Beatson Institute) and briefly sterilised 
by rinsing twice in ice-cold 70 % ethanol for 5 seconds and twice in ice-cold PBS 
for 5 seconds. The skin, typically 1 cm2, was removed and cut into small pieces 
with scissors and forceps and incubated in 2 ml of collagenase type 1 and 4 
(Sigma) at 37 oC, 5 % CO2 for 40 minutes. The epidermis and dermis were 
separated and transferred to 10 ml wash buffer, centrifuged at 1100 rpm at 
room temperature for 5 minutes and resuspended in 2 ml Cell Dissociation Buffer 
(Gibco). After incubating at 37 oC 5 % CO2 for 10 minutes, the tissue was 
repeatedly put through 18 g and then 20 g needles to further dissociate and then 
resuspended and left to settle in 10 ml wash buffer (for 10 minutes. The 
supernatant was centrifuged at 1100 rpm for 5 minutes and resuspended in 2 ml 
PBS and the cells counted. Cells were centrifuged as before and plated at a 
density of 1 x 106 per well of a 6-well tissue culture plate in melanocyte growth 
medium containing 200 nM TPA and 100 µg/ml primocin (Invitrogen). 
After 2 days in culture, Geneticin (Gibco) was added to the culture medium at 
50 µg/ml for 3 days every week in order to selectively impair the growth of 
fibroblasts. To further select the cell population in favour of melanocytes, 
culture plates were aspirated and treated with PBS-EDTA for approximately 3 
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minutes at room temperature to remove the less-adherent fibroblasts. Pure 
populations of melanocytes were achieved after 1.5 months culture of N-RasQ61K 
positive cells and after 4 months culture of N-RasQ61K negative cells. Cell lines 
were genotyped for N-RasQ61K and P-Rex1 status to ensure there had been no 
cross-contamination, as described below. 
Melanoma cells were derived from surgically excised tumours in the same way as 
skin derived melanocytes, as described above. 
 
2.6 Molecular Cloning 
2.6.1 PCR amplification for cloning 
Each PCR reaction was adjusted to 50 µl volume with autoclaved, distilled water 
and contained: 1 x Pfx application buffer, 0.3 mM each dNTP, 1 mM MgSO4, 0.3 
uM each primer, 20 ng template DNA and 2.5 units Platinum Pfx DNA 
polymerase. Temperature cycling was performed in a DNA Engine Thermal Cycler 
(Biorad) with the following conditions: denaturation for 2 minutes at 94 oC 
followed by 30 cycles comprising dentauration at 94 oC for 15 seconds, annealing 
at 55 oC for 30 seconds and extension at 68 oC for 1 minute per kb intended 
product. 
2.6.2 Primers for PCR 
PRIMER SEQUENCE 
Myc-Tag pLHCX F GTTAACCACCATGGAGCAGAAGCTGATC 
P-Rex1 pLHCX R CCATCGATTCAGAGGTCCCCATCCACCGG 
P-Rex1 pLHCX iDHPH R CCATCGATTCACTCGCGCTGCTCCCGCTCGCGG 
P-Rex1 pLHCX IP4P R CCATCGATTCAGAAGGCTGAATCAGCCTGGTC 
Tiam1 pLHCX R ATCGATTCAGATCTCAGTGTTCAG 
Table 5 – Primers for PCR cloning 
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2.6.3 Agarose gel electrophoresis 
Agarose  was added to TAE buffer at between 1 and 2 % depending on the size of 
the DNA to be visualised. Agarose in TAE buffer was heated and Ethidium 
Bromide added at 0.5 µg/ml prior to solidification in a gel tray. DNA samples and 
1 kb ladder (Invitrogen) in 1 x DNA loading buffer were loaded on to the gel and 
electrophoresis performed at 100 v in 1 x TAE buffer. DNA bands were visualised 
using a UV transilluminator. 
 
2.6.4 Restriction enzyme digests 
Restriction enzyme digests contained 1 x appropriate enzyme buffer, 
approximately 10 µg DNA and a 5 to 10-fold unit excess of enzyme, made up to 
volume of 20 µl with distilled water. Reactions were incubated at the 
appropriate temperature for 1 hour. If vector DNA had been digested leaving 
complimentary binding sites, DNA was incubated with 5 units Calf Intestinal 
Alkaline Phosphatase at 37 oC for 30 minutes. 
 
2.6.5 Ligations 
Ligations were performed using the Rapid DNA Ligation Kit (Roche). An 
approximate 2 fold molar excess of insert DNA to vector DNA was diluted in DNA 
Dilution Buffer to a final volume of 10 µl. This was combined with T4 DNA 
Ligation Buffer was to a final volume of 20 µl and 5 U T4 DNA ligase was added. 
The ligation reaction was incubated at room temperature for 5 minutes before 
transforming competent bacteria. 
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2.6.6 Design of shRNA constructs 
Oligos siRNA sequences were designed using Biopredsi, an online computational 
algorithm that predicts 21 nucleotide siRNA sequences for knockdown of a given 
gene (http//www.biopredsi.org./start.html). The resulting sequences were 
entered into an online shRNA oligo construction tool 
(http//katahdin.cshl.org:9331/homepage/sirna/rnai.cgi?type=shrna) to design 
complimentary 110 nucleotide oligos suitable for ligation into the vector LMP. 
 
2.6.7 Oligos for shRNA constructs 
PRIMER SEQUENCE 
LMP  
P-REX1 
SEQ2 F 
TCGAGAAGGTATATTGCTGTTGACAGTGAGCGCCCACAGCTTACAAGAGTTTAATAGTGAAGC- 
CACAGATGTATTAAACTCTTGTAAGCTGTGGTTGCCTACTGCCTCGG 
LMP  
P-REX1 
SEQ2 R 
AATTCCGAGGCAGTAGGCAACCACAGCTTACAAGAGTTTAATACATCTGTGGCTTCACTATTA- 
AACTCTTGTAAGCTGTGGGCGCTCACTGTCAACAGCAATATACCTTC 
LMP  
P-REX1 
SEQ3 F 
TCGAGAAGGTATATTGCTGTTGACAGTGAGCGAAAAGAAAGGTATGTTGTCTAATAGTGAA- 
GCCACAGATGTATTAGACAACATACCTTTCTTTGTGCCTACTGCCTCGG 
 
LMP  
P-REX1 
SEQ3 R 
AATTCCGAGGCAGTAGGCACAAAGAAAGGTATGTTGTCTAATACATCTGTGGCTTCACTATTA- 
GACAACATACCTTTCTTTTCGCTCACTGTCAACAGCAATATACCTTC 
LMP  
P-REX1 
SEQ4 F 
TCGAGAAGGTATATTGCTGTTGACAGTGAGCGATCAGTGCATTCTGAAGGTCAATAGTGAAGC- 
CACAGATGTATTGACCTTCAGAATGCACTGACTGCCTACTGCCTCGG 
LMP  
P-REX1 
SEQ4 R 
AATTCCGAGGCAGTAGGCAGTCAGTGCATTCTGAAGGTCAATACATCTGTGGCTTCACTATTGA- 
CCTTCAGAATGCACTGATCGCTCACTGTCAACAGCAATATACCTTC 
Table 6 – Oligo sequences for shRNA constructs 
 
2.6.8 Annealing shRNA oligos 
Oligos were dissolved in sterile, nuclease-free water to a concentration of 3 
mg/ml. The annealing reaction consisted of 1 µl each oligo in 48 µl annealing 
buffer (100 mM NaCl and 50 mM HEPES pH 7.4). The mixture was incubated for 4 
min at 90 oC and then for 10 minutes at 70 oC. The samples were step-cooled to 
37 oC over 20 minutes and the cooled to 4 oC and stored until ligation into vector 
LMP. 
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2.6.9 Transformation of competent cells 
Competent E. Coli DH5a cells (Beatson Institute) were stored at –70 oC and 
thawed on ice. Plasmid DNA, typically 20 ng, was gently mixed with 50 µl of cells 
and incubated for 30 minutes on ice. Cells were then heat-shocked at 42 oC for 
30 seconds and placed back on ice for 1 minute. 250 µl SOC medium was added 
and cells were incubated with shaking at 37 oC for 40 minutes, 250 rpm. 200 µl 
of the transformation mixture was spread over pre-warmed LB agar plates 
containing 50 µg/ml ampicillin or kanamycin as appropriate and incubated 
overnight at 37 oC. 
 
2.6.10 Screening of transformants 
Individual colonies of bacteria were used to inoculate 5 ml LB media containing 
50 µg/ml ampicillin or kanamycin as appropriate and cultured overnight at 37 oC. 
Plasmid DNA was prepared using the QIAprep Spin Miniprep Kit (Qiagen) and 
analysed for the presence of desired insert by restriction digest and subsequent 
visualisation by gel electrophoresis. Samples that tested positive were 
sequenced using appropriate sequencing primers. After sequence confirmation, 
plasmid DNA was used to transform fresh bacteria and 100 ml cultures were used 
to prepare DNA using QIAprep Maxiprep Kit (Qiagen) (some procedures 
performed by Beatson Research Services). 
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2.6.11 Primers for sequencing 
PRIMER  SEQUENCE 
P-Rex1 Seq 1 GATCCAGAGGATCTGCAAGTACC 
P-Rex1 Seq 2 GAGCAAGAAGTCCACCAAGAGGAC 
P-Rex1 Seq 3 GTCAGTGCATTCTGAAGGTCAATG 
P-Rex1 Seq 4 GTGCCATGTGCTGGAGAAGATCG 
P-Rex1 Seq 5 CAAGCAGGACAAGCTTCATGGCTG 
P-Rex1 Seq 6 CAACAATGGCGAGTACGAGGAG 
Tiam1 Seq 3 CAAGCGAGGAAGTCATTTGG 
Tiam1 Seq 4 GCGGCCGCATGAGCACCACCAACAGCG 
Tiam1 Seq 5 CTGGTCCTCCGCGTCTTGTG 
Table 7 – Primers for sequencing 
2.7 RNA isolation and cDNA synthesis 
Total cellular RNA was isolated from cells using the RNeasy kit according to the 
manufacturer’s instructions (Qiagen). Cells were grown to 80 % confluency in 6 
cm dishes and lysed in 350 µl buffer RLT and homogenised in a Qiashredder 
column. Lysates were diluted 1:1 with 70 % ethanol, mixed well and added to an 
RNeasy spin column and centrifuged for 15 sec at 10,000 rpm. Flow-through was 
discarded and 700 µl buffer RW1 added to column and the sample centrifuged as 
before. Flow-through was discarded and 700 µl buffer RPE was added and the 
column spun as before, and this was repeated once more. RNA was eluted from 
the column in 40 µl water. 
cDNA was synthesised using an RT-PCR kit according to manufacturer’s 
instructions (Applied Biosystems). Reverse transcription was performed in a 
volume of 20 µl comprising 1 µg RNA, 2.5 uM random hexamers, 1 mM each 
dNTP, 5 mM MgCl2, 1 x PCR buffer II, 1 U/µl RNase inhibitor, and 2.5 U/µl MuLV 
reverse transcriptase. Reactions were incubated at room temperature for 10 
min, at 42 oC for 15 min, 99 oC for 5 min, 5 oC for 5 min and stored at -20 oC. 
Subsequent 50 µl volume PCR reactions comprised 10 µl RT-reaction in 2 mM 
MgCl2, 1 x PCR buffer II, 1.5 U AmpliTaq DNA polymerase and forward and 
reverse primers at 0.15 µM each. Reactions were kept on ice and then denatured 
at 95 oC for 2 min and subjected to the indicated number of cycles of 95 oC for 2 
min and 60 oC for 1 min, followed by a final step at 72 oC for 7 min. 
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2.7.1 Primers for RT-PCR 
Primer sets were designed with the aid of PerlPrimer software for optimum 
annealing properties, gene specificity, and binding across exon-exon boundaries. 
PRIMER SEQUENCE 
P-Rex1 F ATCATGTCCAAGGGTGTGAGGC 
P-Rex1 R GTCCTCAATGATGGAGTAGATC 
GAPDH F  
GAPDH R  
Table 8 – Primers for RT-PCR 
 
2.8 Transfection of DNA 
2.8.1 Transient transfection of plasmid DNA 
Cells were transfected by nucleofection. Cells were pelleted by centrifugation, 
resuspended to 5 x 106 cells per ml in the appropriate nucleofection reagent and 
100 µl added to a 1.5 ml tube containing 5 µg DNA. Cells and DNA were pipetted 
into a nucleofection cuvette and placed in a nucleofection device and subjected 
to the appropriate program. Pre-warmed media was added to the cuvette and 
cells were carefully pipetted into a 6 well tissue culture plate containing 2.5 ml 
medium and cultured under standard conditions. 
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2.8.2 siRNA transfections 
The following siRNA duplexes were obtained as annealed and desalted duplexes. 
Gene Accession 
No. 
Company, Cat No. Sense and Antisense Sequence 
Non-
targeting 
control 
 Qiagen 1027281 Not disclosed 
Non-
targeting 
control 
 Qiagen 1022070 Not disclosed 
Non-
targeting 
control pool 
 Dharmacon d-
001206-13-20 
Not disclosed 
P-Rex1 NM_020820 Qiagen SI00692391 ACAUGAUGAUGAACAAGAA 
UUCUUGUUCAUCAUCAUGU 
P-Rex1 NM_020820 Qiagen  GGGUCAGCCCACCCUUCAA 
UUGAAGGGUGGGCUGACCC 
P-Rex1 NM_020820 Qiagen SI00692412 GGCCAAAGAGAUCAUCAAA 
UUUGAUGAUCUCUUUGGCC 
P-Rex1 NM_020820 Qiagen SI03246383 GGGACUUUGUUAAAGAUCU 
AGAUCUUUAACAAAGUCCC 
P-Rex1 NM_020820 Ambion AM16708 GGGACUUUGUUAAAGAUCU 
AGAUCUUUAACAAAGUCCC 
P-Rex1 NM_020820 Dharmacon M-
010063-00-0010 
SMARTpool 
GAGAUGAGCUGCCCUGUGAUU 
UCACAGGGCAGCUCAUCUCUU 
 
GGAGAAAGCUGAGCACUGUUU 
ACAGUGCUCAGCUUUCUCCUU 
 
GAAAGAAGAGUGUACAAUCUU 
GAUUGUACACUCUUCUUUCUU 
 
GGAAGAAGGAGUCAACUUGUU 
CAAGUUGACUCCUUCUUCCUU 
 
Rac1 NM_006908 
NM_018890 
NM_198829 
 
Qiagen 
SI02655051 
Not disclosed 
Rac2 NM_002872 Qiagen 
SI00044926 
 
CGUGUUUGACAACUAUUCA 
UGAAUAGUUGUCAAACACG 
Cdc42 NM_00103980
2 
Qiagen SI03049914 GCAUUAGUGUUGAACCAAU 
AUUGGUUCAACACUAAUGC 
Table 9 – siRNA oligo sequences 
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Cells were plated at 0.8 x 105 cells per well in a 12 well tissue culture plate 
(Falcon) in 1 ml media 24 hours prior to transfection. To 150 µl serum free 
medium, 4.4 µl of 2 µM stock oligo and 2.2 µl Hiperfect was added, mixed gently 
and left at room temperature for 10 minutes. The lipid oligo complex was then 
pipetted dropwise on to the cells and media to give a final oligo concentration of 
8 nM. Cells were grown under standard conditions for 48 hrs and then 1 x105 
cells were split into wells of 6 well tissue culture plates with siRNA oligos at the 
same concentration. Typically, assays were performed and cell lysates collected 
48 hrs after transfections. 
 
2.8.3 Retroviral Infections 
Phonenix-Ampho retroviral packaging cells were maintained as described above. 
For each retroviral infection, 2x106 cells were plated in a 100 mm dish and the 
following day cells were transfected using calcium chloride precipitation 
method. 5 µg DNA in 440 µl distilled H20 was mixed with 500 µl 2 x HBS (50 mM 
HEPES, 250 mM NaCl, 1.5 mM NaHPO4, pH 7.1) and 60 µl 2 M CaCl2 dropwise with 
vigorous shaking followed by precipitation for 30 minutes at 37oC and dropwise 
addition to Phonenix Ampho cells. Viral supernatant was harvested at 12 hr 
intervals, purified through a 0.45 µm filter and added to target cells at 1 x105 
cells / 6 well dish with addition of polybrene (hexadimethrine bromide; Sigma) 
at a final concentration of 5 µg/ml. After 3 rounds of infection over 36 hrs, 
target cells were passaged into 100 mm dishes and 48 hours later selected with 
appropriate drug (hygromycin, 50 µg/ml, Invitrogen; or puromycin, 5 µg/ml, 
Invivogen). Cells infected with GFP expressing sequences, such as the shRNA LMP 
vector, were sorted by FACS on the basis of GFP expression. All retrovirally 
produced cell lines were generated on at least 2 separate occasions to ensure 
the resulting phenotypes were consistent and, unless otherwise stated, all 
resulting cell populations were pools of selected colonies. 
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2.8.4 FACS of GFP positive cell populations 
Cell pellets of 1 x106 were resuspended in 1 ml PBS and put through a 40 µm 
strainer. Cells were sorted using a BD FacScan on basis of fluorescence resulting 
from excitation of cells with a 488 nm laser. Typically, the brightest 10 % of the 
positive cell population were isolated for experimental use. The FacScan was 
operated by Tom Gilbey, Beatson Institute. 
 
2.9 Protein Immunoblotting 
2.9.1 Protein extraction from cells 
Protein extracts were made from cells when approximately 70 % confluent. Cells 
were washed in tissue culture dishes with ice cold PBS and lysed in either 2 X 
Western sample buffer or cell lysis buffer supplemented with protease inhibitors 
and phosphatase inhibitors 50 µM Na3(VO)4, 50 mM NaF. Cells were scraped and 
the lysate transferred to ice cold 1.5 ml tubes. Lysate in 2 x Western sample 
buffer was stored at -20 oC. Lysate in cell lysis buffer was left on ice for 10 
minutes and then centrifuged at 13,000 rpm for 5 minutes at 4 oC. The protein 
concentration of the resulting supernatent was then determined and stored at – 
70 oC. 
 
2.9.2 Protein extraction from tissue 
Tissue was snap frozen in liquid nitrogen and stored at -70 oC. Tissue samples 
were homogenised with a pestle and mortar cooled with liquid nitrogen and dry 
ice. The samples were resuspended in cell lysis buffer with supplements as 
described above and left on ice for 20 minutes and then treated as described 
above. 
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2.9.3 Determination of protein concentration 
Protein concentrations of lysates in cell lysis buffer were determined by a 
bicinchonic acid colourimetric assay based on the method by Lowry. Lysates 
were incubated in a 50:1 solution of Bicinchonic acid:copper II sulphate solution 
in a 96 well plate for 30 minutes for 37 oC. Optical density’s of solutions were 
measured using a Dynatech MR7000 spectrophotometer and compared to a 
standard curve from 6 BSA standards at 80, 100, 200, 400, 1000, 2000 µg/ml. 
 
2.9.4 Separation of proteins by polyacrylamide gel 
electrophoresis (SDS-PAGE) 
Western sample buffer was used to dilute protein samples to give a 1 x solution 
and heated at 95 oC for 3 minutes. Samples were resolved on denaturing 
polyacrylamide gels according to molecular weight by electrophoresis in gel 
tanks with 1 x SDS running buffer at 120 V for approximately 2 hours until the 
dye front had reached the bottom of the gel. The separating gel contained 
between 8 % and 15 % acrylamide depending on the molecular weight of the 
protein to be visualised and otherwise constituted 375 mM Tris-Base pH 8.8, 0.1 
% SDS, polymerised with 0.1 % ammonium persulphate and 0.0004 % TEMED. 
Stacking gels contained 4 % acrylamide, 125 mM Tris-Base, pH 6.8, 0.1 % SDS 
polymerised with 0.1 % ammonium persulphate and 0.0004 % TEMED. 
 
2.9.5 Western blotting 
Proteins, separated by polyacrylamide gel electrophoresis, were transferred 
from the gel to Immobolin-P membrane between Whatman 3MM paper by semi-
dry blotting at 20 V for 2 hours in transfer buffer. Membranes were blocked in 
TBST, 5 % milk (Marvel) for 1 hour at room temperature and incubated with 
primary antibody at the appropriate dilution, time and temperature as advised 
by the manufacturer. Membranes were washed 3 times with TBST for 5 minutes, 
incubated with the appropriate secondary antibody in TBST, 5 % milk for 1 hour 
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at room temperature and washed 3 times with TBST for 5 minutes. All 
incubations and washes were performed with gentle agitation. Proteins on 
membranes were visualised using enhanced chemiluminescent detection reagent 
(ECL, Amersham) followed by autoradiography using Fuji Super RX medical X-ray 
film and a Kodak X-Omat 480 RA X-Ray processor. 
 
2.10 Invasion assays 
An aliquot of matrigel (BD Biosciences), stored at -70 oC, was thawed on ice and 
diluted 1:2 with ice-cold PBS and 70 µl was pipetted into a transwell insert, 8 um 
diameter pores (Corning Inc.), within a 24 well tissue culture plate (Falcon). 
After 1 hour of incubation at 37 oC, the transwell and plate were inverted and 
100 µl of cell suspension at a concentration of 5 x 10 per ml of medium was 
pipetted on to the underside of the transwell filter. The base of the 24 well 
plate was carefully replaced and the cells allowed to adhere to the filter for 4 
hours at 37 oC. The plate was then placed right-side-up and each transwell was 
carefully dipped in and out of 2 wells of serum free medium before being placed 
in wells containing 1 ml serum free medium, containing any appropriate growth 
factors or inhibitors. 100 µl of medium was pipetted into the transwells, above 
the matrigel plug and the assay allowed to proceed under standard culture 
conditions for 3 days. For experiments involving growth factor stimulation, 
appropriate growth factors were added to the 100 µl of serum free medium 
above the matrigel plug at the indicated concentrations. For experiments 
involving chemical inhibitors, appropriate inhibitors were added to both the 
serum free medium below the transwell and the medium above the matrigel 
plug. When using the PI3 kinase inhibitor wortmannin, fresh inhibitor was added 
to the serum free medium below cells daily. 
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2.10.1 Quantification of invasion 
Cells were stained by placing 500 µl of serum free medium containing 4 µM 
calcein AM above and below transwell invasion assays and incubating for 2 hours 
at 37 oC. Transwells were placed on a glass coverslip and visualised by confocal 
microscope using a 10 x objective at an excitation wavelength of 488 nm and 
emission wavelength of 515 nm. Optical sections of invaded cells were scanned 
at intervals of 15 µm upwards from the underside of the transwell filter. The 
resulting images were viewed using Image J software, which allocates each pixel 
an intensity value and allows a threshold intensity level to be set, below which 
pixels are not displayed. The threshold intensity of the images was set in order 
to register only cells that lay within each individual optical section, and the sum 
of the areas of invaded cells was calculated, starting from section 30 µm above 
the filter plane. Overall results were determined from at least 3 repeat 
experiments in which optical sections were taken from at least 3 areas of each 
transwell. 
 
2.11 Wound healing assays 
Cells were plated in wells of a 6 well tissue culture plate at a density that 
resulted in a confluent monolayer 24 hours later. A scratch was made in the 
monolayer using a 10 µl pipette tip and the media changed in order to remove 
de-adhered cells. Timelapse images of the wounded monolayer taken using a 
Nikon TE2000 microscope. 
 
2.12 Dunn chamber assays 
Cells were seeded at a density of 5 x 104 cells per 6 well in a 6 well tissue 
culture plate containing a glass coverslip (18 mm x 18 mm, 0.25 – 0.35 mm 
Thick, TAAB) and grown overnight in standard media. Cells were serum-starved 
for 24 hrs. Dunn chambers (Hawksley) were rinsed with pre-warmed serum-free 
media and the glass coverslips were placed on the chambers, cells faced down, 
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such that a small opening to the outer circular trench of the chamber remained. 
Excess media was removed with blotting paper and the coverslips were gently 
pressed on to the Dunn chamber around their edges. Coverslips were sealed 
along three edges with hot wax using a fine brush. 
2.13 Rac pulldowns 
2.13.1 Gst-pak crib domain production and purification 
A starter culture of BL21 cells transformed with pGEX2TK containing coding 
sequence for the PAK CRIB domain (J. Collard) was grown from glycerol stocks 
overnight at 37oC in L-Broth with 100 µg/ml ampicillin. This was diluted 1:100 
into 1 litre of fresh L-Broth with ampicillin and grown at 30 oC until an O.D. 600 
nm of 0.6 was reached. Protein expression was induced with addition of 0.1 mM 
IPTG and the culture grown for a further 4 hours at 30 oC. The culture was 
centrifuged at 4000 rpm for 20 minutes at 4 oC and the resulting bacterial pellet 
frozen at -70 oC. The pellet was allowed to thaw on ice for 30 minutes and 
resuspended in 7 ml bacterial lysis buffer after which lysozyme was added at 1 
mg/ml and the suspension was rocked gently on ice for 30 minutes. DTT was 
added at 5 mM, Tween 20 at 1 % and SDS at 0.03 % and the suspension was 
centrifuged at 50,000 rpm for 1 hour at 4 oC. 1 ml aliquots of the resulting 
supernatant were snap frozen in liquid nitrogen and stored at – 70 oC until 
required. On the day of use, 100 µl washed glutathione beads were washed 3 
times in bacterial lysis buffer and bound to 1 ml GST-pak crib domain by mixing 
and rotating for 1 hour at 4 oC. Beads were washed 3 times in lysis buffer and 
reuspended in lysis buffer to a volume of 1 ml. 
 
2.13.2 Pulldowns 
Cells were plated at 3 x105 cells per 100 mm dish and cultured under standard 
conditions. After 24 hours, medium was aspirated and replaced with serum free 
medium. Cells were cultured for a further 24 hours and then stimulated 
accordingly. Media was removed, the dishes were placed on ice and the cells 
were washed with 10 ml ice cold PBS. 1 ml cell lysis buffer was added to each 
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dish, the cells were scraped and the lysates transferred to ice cold 1.5 ml tubes. 
The lysates were centrifuged at 13,000 rpm for 3 minutes at 4 oC and 80 µl of 
supernatent was added to 20 µl 5 X sample buffer as a loading control for total 
Rac levels. The remaining supernatant was added to 100 µl resuspended 
glutathione-GST-PAK-CRIB beads and rotated for 45 minutes at 4 oC. Beads were 
washed 3 times in 1 ml cell lysis buffer and the pellet resuspended in 50 µl 1 X 
Western sample buffer. Samples were run on a 4 – 20 % polyacrylamide gel as 
described. 
 
2.14 Microscopy 
2.14.1 Microscopes 
Phase contrast images and short-term (< 5 min) movies were taken using an 
Olympus C X41 microscope fitted with a monochrome CCD digital camera and 
QCapturePro image capture software. 
Images for long-term timelapse movies (~24 hrs) were taken using a Nikon 
TE2000 with Metamorph software. 
Confocal images were made using a Leica SP2 confocal and Leica Confocal 
Control software. 
 
2.14.2 Immunofluorescence 
Cells were cultured on 10 mm diameter glass coverslips. Medium was aspirated 
and the cells were rinsed briefly in PBS and fixed in 4 % formaldehyde for 15 
minutes. Coverslips were then washed and permeablised 3 times for 5 minutes in 
PBS-T. Cells were blocked for 30 minutes in blocking buffer (10 % FBS, 0.5 % BSA 
in PBS) and then primary antibody (in blocking buffer) was added for 1 hour. 
Cells were washed 3 times for 5 minutes in blocking buffer and then secondary 
antibody and / or TRITC-conjugated phalloidin (in blocking buffer) was added for 
40 minutes in darkness. Cells were washed twice in blocking buffer for 5 minutes 
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and permeablised again in PBS-T before mounting the coverslips on glass slides 
with Vectashield and sealing with nail polish. Coverslips were kept at 4 oC in 
darkness and viewed by confocal microscopy. 
 
 
2.15 Generation, maintenance and treatment of mouse 
colonies 
2.15.1 Transgenic mice 
All proceedings were carried out in accordance with Home Office regulations. All 
mice were kept under non-barrier conditions and given a standard diet and 
water ad libitum. 
Transgenic mice used in this study were: P-Rex1-/- mice, provided by H. Welch, 
see (Welch, Condliffe et al. 2005); Tyr::N-RasQ61K mice, provided by F. 
Beermann, see (Ackermann, Frutschi et al. 2005); DCT::LacZ mice, provided by 
Ian Jackson . All mice were bred on a C57BL/6J genetic background. 
 
2.15.2 Genotyping of mice 
Mice were genotyped by PCR from tail tip lysates. All steps were frequently 
performed by S.Wylie, B. Clark, Beatson Institute. Tail tips were lysed in 100 µl 
lysis buffer (100m M Tris pH 8.5, 5 mM EDTA, 0.2 % SDS, 200 mM NaCl, 10 µg/ml 
proteinase K) overnight at 55 oC. Samples were heated to 96 oC for 5 min, 
diluted in 500 µl water and centrifuged for 5 min in a microfuge and stored at 4 
oC. For PCR, 1 µl supernatant was used per reaction. 
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PRIMER SEQUENCE 
P-Rex1 WT F GACCTGAGGTTTTTTTCTGGCCTCCGTGGC 
P-Rex1 WT R GAAAGAGGCAGAAGCTGGGCACGCCTGGCC 
P-Rex1 KO F AGGGGGAAGGCTGAGGTGCTGGTGATGCTG 
P-Rex1 KO R TCCTCGTGCTTTACGGTATCGCCGCTCCCG 
P16 WT F ATGATGATGGGCAACGTTC 
P16 WT R CAAATATCGCACGATGTC 
P16 Null F CTATCAGGACATAGCGTTGG   
P16 Null R AGTGAGAGTTTGGGGACAGAG 
N-RasQ61K F GATCCCACCATAGAGGATT 
N-RasQ61K R CTGGCGTATTTCTCTTACC 
LacZ CTGGCGTTACCCAACTTAAT 
LacZ ATAACTGCCGTCACTCCAAC 
Table 10 – Oligo sequences for genotyping 
 
2.15.3 Monitoring of cohorts 
Mice were checked every 3 days for general health. Common causes of ill-health 
in P-Rex1-/- mice were exencephaly and subsequent hydrocephaly that developed 
at a few weeks of age in a small percentage of mice, as was observed previously 
(H. Welch, personal communication). A common cause of ill-health in INK4a-/- 
mice was lymphoma. Mice suffering from lymphoma were characterised by their 
enlarged spleen and liver, a hunched appearance and panting. Suffering mice 
were culled (O. Sansom, Beatson Institute). 
Melanoma development in N-RasQ61K INK4a+/- and -/- mice was monitored weekly 
by thorough examination of the skin. Melanomas were measured and recorded 
when reaching at least 2 x 2 mm in size. Mice with melanoma(s) were culled if 
the skin became broken, or if sizeable tumours were located in sensitive areas 
such as the testis or near eyes, or the animal appeared unwell as assessed by 
hunched appearance and general malaise. 
Liver, spleen and lungs were fixed in 10 % formaldehyde. Liver and lungs were 
examined macroscopically for signs of metastasis, previously reported as being 
small pigmented nodules (Ackermann, Frutschi et al. 2005). Melanomas were 
excised from the skin and similarly fixed. 
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2.16 Histology and staining of tissue 
Samples fixed in formaldehyde were embedded in paraffin, sectioned by 
microtome and stained with H&E according to standard protocols. All steps 
performed by C. Nixon and colleagues, Beatson Institute. 
 
2.16.1 X-Gal staining of embryos 
Embryos, E11.5, E13.5 and E15.5, were dissected from yolk sacks and placed in 
ice-cold PBS. Yolk sacks were frozen for genotyping purposes. PBS was aspirated 
and embryos were fixed in ice-cold 0.25 % glutaraldehyde for 30 min. Embryos 
were rinsed in ice-cold PBS for 10 min and then placed in twice in 
permeablisation solution (2 mM MgCl2, 0.01 % Na-deoxycholate, 0.02 % NP-40 in 
PBS) for 20 minutes each time. Permeablisation solution was aspirated and 
embryos were placed overnight at room temperature in X-Gal staining solution 
(0.01 % Na-deoxycholate, 0.02 % NP-40, 2 mM MgCl2, 5 mM Potassium 
Ferricyanide, 5 mM Potassium Ferrocyanide, 0.04 % X-Gal). 
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3 P-REX1 PROMOTES CHEMOTACTIC INVASION 
IN HUMAN FIBROBLASTS 
 
Changes in the expression of genes and changes in the activity of their 
respective proteins contribute to the metastatic and invasive potential of a 
tumour. Great effort has been taken to identify which genes are of most 
significance to the invasive phenotype and many studies have utilised DNA 
microarray technology to this end.  
Previous work in this lab has identified by microarray a number of genes that are 
transcriptionally upregulated in human telomerase immortalised foreskin 
fibroblasts (TIFFs) following expression of the v-Fos or H-RasV12 oncogenes (Scott, 
Vass et al. 2004). These 30 genes are hypothesised to positively contribute to 
the ability of these transformed cells to invade through a 3D reconstituted 
basement membrane matrix, matrigel. Previous similar experiments employing 
substractive hybridisation techniques identified a number of genes upregulated 
and downregulated upon v-Fos transformation of rat fibroblasts that were shown 
to be essential for regulating their invasive phenotype (Spence, Johnston et al. 
2000; McGarry, Winnie et al. 2004; Ozanne, Spence et al. 2006).  
P-Rex1 is a Rac GEF identified by microarray as being upregulated in v-Fos and 
H-RasV12 expressing invasive human fibroblasts. Activation of Rac by GEFs has 
previously been shown to either promote or reduce cell motility and invasion 
dependent upon cell type and context.  
The aim of the studies in this chapter is to examine if P-Rex1 can stimulate cell 
invasion of human fibroblasts and, if so, to investigate the mechanism by which 
this may occur. 
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3.1.1 P-Rex1 is upregulated upon expression of v-Fos or H-RasV12 
in human fibroblasts 
In order to confirm DNA microarray data showing a 12-fold and 40-fold 
upregulation of P-Rex1 transcript following expression of v-Fos or H-RasV12, 
respectively, in telomerase immortalised foreskin fibroblasts (TIFFs), RT-PCR was 
performed using primers specific to P-Rex1. A control reaction used primers 
specific for GAPDH to ensure equal loading of cDNA into the reactions. The 
upregulation of P-Rex1 transcript compared to normal TIFFs was confirmed by 30 
cycles of PCR with P-Rex1 primers and 25 cycles of PCR with GAPDH primers (Fig. 
3.1).  
 
3.1.2 Overexpression of P-Rex1 induces cytoskeletal 
rearrangement and modified migration 
To investigate the potential of P-Rex1 to modify cell morphological and 
migratory properties, N-terminal GFP-tagged P-Rex1 was overexpressed in TIFFs 
by nucleofection mediated transfection. Cells were plated on glass coverslips 
under standard culture conditions and examined 24 hrs post-transfection by 
phase contrast and confocal microscopy. P-Rex1 overexpressing cells acquired a 
round shape due to extensive lamellipodial extensions compared to non-
transfected elongated cells (Fig. 3.2a). GFP-tagged P-Rex1 localised throughout 
the cytoplasm and at peripheral actin rich membrane ruffles, and not in the 
nucleus. Numerous vesicles were often present throughout the cytoplasm upon 
P-Rex1 overexpression, likely due to the promotion of macropinocytosis as 
documented following Rac activation (Ridley, Paterson et al. 1992). These 
phenotypes are very similar to those observed upon overexpression of active 
RacV12. Overexpression of N-terminal Myc-tagged P-Rex1 resulted in an identical 
morphology and pattern of localisation to that of GFP-tagged P-Rex1. Although 
P-Rex1 was clearly present in membrane ruffles, overexpression of proteins can 
lead to aberrant or misrepresented localisation. To test whether this could be 
the case with P-Rex1 overexpression, GFP alone was expressed in TIFF cells 
overexpressing Myc-tagged P-Rex1.  
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Figure 3.1 - P-Rex1 expression is upregulated 
following H-RasV12 or v-Fos expression 
 
Human telomerase immortalised foreskin fibroblasts (TIFFs) were retrovirally 
infected with v-Fos or H-RasV12 oncogenes as previously described (Scott, Vass 
et. al. 2004) and transcript levels of P-Rex1 were measured by semi-quantitative 
PCR over 25 cycles on cDNA from total RNA cell lysates. Primers to GAPDH 
were used as a control for cDNA concentration. Reactions were resolved by 
agarose gel electrophoresis and visualised by UV light exposure following 
ethidium bromide staining. 
WT1       v-Fos WT2      H-RasV12
P-Rex1
GAPDH
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Figure 3.2 - P-Rex1 overexpression induces 
morphological changes in TIFFs 
 
TIFFs were transfected with GFP-tagged P-Rex1 by nucleofection and the 
morphology of cells was assessed 24 hrs later. A) cells were permeablised and 
actin was stained with TRITC-conjugated phalloidin and examined by confocal 
microscopy. B) cells were examined by phase contrast microscopy.
A
B
Tiff-P-Rex1Tiff
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To further study the function of P-Rex1, stable overexpressing cell lines were 
generated by retroviral infection of TIFFs with N-terminal Myc-tagged P-Rex1. All 
TIFF clones that expressed recombinant P-Rex1 had the same rounded shape 
with prominent peripheral ruffles as observed upon transient overexpression 
(Fig. 3.2b). At confluency, TIFF cells aligned parallel with each other in dense 
swirls while TIFF-P-Rex1 cells grew in a compacted cobblestone pattern. 
Timelapse microscopy of random cell movement and subsequent digital tracking 
analysis revealed that P-Rex1 overexpression caused a 26 % increase in total 
distance moved over a given time, but that this increased movement was erratic 
and resulted in a decrease in persistence associated with a 50 % reduction in the 
Euclidean distance travelled (Fig. 3.3). Normal TIFF cells moved in a direction 
aligned with their elongated polarised shape, extending with single pseudopodia. 
In contrast, TIFF-P-Rex1 cells often extended multiple lamellipodia in a number 
of opposing directions, but most often moved in the direction of the largest of 
these (Supplemental Movie 1). 
To provide directionality to the TIFF and TIFF-P-Rex1 cells, ‘wound healing’ 
assays were performed in which a single scratch was made in a confluent 
monolayer of cells using a 10 µl pipette tip. Given such a directional cue, P-Rex1 
overexpression reduced the time required for cells to close the gap compared to 
normal TIFFs (Fig. 3.4). P-Rex1 overexpressing cells moved forward from the 
wound with lamellipodia and extensive ruffles at the free leading edge. 
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Figure 3.3 P-Rex1 overexpression enhances cell 
speed but represses persistence 
 
Movement of TIFF and TIFF-P-Rex1 cells was monitored over a period of 24 
hrs by timelapse microscopy under standard culture conditions. A) Images 
show the morphology difference resulting from P-Rex1 overexpression (see 
also Supplemental Movie 1. B) Cell movements were measured by tracking the 
movements of cell nuclei and plotted using ImageJ software, which was also 
used to calculate C) total accumulated distance of cell movement, and D) the 
Euclidean distance moved.
0
100
200
300
400
500
600
700
800
900
Tiff Tiff P-Rex1
A
cc
um
ul
at
ed
 D
is
ta
nc
e
0
50
100
150
200
250
300
Tiff Tiff P-Rex1
E
uc
lid
ea
n 
D
is
ta
nc
e
A
Tiff-P-Rex1
B
D
Tiff
800 µm
C
Myc
ERK2
pLHCX
pLHCX
P-Rex1
75 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 – P-Rex1 enhances ‘wound healing’ of 
fibroblasts 
 
TIFF and TIFF-P-Rex1 cells were seeded at equal cell density and grown to 
confluence and a scratch made in the cell monolayer, representative images 
shown. 
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3.1.3 Overexpression of P-Rex1 induces invasion, overexpression 
of Tiam1 does not 
The migratory capacity and morphology of cells can differ enormously when 
placed on 2D or in 3D substrates. Therefore, inverse invasion assays were 
performed in which the ability of cells to invade through Matrigel was 
determined. Stable cell lines were generated of TIFFs overexpressing myc-
tagged ‘GEF-dead’ P-Rex1 containing 2 inactivating point mutations in the 
catalytic DH domain, and myc-tagged Tiam1, another Rac GEF, in order to 
compare with P-Rex1 WT (Fig. 3.5a). Expression of Tiam1 induced similar 
morphological change as P-Rex1; cells became rounded with peripheral 
membrane ruffles (Fig. 3.5b). While the morphology of TIFF-P-Rex1 cells did not 
alter over multiple passages, TIFF-Tiam1 cells gradually became less ruffled and 
more spread. Expression of GEF-dead P-Rex1 did not change TIFF cell 
morphology and expressed evenly throughout the cytoplasm. 
TIFF-P-Rex1 cells were strongly invasive towards a chemoattractant of 10 % 
serum, invading a distance of approximately 100 µm in 2 days, while TIFF-GEF-
dead P-Rex1 and TIFF-Tiam1 cells did not invade the matrigel plug (Fig. 3.6). 
These results demonstrate that the induction of lamellipodia and membrane 
ruffles is not sufficient to stimulate invasion. The morphology of invading TIFF-P-
Rex1 cells was mesencyhmal. Cells were elongated and sent out one or multiple 
thin projections into the surrounding matrix (Fig. 3.6c). 
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Figure 3.5 – P-Rex1 WT and Tiam1 induce a similar 
morphological change upon overexpression 
 
TIFFs were infected with either empty retrovirus, or retrovirus to stably 
overexpress Myc-tagged P-Rex1 WT, P-Rex1 GEF-dead or Tiam1. A) Cells 
were lysed in SDS lysis and extracts resolved by SDS-PAGE and levels of 
recombinant proteins analysed by Western blotting using anti-myc antibody. 
Blots were re-probed with ERK2 specific antibody to ensure equal loading. B) 
Cells were cultured on glass coverslips, fixed, permeabilised and stained with 
TRITC-conjugated phalloidin  to visualise actin (red) and immunostained with 
anti-myc antibody and a FITC-conjugated secondary antibody to visualise 
recombinant protein (green) and examined by confocal microscopy. 
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Figure 3.6 - P-Rex1 overexpression stimulates 
invasion of TIFFs, Tiam1 does not 
 
Invasiveness of stable TIFF cell lines expressing empty vector, P-Rex1 WT, P-
Rex1 GEF-dead or Tiam1 was measured by the inverse invasion assay. A) 
Invading cells were stained with the fluorescent dye calcein and invasion was 
visualised by confocal microscopy. B) Invasion was quantified using ImageJ 
software and expressed as a percentage of the invasion of TIFF-P-Rex1 cells. See 
Materials and Methods for details of invasion quantification. C) High magnification 
image of TIFF-P-Rex1 cells invading in matrigel.
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Cytokinesis, the physical division of post-mitotic cells, requires a highly co-
ordinated regulation of the cytoskeleton (Barr and Gruneberg 2007). In 
particular, RhoA activity is required for actomyosin based contraction of the 
cleavage furrow. To examine whether Rac activation by P-Rex1 expression in 
TIFFs affects cell proliferation in addition to its effects on morphology, motility 
and invasiveness, simple growth assays were performed on TIFFs and TIFF-P-Rex1 
cells. Cells were seeded in 6 well tissue culture plates and counts were taken 
over the course of 5 days, during which no differences in cell number between 
TIFFs and TIFF-P-Rex1 cells were observed (Fig. 3.7). In addition, during confocal 
microscopy examination of TIFF and TIFF-P-Rex1 cells that had been DAPI 
stained for visualisation of nuclei, there was no difference observed in the 
number of multinucleate cells. This demonstrates that P-Rex1 does not alter cell 
division. 
To confirm that the morphological and invasive phenotypes of the P-Rex1 
expressing clones selected after retroviral infection were wholly due to P-Rex1 
overexpression, and to assess the efficiency of RNAi transfection methods, TIFF-
P-Rex1 cells were subjected to transient siRNA and stable shRNA transfection. 
This resulted in a robust reduction in exogenous P-Rex1 protein levels and an 
accompanying reversion of the induced morphology and invasiveness compared 
to non-targetting siRNA (Fig. 3.8). 
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Figure 3.7 - P-Rex1 overexpression does not alter cell 
growth rate 
 
TIFFs and TIFF-P-Rex1 cells were seeded at equal cell number in 6 well 
tissue culture plates and cell counts were made at 24 hr intervals under 
standard culture conditions. 
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Figure 3.8 - RNAi to P-Rex1 reverses the morphology 
and invasion caused by overexpression 
 
TIFF-P-Rex1 cells were subjected to siRNA mediated knockdown of P-Rex1 
using 3 indpendent oligo sequences and non-targetting sequences as a control. 
A) Cells were lysed in lysis buffer and extracts resolved by SDS-PAGE and 
levels of recombinant P-Rex1 analysed by Western blotting with myc-specific 
antibody. Blots were reprobed with an ERK2 specific antibody to ensure equal 
loading. B) Cells cultured on glass coverslips were fixed, permeabilised and 
stained with TRITC-conjugated phalloidin to visualise actin (red) and 
immunostained with myc-specific antibody and FITC conjugated secondary 
antibody to visualise recombinant P-Rex1 (green) and examined by confocal 
microscopy. C) Matrigel invasion of cells was measured using the inverse 
invasion assay and is expressed as a percentage of the invasion of untreated 
cells. 
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3.1.4 P-Rex1 induced morphology and invasion are dependent on 
Rac1 
The morphology of TIFF-P-Rex1 cells is similar to that of cells expressing active 
Rac1. The levels of active GTP-bound Rac1 were therefore measured in TIFF and 
TIFF-P-Rex1 cells using the PAK-crib domain pulldown assay, which relies on the 
differential binding of GTP- and GDP-bound Rac to the crib-domain of the Rac 
effector protein PAK. Steady state GTP-Rac1 levels were elevated in TIFF-P-Rex1 
cells compared to TIFFs when maintained in 10 % serum (Fig. 3.9). Upon serum 
starvation, GTP-Rac1 levels were reduced in both cell lines to an approximately 
equal state. Upon stimulation with 10 % serum, the level of GTP-Rac1 after 5 
minutes in TIFF-P-Rex1 cells was dramatically enhanced compared to that of 
TIFFs. Rac2 protein could not be detected in these cells by Western blot analysis 
with the available antibody and so the activation of Rac2 by P-Rex1 
overexpression could not be determined.  
To determine whether the 2D morphology and invasiveness induced by P-Rex1 
was dependent on Rho family GTPase activity, cells were treated with siRNA to 
Rac isoforms and Cdc42. Treatment with Rac1 and Cdc42 siRNA reduced 
respective protein levels, while Rac2 could not be detected in these cells (Fig. 
3.10, and data not shown). The ruffling and broad lamellipodia induced by P-
Rex1 were partially reverted by siRNA to Rac1, but not by siRNA to Rac2, Rac3 or 
a closely related Rho-family GTPase, Cdc42 (Fig. 3.10). Reducing Rac1 levels was 
also able to reduce the invasion of TIFF-P-Rex1 cells (Fig. 3.11). Although the 
total level of invasion following Cdc42 knockdown was unchanged (as measured 
by area occupied by cells in the matrigel, which is proportional to the number of 
cells), the cells invaded a shorter distance into the matrigel. Surprisingly, the 3D 
morphology of the cells that did invade following Rac1 RNAi was no different to 
that of normal TIFF-P-Rex1 cells (Fig. 3.11b). These results, showing that 
inhibition of Rac activity reverts P-Rex1 induced phenotypes and that P-Rex1 
overexpression elevates active Rac levels strongly support P-Rex1 being placed 
upstream of Rac activation, consistent with evidence from other experimental 
systems (Welch, Coadwell et al. 2002). 
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Figure 3.9 - P-Rex1 overexpression elevates the level 
of active Rac1 
 
Levels of active GTP-bound Rac1 were measured by use of the 
PAK-crib domain pulldown assay. TIFF and TIFF-P-Rex1 were 
cultured under either standard conditions (10 %), serum starved for 
24 hrs (SF) or stimulated with 10 % serum for 10 minutes (+). Total 
cell lysates and proteins bound to PAK-crib domain bound 
glutathione beads were resolved by SDS-PAGE and levels of Rac1 
were analysed by Western blotting using a Rac1 specific antibody. 
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Figure 3.10 - Rac1 is required for P-Rex1 induced 
morphology 
 
TIFF-P-Rex1 cells were treated with siRNA to P-Rex1, Rac1, Rac2, Rac3 and 
Cdc42. A) Cells were lysed in lysis buffer, extracts were resolved by SDS-PAGE 
and levels of proteins were analysed by Western blot using respective 
antibodies. Blots were reprobed with an ERK2 specific antibody to ensure equal 
loading. B) Cell morphology was examined by phase contrast light microscopy. 
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Figure 3.11 - Rac1 is required for P-Rex1 induced 
invasion 
 
TIFF-P-Rex1 cells were treated with siRNA to P-Rex1, Rac1, Rac2 
and Cdc42. A) Cell invasion was measured by the inverse invasion 
assay and expressed as a percentage of the invasion of TIFF-P-Rex1 
cells treated with non-targeting control sequence. B) Morphology of 
cells invading matrigel stained with calcein. 
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3.1.5 Domain mutations of P-Rex1 affect its ability to alter 
morphology and invasiveness 
P-Rex1 is a 185 kDa protein comprising a DH and PH domain, tandem DEP and 
PDZ domains and a C-terminal domain with high homology to IP4P (Fig. 3.12a). 
To investigate the functional importance of these domains, sequences encoding 
previously described mutants containing domain deletions (Hill, Krugmann et al. 
2005) were cloned into the retroviral insertion vector pLHCX and stably 
expressed in TIFFs. The resulting morphologies and invasive capacities of the 
cells were then assessed. The ‘GEF-dead’ mutant contains 2 point mutations 
resulting in a Glutamine to Alanine conversion at position 56 and an Asparagine 
to Alanine conversion at postion 238, both within the catalytic DH domain. The 
ΔPH mutant lacks the region inclusive of Leucine 272 and Glutamine 395; the 
ΔDEP mutant lacks the region inclusive of Lysine 423 and Alanine 597; the ΔIP4P 
mutant lacks the region C-terminal of Valine 842; the iDHPH domain lacks the 
region C-terminal of Glutamic acid 395.  
All versions of N-terminal Myc-tagged P-Rex1 expressed to approximately equal 
levels at the predicted molecular weights (Fig. 3.12b). Removal of either the 
DEP or IP4P domains completely ablated the morphological change and 
invasiveness associated with P-Rex1 WT overexpression (Fig. 3.13 and 3.14). 
Both mutants expressed evenly throughout the cytoplasm. The ΔPH domain 
mutant was able to stimulate similar cytoskeletal rearrangements as P-Rex1 WT 
and also induced a high degree of invasion towards serum. Expression of the 
isolated DHPH of P-Rex1 induced a low level of invasion and caused a modest 
change in cell morphology, with cells becoming slightly less elongated. The 
isolated DHPH mutant expressed at very low levels throughout the cytoplasm 
and more strongly in the nucleus. All of these morphologies of stable 
overexpressing cell lines were consistent with transient overexpression 
experiments (not shown). However, transient overexpression of the iDHPH P-
Rex1 mutant caused more pronounced cell rounding than stable expression and 
the protein localised more throughout the cytoplasm in a punctuate pattern, 
suggesting that cells may not tolerate its long-term expression as well. These 
results indicate that a functional DH domain and the presence of the DEP and 
IP4P domains are crucial for full P-Rex1 induced morphology and invasion, while 
the PH is seemingly dispensable for these phenotypes.  
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Figure 3.12 - Expression of P-Rex1 mutants and 
Tiam1 in TIFFs 
 
A) Schematic diagram of the domain structure of P-Rex1 WT and mutants. B) 
TIFFs were retrovirally infected with empty vector or sequences encoding P-
Rex1 WT, GEF-dead, ΔPH, ΔDEP, ΔIP4P or iDHPH P-Rex1. After selection of 
pooled cell populations, cells were lysed in lysis buffer and extracts were 
resolved by SDS-PAGE and the levels of recombinant protein were analysed by 
Western blotting with a myc-specific antibody. Blots were reprobed with an 
ERK2 specific antibody to ensure equal loading. 
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Figure 3.13 - Effect of domain mutations on P-Rex1 
induced morphology 
 
Stable cell lines expressing various domain mutations of P-Rex1 were cultured 
on glass coverslips, fixed and permeablised and stained with TRITC-conjugated 
phalloidin to visualise actin (red) and immunostained with a myc specific 
antibody followed by FITC-conjugated secondary antibody to visualise 
recombinant protein (green) and examined by confocal microscopy. 
P-Rex1 WT P-Rex1 Gef-Dead
P-Rex1 Δ PH                         P-Rex1 iDHPH
P-Rex1 Δ DEP                        P-Rex1 Δ IP4P
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Figure 3.14 - Effect of domain mutations on P-Rex1 
induced invasion 
 
Invasiveness of stable cell lines expressing various domain mutations of P-Rex1 
was measured by the inverse invasion assay and expressed as a percentage of 
the invasion of P-Rex1 WT overexpressing TIFFs. 
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These results are consistent with evidence from cell-free systems which have 
identified the PH domain as inhibitory to GEF activity, but show that the 
elevated cell-free basal level of GEF activity elicited from the ΔDEP, ΔIP4P and 
iDHPH domain mutants (Hill, Krugmann et al. 2005) does not correlate with 
promotion of P-Rex1 function in intact cells. 
 
3.1.6 P-Rex1 phenotypes require growth factor stimulation 
All morphologies described so far were in the presence of 10 % serum, and all 
invasion assays were performed towards 10 % serum. To investigate the 
dependence of P-Rex1 function on extracellular signalling, a number of 
experiments were performed in which TIFF-P-Rex1 cells were serum starved and 
various ligands were added and the morphology and invasiveness of the cells 
were assessed. In all of these experiments, the readout of P-Rex1 activity was 
intense membrane ruffling and extensive lamellipodia formation and invasion, 
all features that were never observed in normal TIFF cells, with the exception of 
invasion in response to high PDGF concentrations (see later). 
Starving TIFF-P-Rex1 cells of serum overnight resulted in a dramatic reversion of 
the P-Rex1 induced morphology; cells became elongated and the broad 
lamellipodia and peripheral membrane ruffles became absent. Serum starvation 
increased the length/width ratio of TIFF-P-Rex1 by almost 4-fold and that of 
TIFFs by a more modest 1.4-fold (Fig. 3.15a). Addition of 10 % serum to the 
starved TIFF-P-Rex1 cells stimulated the familiar morphology over the course of 
3 hrs (Fig. 3.15b). Myc-tagged P-Rex1 was found diffusely throughout the 
cytoplasm in serum starved cells and appeared much less intense than in serum 
stimulated cells, where it frequently appeared at the cell periphery.  
To test the importance of serum stimulation on P-Rex1 induced invasion, assays 
were performed in which 10 % serum media or serum-free media was placed 
either above or below, or both above and below, the matrigel plug into which 
the cells invade. Surrounding the cells with serum free media reduced the 
degree of invasion by approximately 65 %, while surrounding the cells with 10 % 
serum reduced invasion by approximately 80 % (Fig. 3.15c). Inverting the  
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Figure 3.15 - P-Rex1 induced morphology and 
invasion is promoted by serum 
 
A) Length and width of TIFF and TIFF-P-Rex1cell was measured with and without 
serum and expressed as a ratio(n ≤ 40). B) TIFF-P-Rex1 cells cultured on glass 
coverslips were serum starved for 24 hrs (SF) and then stimulated with 10 % serum. 
Cells were fixed at indicated timepoints, permeablised and stained with TRITC-
conjugated phalloidin to visualise actin (red) and immunostained with a myc specific 
antibody followed by FITC-conjugated secondary antibody to visualise recombinant 
protein (green) and examined by confocal microscopy. C) Invasion of TIFF and TIFF-
P-Rex1 cells was measured by the inverse invasion assay where serum free media 
was placed below cells and 10 % serum placed above cells (SF / 10%), serum free 
media was placed above and below cells (SF / SF), 10 % serum was placed above 
and below cells (10% / 10%), or 10% serum was placed below cells and serum free 
media above cells (SF / 10%). Invasion is expressed as a percentage of the invasion 
of TIFF-P-Rex1 cells invading from serum media towards 10 % serum. 
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gradient of serum by placing 10 % serum only below the matrigel plug reduced 
invasion by approximately 85 %. As shown previously, normal TIFFs invaded to an 
extremely low level. Substituting matrigel for growth-factor reduced matrigel 
had little impact on the level of invasion of TIFF-P-Rex1 cells in the absence of 
serum, indicating that the residual level of invasion in serum free conditions 
could be due to haptotaxis, or due to the small amount of serum that could have 
infiltrated the matrigel while cells were left to adhere to the base of the 
transwell filter. Together, these results clearly demonstrate that P-Rex1 induced 
invasion is promoted by a chemotactic gradient. 
To determine which specific growth factors could activate P-Rex1 function, a 
number of growth factors were added to serum starved cells or as chemotactic 
attractants in invasion assays. PDGF was the only growth factor capable of 
substituting for 10 % serum in promoting lamellipodia and membrane ruffle 
formation and matrigel invasion (Fig. 3.16 and 3.17). PDGF stimulation of TIFF 
cells did not stimulate broad lamellipodia formation, but did result in membrane 
ruffle formation, although these were much smaller and less numerous than 
those observed in TIFF-P-Rex1 cells. To ensure that all the tested growth factors 
were biologically active at the concentrations used, pERK levels were measured 
and found to be approximately equal following 10 minute stimulations of serum 
starved cells with 10 % serum, PDGF, EGF, HGF or LPA (Fig. 3.17c). P-Rex1 is 
known to be activated by PIP3, a lipid messenger downstream of PI3 kinase 
(Welch, Coadwell et al. 2002). To indicate PIP3 levels generated in response to 
the various growth factors, pAkt levels were measured following stimulation of 
serum starved cells. Akt is localised to the plasma membrane upon PIP3 
accumulation and is subsequently phosphorylated by PDK1, so pAkt levels 
provide a good indication of PIP3 levels in the cell. Consistent with the enhanced 
morphological and migratory response to serum and PDGF over the other growth 
factors tested, serum and PDGF stimulation resulted in higher pAkt levels than 
stimulation by EGF, HGF or LPA (Fig. 3.17c) and this is likely to be indicative of 
higher PIP3 levels. The chemotactic response of invading TIFF-P-Rex1 cells to 
PDGF was dose dependent, and at 50 ng/ml TIFF cells also invaded to a limited 
degree (Fig. 3.18a). 
 
 
93 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16 - P-Rex1 induced morphology is 
promoted by PDGF 
 
TIFF-P-Rex1 cells were serum starved for 24 hrs and stimulated with the 
indicated growth factors (EGF 100 ng/ml, HGF 100 ng/ml, PDGF 50 ng/ml). 
Morphology was assessed by phase contrast microscopy 1 hr after stimulation. 
Serum free
+ EGF
+ HGF
+ PDGF
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Figure 3.17 - P-Rex1 induced morphology and 
invasion is promoted by PDGF 
 
A) TIFF-P-Rex1 cells were serum starved for 24 hrs and stimulated with the 
indicated growth factors (10 % serum, PDGF 50ng/ml) for 1 hr and cells were 
examined by confocal microscopy for actin (red) and myc-tagged P-Rex1 
(green). B) Invasion of TIFF-P-Rex1 cells towards the indicated growth factors 
(EGF 100 ng/ml, HGF 100 ng/ml, PDGF 50 ng/ml, LPA 10 µM) was measured 
by the inverse invasion assay and expressed as a percentage of the invasion of 
TIFF-P-Rex1 cells towards 10 % serum. C) TIFF-P-Rex1 cells were serum 
starved for 24 hrs and stimulated with the indicated growth factors for 10 min. 
Cells were lysed in lysis buffer and extracts were resolved by SDS-PAGE and 
the levels of phospho-ERK and phospho-Akt were analysed by Western blotting 
with phospho-ERK and phospho-Akt specific antibodies. Respective blots were 
reprobed with ERK2 and Akt specific antibodies to ensure equal loading. 
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Fig. 3.18 – P-Rex1 overexpression sensitises cells to 
PDGF gradients 
 
A) Invasion of TIFF and TIFF-P-Rex1 cells was measured in response to 
different concentrations of PDGF. Invasion is expressed as a percentage of the 
invasion of TIFF-P-Rex1 cells invading towards 50 ng/ml PDGF. B) 2D 
chemotaxis of TIFF and TIFF-P-Rex1 cells was measured by use of Dunn 
chamber with or without serum and 50 ng/ml PDGF as a chemoattractant.  
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To further analyse this chemotactic response, Dunn chambers were used to 
monitor the movement of cells in a stable gradient of growth factor over a 24 hr 
period. TIFF-P-Rex1 cells moved in random directions when placed in serum free 
media, but moved almost exclusively in the direction of a PDGF gradient (Fig. 
3.18b). TIFFs also moved towards a PDGF gradient, but in a far less distinct 
manner. Together with the PDGF induced invasion and morphology data, these 
results demonstrate that P-Rex1 expression sensitises cells to respond to PDGF. 
P-Rex1 has previously been shown to be activated both by Gβγ subunits 
downstream of G-protein coupled receptor signalling and by the lipid messenger 
PIP3 (Welch, Coadwell et al. 2002). To test the importance of these upstream 
activators to P-Rex1 function in fibroblasts, TIFF-P-Rex1 cells were treated with 
the PI3K inhibitor wortmannin, and the inhibitor of G-protein subunit uncoupling 
pertussis toxin. Wortmannin could inhibit PI3K activity, as measured by Akt 
phosphorylation, and inhibit the serum stimulated formation of P-Rex1 induced 
lamellipodia and membrane ruffles (Fig. 3.19). Inhibition of G-protein subunit 
release by pertussis toxin also suppressed lamellipodia and ruffle formation and 
ruffles. PIP3 and Gβγ subunits have been shown to act synergistically to elicit 
maximum P-Rex1 activity. Inhibition of MEK in the MAP Kinase pathway did not 
affect P-Rex1 induced morphology, but was biochemically active in these cells as 
it was shown to reduce basal and stimulated levels of phospho-ERK. Inhibition of 
ROCK, a kinase effector downstream of Rho, caused retraction of the cell 
periphery leaving long thin extensions, but large lamellipodia and ruffling were 
still clearly present. 
The response of P-Rex1 to PDGF alone, which primarily signals through its RTK to 
increase PIP3 levels, suggests that in the context of these experiments i.e. high 
expression of P-Rex1 and high concentration of PDGF, PIP3 is sufficient for P-
Rex1 function.  
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Figure 3.19 P-Rex1 induced morphology is 
dependent on PI3K and GPCR signalling 
 
A) TIFF-P-Rex1 cells were cultured under standard conditions and treated with 
the indicated chemical inhibitors (200 nM wortmannin 1 hr, 20 ng/ml pertussis 
toxin 16 hrs, 5 µM Y-27632 16 hrs, 50 µM UO126 16 hrs) and cell morphology 
was examined by phase contrast light microscopy. B) TIFF-P-Rex1 cells were 
serum starved for 24 hrs and stimulated with 10 % serum for 10 min with and 
without pre-treatment for 30 minutes with the indicated chemical inhibitors. Cells 
were lysed in lysis buffer and extracts were resolved by SDS-PAGE and the 
levels of phospho-Akt and phospho-ERK were analysed by Western blotting with 
a phospho-Akt or phosho-ERK specific antibody, respectively. Blots were 
reprobed with an Akt or ERK specific antibody to ensure equal loading. 
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The ΔPH domain P-Rex1 mutant has been shown to be constitutively active and 
unresponsive to PIP3 in cell free systems. Serum starving TIFF-P-Rex1ΔPH cells 
overnight resulted in the same as reversion of phenotype as serum starving TIFF-
P-Rex1 wt cells i.e. loss of lamellipodia and ruffles, and a 3.5-fold increase in 
the cell length/width ratio (Fig. 3.20a). These results suggest that the ΔPH 
mutant is not constitutively active in cells. To confirm that the ruffling of TIFF-
P-Rex1ΔPH cells was fully dependent on P-Rex1ΔPH expression (and not the 
result of clonal selectivity), siRNA was performed using a pool of P-Rex1 
sequences and this totally reverted the phenotype back to bipolar non-ruffling 
cells (Fig. 3.20b). To test whether PIP3 can regulate P-Rex1ΔPH in cells, TIFF-P-
Rex1 wt and TIFF-P-Rex1ΔPH cells were treated with wortmannin in the 
presence of serum. As shown previously, wortmannin very effectively inhibited 
P-Rex1 wt induced ruffling in the presence of serum within 30 minutes. 
However, there was very little inhibition of P-Rex1ΔPH induced ruffling (Fig. 
3.20c). Similarly to wt P-Rex1, P-Rex1ΔPH-induced ruffling was sensitive to 
inhibition of G-protein signalling by treatment with pertussis toxin. The 
effectiveness of wortmannin was tested by measuring steady state pAkt levels 
with and without treatment (Fig. 3.20d). This suggests that P-Rex1ΔPH is 
constitutively active with regard to its regulation by PIP3, but retains a 
requirement for Gβγ mediated activation to elicit its effects on cytoskeleton 
rearrangement. These results also support the idea that application of 
wortmannin in these experiments is acting to limit P-Rex1 activation and is not 
inhibiting other targets in parallel or downstream pathways that may be 
absolutely required for membrane ruffling.  
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Figure 3.20 – P-Rex1ΔPH induced morphology 
requires G-protein signalling, but does not require 
PIP3 stimulation 
 
A) Length/width ratios of TIFF, TIFF-P-Rex1 wt and TIFF-P-Rex1ΔPH cells at 
low density were measured in the presence of 10 % serum and after having 
been starved of serum for 18 hrs. B) TIFF P-Rex1ΔPH cells were treated with 
siRNA to P-Rex1 or a non-targeting control sequence and morphology assessed 
by phase contrast microscopy and length/width ratio of non-confluent cells 
calculated. Knockdown was assessed by Western blot using a Myc-specific 
antibody. C) TIFF-P-Rex1 wt and TIFF-P-Rex1ΔPH cells were treated with 20 
ng/ml pertussis toxin for 16 hrs or 200 nM wortmannin for 30 min and the 
presence of large membrane ruffles was assessed by phase contrast 
microscopy. Example ruffles are indicated with red arrows. D) pAkt levels were 
measured in lysates of TIFF, TIFF-P-Rex1 wt and TIFF-P-Rex1ΔPH cells in the 
presence of serum with and without 30 minutes treatment with 200 nM 
wortmannin by Western blot using a pAkt specific antibody and reprobing with 
an Akt specific antibody to ensure equal loading. 
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It has been suggested that Rac activation occurs both downstream and upstream 
of PI3 kinase activation. To determine whether PI3 kinase activity was elevated 
upon Rac activation by P-Rex1 overexpression, the levels of phospho-Akt after 
serum stimulation were measured in TIFF and TIFF-P-Rex1 cells. Steady state 
and serum-stimulated phospho-Akt levels were found to be unchanged between 
TIFF and TIFF-P-Rex1 cells (Fig. 3.21), suggesting that P-Rex1 does not increase 
global cellular PI3K activity, although whether it affects localised PI3 kinase 
activity was not tested. Likewise, the steady state and serum-stimulated levels 
of phospho-ERK were unchanged between TIFF and TIFF-P-Rex1 cells. 
 
3.1.7 P-Rex1 does not contribute to invasion of fibroblasts 
stimulated by v-Fos or H-RasV12 expression 
P-Rex1 is transcriptionally upregulated in fibroblasts expressing v-Fos or H-RasV12 
oncogenes. To test whether this upregulation contributes to the invasiveness of 
these cells, stable cell lines were generated expressing a shRNA vector to 
knockdown P-Rex1 levels and their invasiveness quantified. Two shRNA 
sequences were identified that resulted in a substantial, but not total, reduction 
of P-Rex1 in v-Fos and H-RasV12 expressing TIFFs, but this had no effect on their 
degree of invasion (Fig. 3.22). Expression of H-RasV12 in TIFFs results in a high 
degree of membrane ruffling, but RNAi to P-Rex1 did not reduce this. This 
suggests that the level of upregulation of P-Rex1 in TIFF-RasV12 cells is not 
sufficient to stimulate invasion, or that other mechanisms compensate for the 
loss of P-Rex1 upon knockdown, or that the knockdown of P-Rex1 is not of 
sufficient magnitude to elicit a robust phenotype in the assays used. 
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Figure 3.21 - P-Rex1 overexpression does not alter 
phospho ERK or phospho Akt levels 
 
TIFF and TIFF-P-Rex1 cells were cultured under standard conditions (10 %) or 
serum starved for 24 hrs (SF) and stimulated with 10 % serum for the indicated 
times. Cells were lysed in lysis buffer and extracts were resolved by SDS-PAGE 
and the levels of phospho-ERK and phospho-Akt were analysed by Western 
blotting with respective phospho-specific antibodies. Blots were reprobed with an 
ERK2 specific antibody to indicate loading. 
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Fig. 3.22 – P-Rex1 knockdown does not reduce TIFF-
RasV12 invasion 
 
A) TIFF-RasV12 cells were infected with empty vector, a non-targeting control 
sequence and 2 different shRNA sequences to P-Rex1. Levels of P-Rex1 
protein were assessed by western blot analysis. B) Invasion of cells was 
assessed by inverse invasion assay; invasion is quantified as a percentage of 
the invasion of empty vector infected TIFF-RasV12 cells. 
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3.2 Chapter Summary 
P-Rex1 was previously identified as one of 30 genes upregulated in invasive 
fibroblasts expressing v-Fos or H-RasV12 oncogenes and was hypothesised to be a 
positive mediator of the invasive phenotype. The experiments described in this 
chapter show that while P-Rex1 does not seem to contribute to the invasiveness 
of v-Fos or H-RasV12 expressing fibroblasts, it is able to induce invasion and 
dramatic morphological changes upon overexpression in TIFFs. P-Rex1 was shown 
to induce lamellipodia with highly active actin rich peripheral membrane ruffles 
and a highly invasive phenotype that were both dependent on stimulation by 
serum or PDGF. This was distinct from overexpression of another Rac GEF, 
Tiam1, which resulted in similar cytoskeletal rearrangements but did not induce 
invasion. While overexpression of P-Rex1 reduced persistence of random 
movement, it sensitised cells to serum and PDGF chemotactic gradients. P-Rex1 
overexpression enhanced levels of active GTP-bound Rac and the induced 
phenotypes were dependent on Rac1, PI3 kinase and G-protein coupled receptor 
signalling. Use of chemical inhibitors such as the PI3 kinase inhibitor wortmannin 
and the inhibitor of G-protein uncoupling pertussis toxin in these experiments 
will of course affect numerous proteins in the cell other than P-Rex1, but the 
ineffectiveness of wortmannin against P-Rex1ΔPH induced ruffles argues that PI3 
kinase activity is not absolutely required for these cytoskeletal structures. The 
positive correlation between specific growth factor stimulation, PIP3 levels as 
measured by Akt phosphorylation, and resulting P-Rex1 induced ruffles and 
invasion was further demonstration of the importance of PIP3 in activating P-
Rex1. Domain function analysis showed that a functional DH domain and the 
presence of the DEP and IP4P domains are required for full P-Rex1 activity, while 
the PH domain is likely required only for stimulation by PIP3. Together, these 
data support the hypothesis that P-Rex1 is able promote 2D and 3D chemotactic 
migration and matrix invasion.
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4 P-REX1 REGULATES CELL MORPHOLOGY AND 
INVASION IN HUMAN MELANOMA CELLS 
The previous chapter has shown how the Rac GEF P-Rex1 has the capacity to 
force an invasive phenotype and specific cytoskeletal rearrangements upon 
human fibroblasts. Whether P-Rex1 is expressed in and regulates cell function in 
tumour derived cell lines remained an open question. P-Rex1 expression is 
reported to be largely limited to neural tissues and neutrophils (Welch, Coadwell 
et al. 2002; Yoshizawa, Kawauchi et al. 2005). In order to determine whether it 
is expressed in human tumour derived cell lines, an online gene expression 
databases was utilised (www. cgap.nci.nih.gov), which showed P-Rex1 
expression to be consistently high in a number of melanoma derived cell lines. 
Melanoma often proceeds along a well characterised pathway from benign naevi 
to metastatic lesion. Numerous cell lines have been generated from human 
melanoma tissue, most commonly from metastasise. The genetic and phenotypic 
characteristics of melanoma derived cell lines used in this chapter are outlined 
in Table 11. 
Cell Line B-Raf status Ras status Derived from Invasive 
morphology 
 
A375mm V600E WT Malignant melanoma Amoeboid 
WM266.4 V600D WT Malignant melanoma Mixed 
CHL-1 WT WT Malignant melanoma Mesenchymal 
RPMI8332 WT WT Malignant melanoma Mesenchymal 
Melim V600D WT Malignant melanoma Not tested 
SKMEL28 V600E WT Malignant melanoma Not tested 
 Table 11 – Melanoma cell line characteristics 
The aims of the studies in this chapter are to determine whether P-Rex1 is 
expressed in melanoma derived cell lines and contributes to cell function, with 
an emphasis on cell morphology and invasion. 
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4.1.1 P-Rex1 expression is upregulated in melanoma derived cell 
lines 
Information on the Cancer Genome Anatomy Project website (www. 
cgap.nci.nih.gov) indicated a consistently high expression of P-Rex1 in melanoma 
derived cell lines (Fig. 4.1a). Western blot analysis confirmed the expression of 
P-Rex1 in a panel of melanoma derived cell lines and showed that this was a 
relative upregulation compared to primary human melanocytes (Fig. 4.1b). 
Melanocytes are routinely grown in the presence of TPA, which acts as a mitogen 
(Bennett, Cooper et al. 1987) and contributes to their differentiated state 
through changes in gene expression (Prince, Wiggins et al. 2003). To check that 
the low level of P-Rex1 expression in normal human melanocytes was not due to 
their specialised growth media, melanocytes were cultured in standard 10 % 
serum containing DMEM without TPA for a period of 5 days. Western blot analysis 
shows that these culture conditions did not affect P-Rex1 protein levels (Fig. 
4.1c). The observed upregulation of P-Rex1 expression was reminiscent of that 
seen between normal human fibroblasts and fibroblasts expression H-RasV12 or v-
Fos. A potential shared characteristic of the H-RasV12 and v-Fos expressing cells 
and melanoma cell lines is an enhanced activity of the MAP Kinase pathway or, 
in the case of v-Fos, an enhanced activity of an effector downstream of MAP 
Kinase activity. Therefore, the hypothesis that MAP Kinase activity could drive P-
Rex1 expression was tested by treating cells with the MEK inhibitor UO126. 
Treatment with 10 µM UO126 for 48 hrs resulted in a very modest reduction in P-
Rex1 protein levels in A375mm and WM266.4 melanoma cell lines, which both 
harbour activating B-Raf mutations (Fig. 4.1d). Expression of P-Rex1 was quite 
even across cell lines harbouring wt B-Raf, such as CHL-1 cells (which have very 
low levels of pERK, G. Inman, personal communication), or activating B-Raf 
mutations, such as A375mm cells. Together with data from the previous chapter, 
these results show that P-Rex1 is upregulated in a broad spectrum of human 
melanoma derived cell lines compared to normal human melanocytes and that 
high MAP kinase activity can elevate, but is not absolutely required for, its 
expression.  
 
 
107 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 - P-Rex1 expression is expressed in 
melanoma derived cell lines but not melanocytes 
 
A) Image taken from the Cancer Genome Anatomy Project website 
(www.cgap.nci.nih.gov) indicating a consistent high expression of P-Rex1 
in melanoma derived cell lines. B) Normal human primary melanocytes 
(Mel) and a panel of indicated melanoma derived cell lines were analysed 
by Western blot for P-Rex1 protein expression using a P-Rex1 specific 
antibody. C) Expression of P-Rex1 in primary human melanocytes in 
melanocyte specific media (MM) and DMEM with 10 % serum (DMEM) 
was analysed by Western blot. D) Expression of P-Rex1 in 2 melanoma 
derived cell lines was compared with and without treatment with the MEK 
inhibitor UO126 for 48 hrs by Western blot. All blots were reprobed with an 
ERK2 specific antibody to ensure equal loading. 
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4.1.2 Overexpression of P-Rex1 in melanocytes induces 
membrane ruffling 
During the course of the current study, it was observed that the non-
tumourigenic epithelial cell line MCF10A, did not respond to P-Rex1 
overexpression with an induction of lamelipodia and ruffles (data not shown). To 
test whether normal human melanocytes have the capacity to respond to P-Rex1 
activity, they were transiently transfected by nucleofection with GFP-tagged P-
Rex1. This resulted in the characteristic rounded morphology with peripheral 
membrane ruffles, as observed with overexpression of P-Rex1 in fibroblasts, 
compared to expression of GFP alone (Fig. 4.2). Transfection efficiency of 
primary melanocytes was extremely low (approximately 10 %) and so analysis of 
P-Rex1 induced morphology at high density, or measurement of invasion, was 
not possible. Attempts to select P-Rex1 expressing clones were unsuccessful, as 
transfected cells (both GFP-P-Rex1 and GFP) died after approximately 72 hours. 
This result demonstrates that human melanocytes possess all the required 
signalling pathways peripheral to P-Rex1 in order for it to function. 
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Figure 4.2 - Overexpression of P-Rex1 induces a 
change in morphology of melanocytes 
 
Primary human melanocytes were transfected with GFP or GFP-tagged P-
Rex1 by nucleofection. A) Cells were examined 24 hrs post transfection by 
phase contrast and UV microscopy to visualise GFP and GFP-P-Rex1 
expressing cells. B) The percentage of untreated or transfected cells with at 
least 1/8 of the cell periphery occupied by ruffles was measured. 
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4.1.3 Overexpression of P-Rex1 in A375mm melanoma cells 
enhances mesenchymal invasion. 
A375mm melanoma cells have an activating B-Raf mutation and derived from the 
metastasis of metastatic melanoma. They are well characterised as invading in 
an amoeboid, rounded mode (Sahai and Marshall 2003). To determine whether P-
Rex1 contributes to their invasive capacity, stable cell lines were generated in 
which P-Rex1 protein levels were depleted by shRNA sequences to P-Rex1 and 
the resulting cells were assayed in the inverse invasion assay. The invasion of 
A375mm cells was found not to be dependent on endogenous P-Rex1 (Fig. 4.3f). 
In order to examine whether A375mm cells had the potential to respond to P-
Rex1 signalling, stable lines of A375mm cells were generated by retroviral 
infection to overexpress myc-tagged P-Rex1 WT (Fig. 4.3a). Stable cell lines 
expressing P-Rex1 GEF-dead were also generated, to serve as a control and also 
because a similar GEF-dead mutant of P-Rex1 had been reported to act as a 
dominant negative, providing an alternative means to RNAi by which to assess 
the contribution of P-Rex1 to A375mm cell function. As a comparison to P-Rex1 
overexpression, cells overexpressing the Rac GEF Tiam1 were also generated. As 
before, P-Rex1 stimulated membrane ruffling (Fig. 4.3b) and enhanced invasion 
by approximately 3.5-fold (Fig. 4.3c) while the GEF-dead P-Rex1 caused no 
change. The morphology of A375mm cells invading through Matrigel was 
amoeboid, as previously described in the literature (Sahai and Marshall 2003). 
Upon overexpression of P-Rex1 in these cells, the invasive morphology became 
more elongated (Fig. 4.3d). Tiam1 overexpression caused an initial increase in 
ruffling activity, but this was lost when the cells became confluent and became 
highly adhesive to each other. Tiam1 overexpression decreased the invasiveness 
of A375mm cells by approximately 80 %. The enhanced ruffling of A375mm-P-
Rex1 cells was serum dependent as it disappeared upon culture in serum-free 
media (Fig. 4,3e). Together, these results demonstrate that while endogenous 
levels of P-Rex1 do not contribute to the amoeboid invasion of A375mm 
melanoma cells, ectopic overexpression of P-Rex1 is able to enhance their 
invasiveness and modulate their invasion to a more mesenchymal style that has 
previously been associated with higher Rac activity. 
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Fig. 4.3 - Ectopic overexpression of P-Rex1 enhances 
the invasion of A375mm melanoma cells 
 
A375mm melanoma were retorivrally infected to stably express an empty vector or 
sequence for Myc-tagged P-Rex1 WT, P-Rex1 GEF-dead or Tiam1. A) Expression of 
recombinant proteins was measured by western blot using an anti-Myc antibody. B) 
Cell morphology was assessed by fixing cells and staining with TRITC-conjugated 
phalloidin (red) and anti-Myc antibody and FITC-conjugated secondary antibody 
(green). C) Invasion was measured by the inverse invasion assay; invasion is 
expressed as a percentage of the invasion of empty vector containing cells. D) 
Morphology of A375mm cells stably expressing empty vector or P-Rex1 WT invading 
matrigel. E) Morphology of A375mm cells stably expressing empty vector or P-Rex1 
WT in 10 % serum or serum starved for 16hrs. F) Invasion of A375mm cells following 
P-Rex1 RNAi. 
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4.1.4 Overexpression of P-Rex1 in WM266.4 melanoma cells 
enhances invasion. 
Like A375mm melanoma cells, WM266.4 cells have an activating B-Raf mutation 
and are derived from metastatic melanoma. The bipolar elongated morphology 
of these cells is quite different to squat epithelial morphology of A375mm, CHL-
1 and RPMI8332 cells and they appear to invade matrigel as a mix of amoeboid 
and mesenchymal cells, as previously reported (Sahai and Marshall 2003). To 
investigate whether P-Rex1 contributes to the invasive properties of WM266.4 
cells, they were treated with transient siRNA oligos to P-Rex1. It was noticed 
that WM266.4 cells were extremely sensitive to siRNA transfection, with a 
significant reduction in cell number observed after treatment with either control 
or P-Rex1 sequences at low oligo concentrations (3 nM) and, to lesser extent, 
with treatment with transfection reagent alone. The mixed invasive morphology 
of WM266.4 cells has previously been investigated and found not to be due to 
clonal variation within the population and so it is thought that the cells can 
switch between invasive morphologies (Sahai and Marshall 2003). This idea is 
supported by the finding in the current study that RNAi to Rac1 resulted in 
almost exclusively amoeboid invading cells, while treatment with the ROCK 
inhibitor Y- resulted in almost exclusively mesenchymal invading cells (Fig. 
4.4a). It was also observed that the density at which cells were seeded on to the 
base of the transwell filter had a remarkable effect on the morphology of the 
invading WM266.4 cells, with a relatively low density favouring amoeboid 
invasion and a relatively high density favouring mesenchymal invasion (Fig. 
4.4b). These properties of WM266.4 cells, together with the effects of the siRNA 
oligo transfection process on cell viability and number, made the results of 
transient RNAi experiments difficult to interpret and inconclusive with regard to 
the effect of P-Rex1 on cell invasion. P-Rex1 was therefore inhibited by shRNA 
sequences. The invasion of stable cell lines with reduced P-Rex1 expression did 
not change compared to that of cells expressing a non-targeting control 
sequence (Fig. 4.4c). Similarly to A375mm melanoma cells, ectopic 
overexpression of P-Rex1 was able to modestly enhance the invasiveness of 
WM266.4 cells, while Tiam1 inhibited invasion and P-Rex1 GEF-dead had no 
effect (Fig. 4.4d). 
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Figure 4.4 – Invasive morphology of WM266.4 
melanoma cells is malleable, but not dependent on 
endogenous P-Rex1 
 
 A) WM266.4 melanoma cells were treated with siRNA to Rac1 or treated with Y-27632 
and morphology of cells invading matrigel assessed by confocal microscopy after 
calcien staining. B) WM266.4 cells were seeded on to transwell filters at the indicated 
cell concentrations and the degree invasion and morphology of invading cells 
assessed. Result shown is typical of 3 experiments. Number of cells of each density 
counted for morphology ≤ 100. C) WM266.4 cells were infected with retroviral 
constructs with shRNA sequence to P-Rex1 or a non-targeting control sequence (scr) 
and invasion assessed. D) WM266.4 cells were infected with an empty retroviral 
construct or sequence encoding P-Rex1 wt, P-Rex1 GEF-dead or Tiam1 and invasion 
assessed. 
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4.1.5 Inhibition of P-Rex1 reduces ruffling of CHL-1 melanoma 
cells 
Unlike many melanoma derived cell lines, CHL-1 cells do not have activating Raf 
or Ras mutations, but they are derived from metastatic melanoma and the 
expression of P-Rex1 in these cells is highly elevated compared to normal 
melanocytes. Additionally, CHL-1 cells have a highly ruffling morphology and so 
presented themselves as a potentially interesting cell line in which to study Rac 
related signalling. To test whether the endogenous level of P-Rex1 in CHL-1 cells 
was important for cell function, P-Rex1 levels were depleted by either 
transiently transfecting cells with siRNA to P-Rex1 or stably infecting cells with 
retroviral constructs containing shRNA sequences to P-Rex1. Both transient and 
stable RNAi methods were able to reduce P-Rex1 protein levels in CHL-1 
melanoma cells (Fig. 4.5a and Fig. 4.6a). The high basal level of membrane 
ruffling in CHL-1 cells was dramatically reduced by lowering P-Rex1 expression 
(Fig. 4.5b and Supplemental Movie 2). To reduce the probability that ‘off-target’ 
effects were responsible for the observed phenotype, 5 different siRNA 
sequences to P-Rex1 were used (including a pool of 4 different sequences as 
indicated) that reduced P-Rex1 levels with approximately equal efficiency, along 
with 3 different siRNA non-targeting control sequences (Fig. 4.5c). Confocal 
microscopy of cells cultured on glass coverslips revealed that the peripheral 
membrane ruffles were actin rich structures, although it should be noted that 
the number and size of the ruffles was smaller on cells cultured on glass than on 
tissue culture plastic. Timelapse microscopy revealed these structures to be 
highly dynamic, with a typical turnover time of approximately 30 seconds. In 
subconfluent cells, the ruffles were almost exclusively peripheral, comprising up 
to 70 % of the free edge of the cell circumference. Ruffles were observed to rise 
at the edge of the cell and fall back towards the cell body and collapse. Cells 
often displayed structures which appeared highly elevated above the planar cell 
surface, moving in response to agitation by the flow of growth medium, although 
these were rarely seen when cells were cultured on glass. In confluent cells, 
ruffles appeared more prominently from the dorsal cell surface, although these 
were not observed to retract into the circular structures typical of dorsal ruffles 
(Buccione, Orth et al. 2004). The ruffles were highly active on stationary cells 
and were not associated with direction of movement. Other than the reduction 
in peripheral ruffles, cell morphology was not dramatically affected, although  
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Figure 4.5 - siRNA to P-Rex1 reduces ruffling in CHL-
1 melanoma cells 
 
CHL-1 melanoma cells were treated with 5 independent siRNA sequences to 
P-Rex1, a sequence to P-Rex2, and 3 independent non-targeting control 
sequences. A) Levels of P-Rex1 were analysed by Western blot using a P-
Rex1 specific antibody, blots were reprobed with an antibody to ERK2 to 
ensure equal loading. B) Cell morphology following treatment was examined by 
confocal microscopy.Cells were stained with TRITC-conjugated phalloidin to 
visualise actin (red) (upper panels). Phase contrast light microscopy (lower 
panels). C) The percentage of ruffling cells (where at least 1/8 of the cell 
periphery was occupied by ruffles) following each treatment was measured.
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Figure 4.6 - shRNA to P-Rex1 reduces ruffling in 
CHL-1 melanoma cells 
 
CHL-1 cells were retrovirally transfected with 2 independent shRNA sequences to 
P-Rex1 and a non-targeting control sequence and empty vector. A) Levels of P-
Rex1 were analysed by Western blot using a P-Rex1 specific antibody. Blots were 
reprobed with an antibody to ERK2 to ensure equal loading. B) Cell morphology 
was examined by phase contrast light microscopy. C) The percentage of ruffling 
cells (where at least 1/8 of the cell periphery was occupied by ruffles) following 
each treatment was measured. 
 
 
 
 
LMP SCR CHL LMP P-REX1 SEQ 1
0
10
20
30
40
50
60
70
80
LMP LMP SCR LMP P-REX1 SEQ 1 LMP P-REX1 SEQ 2
%
 R
uf
fle
d 
C
el
ls
A
B
LMP         P-REX1
SCR     SEQ1  SEQ2
P-REX1
ERK2
C
117 
cells were slightly more spread upon P-Rex1 knockdown. Similar, but more 
modest, results were obtained by stable knockdown using 2 different shRNA 
sequences to P-Rex1 and an empty vector and non-targeting sequence as 
controls (Fig. 4.6). Upon making a scratch in confluent monolayer of CHL-1 cells, 
peripheral ruffles appeared along the free edge of the cells and these ruffles 
were similarly reduced by lowered P-Rex1 expression. Wound healing assays 
using these cells were difficult to interpret as the closure of the wound 
appeared to be largely due to cell proliferation and not due to active migration.  
Membrane ruffling is highly associated with Rac activity and, as shown in 
Chapter 3, P-Rex1 induced ruffling in fibroblasts is largely dependent on Rac1 
expression. Surprisingly, knockdown of Rac1 by siRNA in CHL-1 melanoma cells 
did not reduce ruffling, despite a very robust reduction in Rac1 protein levels 
(Fig. 4.7). Rac2, expression of which is reported to be restricted to 
haematopoietic cells, could not be detected in CHL-1 cells with the Rac2 
specific antibody used (data not shown), and treatment of cells with Rac2 siRNA 
did not reduce ruffling. Use of a Rac antibody that recognises other isoforms in 
addition to Rac1 (i.e. Rac2 and Rac3) showed that Rac1 siRNA was sufficient to 
reduce overall Rac protein levels very effectively. In addition, siRNA to Rac3 did 
not reduce ruffling, although the effectiveness of Rac3 RNAi has not yet been 
directly measured by means of a Rac3 specific antibody. An alternative method 
of Rac inhibition is the chemical inhibitor NSC23766 (Gao T et al. 2004). In 
contrast to Rac RNAi, treatment of cells with NSC23766 was able to reduce 
membrane ruffling (Fig. 4.7b). 
These results show that membrane ruffling in CHL-1 melanoma cells is 
dependent on P-Rex1, but surprisingly, that a strong reduction in Rac protein 
levels does not inhibit the formation of these protrusions. However, the result 
from use of the Rac inhibitor compound was contradictory to these experiments 
and so it is not possible to state with full confidence that membrane ruffling in 
CHL-1 melanoma cells is Rac-independent. 
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Figure 4.7 – Ruffling of CHL-1 melanoma cells is not 
dependent on Rac or Cdc42 
 
CHL-1 cells were treated with a control siRNA oligo, or with sequences 
to P-Rex1, Rac1, Rac2, Rac3 or Cdc42, or with the Rac inhibitor 
NSC23766 and cell morphology was assessed. A) Western blot analysis 
following Rac RNAi using a Rac1 specific antibody, and a pan-Rac 
specific antibody. Blots were reprobed with ERK2 to ensure equal 
loading. B) Cell morphology assessed by phase contrast microscopy. C) 
Quantification of ruffling cells after treatment with non-targeting control 
oligos and sequence to Rac1. 
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To probe possible mechanisms parallel or directly related to P-Rex1 regulation of 
membrane ruffling, cells were put under various conditions of serum and growth 
factor stimulation and a number of characterised chemical inhibitors were 
applied before assessing the cells for their morphology. Serum starvation 
resulted in a reduction of ruffling and this could be reversed by stimulation with 
serum or with HGF, but none of the other growth factors tested including EGF, 
PDGF and LPA (Fig. 4.8). Like serum stimulated ruffles, HGF stimulated ruffles 
were sensitive to P-Rex1 RNAi (Fig. 4.8). Conditioned media from untreated CHL-
1 cells could not stimulate ruffling in P-Rex1 knockdown cells, indicating that 
the inhibition of ruffling resulting from P-Rex1 RNAi is not caused by a 
disturbance in extracellular growth factor production (Fig. 4.9). 
The peripheral ruffles of CHL-1 cells were actin rich (Fig. 4.5b) and treatment 
with the actin polymerisation inhibitor latrunculin A caused a rapid loss of 
ruffling (Fig. 4.10). Ruffling was also sensitive to inhibition of PI3 kinase, and G-
protein signalling, using the chemical inhibitors LY29004 and pertussis toxin, 
respectively. Although these compounds could act on other molecules necessary 
for ruffle formation in CHL-1 melanoma cells, these results are consistent with 
PIP3 and Gβγ being required for activation of P-Rex1 and stimulation of its 
downstream functions. Inhibition of Rho Kinase signalling by the inhibitor Y-
27632 caused contraction of the cell periphery, resulting in long extensions from 
the cell body. However, the intense areas of peripheral ruffling at the tips of 
these extensions were unaffected, suggesting that Rho activity is not required 
for their formation. 
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Figure 4.8 - siRNA to P-Rex1 reduces HGF stimulated 
ruffling in CHL-1 melanoma cells 
 
CHL-1 melanoma cells with treatment of siRNA to P-Rex1 or a non-targeting 
control sequence were serum starved for 24 hrs and stimulated with 50 ng/ml HGF 
for 10 minutes. A) Cell morphology was examined by phase contrast light 
microscopy. B) The percentage of ruffling cells (where at least 1/8 of the free edge 
cell periphery was occupied by ruffles) following each treatment was determined. 
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Figure 4.9 - Ruffling of CHL-1 melanoma cells is 
serum dependent 
 
A) CHL-1 cells were examined by phase contrast light microscopy under standard 
conditions and when serum starved for 24 hrs. B) CHL-1 cells treated with siRNA 
to P-Rex1 were treated with conditioned medium from untreated cells and the 
morphology was examined by phase contrast light microscopy.
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Figure 4.10 - CHL-1 melanoma cell ruffling is 
sensitive to PI3K and G-protein signalling inhibition 
 
CHL-1 melanoma cells were treated with the indicated chemical inhibitors 
(200 nM wortmannin for 30 minutes, 20 ng/ml pertussis toxin for 16 hrs, 5 
µM Y-27632 for 30 minutes, 10 ng/ml latrunculin A for 1 hr) and cell 
morphology was examined by phase contrast light microscopy. 
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4.1.6 Inhibition of P-Rex1 reduces invasion of CHL-1 melanoma 
cells 
The effect of P-Rex1 expression on melanoma cell invasion was tested by use of 
the inverse invasion assay on cells after transient or stable knockdown of P-
Rex1. Transient siRNA to P-Rex1 using 5 different sequences reduced invasion of 
CHL-1 cells by between approximately 20 % and 70 % compared to untreated and 
non-targeting sequence treated cells (Fig. 4.12a, 4.12b). P-Rex1 knockdown 
reduced both the number of invading cells and the distance to which they 
invaded and increased the number of non-invading cells remaining on the base 
filter of the transwell. Stable knockdown of P-Rex1 reduced invasion of CHL-1 
cells by approximately 40 % (Fig. 4.12c).The morphology of CHL-1 cells invading 
matrigel was not the highly elongated morphology characteristic of fibroblasts, 
but neither were they the smooth round morphology of amoeboid invading 
A375mm cells. Instead, the cells were quite squat in appearance, but extended 
thin protrusions in multiple directions from the cell body. Although the amount 
of invasion was reduced upon P-Rex1 RNAi, the morphology of the invading cells 
appeared unaltered (Fig. 4.12d). 
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Figure 4.12 - siRNA or shRNA to P-Rex1 reduces 
invasion of CHL-1 melanoma cells 
 
Invasion of CHL-1 melanoma cells was assessed after siRNA and shRNA to P-
Rex1 by the inverse invasion assay. A) A sample Z-series of invasion of control 
and P-Rex1 siRNA treated cells. B) Invasion of cells treated with 5 independent 
siRNA sequences to P-Rex1, a sequence to P-Rex2, a sequence to Rac1 and 3 
independent non-targeting sequences. C) Invasion of cells stably expressing 2 
independent shRNA sequences and a non-targeting control sequence and empty 
vector. Invasion is expressed as a percentage of the invasion of untreated CHL-1 
cells. D) Image of control and P-Rex1 RNAi treated CHL-1 melanoma cells 
invading matrigel. 
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4.1.7 Inhibition of P-Rex1 reduces membrane ruffling of RPMI8332 
melanoma cells 
To determine whether the function of P-Rex1 in the promotion of peripheral 
ruffles was unique to CHL-1 cells, stable cell lines expressing shRNA sequences 
to P-Rex1 were generated from another ruffling metastatic melanoma cell line 
with wild type Ras and Raf, RPMI8332, by retroviral infection (Fig. 4.13a). When 
cultured to high density, RPMI8332 cells displayed very active dorsal membrane 
ruffles that protruded upwards from the cell body (Fig. 4.13a, Supplemental 
Movie 3). This was not due to increased autocrine / paracrine signalling at high 
density, because transfer of conditioned media from cells grown at high density 
could not stimulate ruffling in cells grown at low density (data not shown). This 
ruffling is therefore likely to result from the physical interaction between 
densely packed cells or simply through the restricted lateral space limiting any 
protrusive forces to be directed upwards. Upon effective stable knockdown of P-
Rex1 levels by 2 different targeting sequences, this dorsal ruffling was 
dramatically reduced compared to an empty vector and non-targeting control 
(Fig. 4.13b and 4.13c). As the ruffling activity of RPMI8332 cells was closely 
related to their density, it was important to determine if P-Rex1 affected the 
growth properties of these cells. The growth rate of P-Rex1 knockdown cells and 
the density to which they could grow was unaffected (Fig. 4.14). High density 
dorsal ruffling in RPMI8332 cells was, like the peripheral ruffling of CHL-1 cells, 
lost upon serum starvation, or PI3 kinase inhibition or inhibition of G-protein 
signalling by wortmannin or pertussis toxin treatment, respectively (Fig. 4.15).  
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Figure 4.13 - shRNA to P-Rex1 reduces dorsal 
ruffling of RPMI 8332 melanoma cells 
 
RPMI 8332 melanoma cells were retrovirally infected with 2 independent shRNA 
sequences to P-Rex1, a non-targeting sequence and empty vector. A) P-Rex1 
expression was analysed by Western blot with a P-Rex1 specific antibody and the 
blot was reprobed with an ERK2 specific antibody to ensure equal loading. B) 
Cells were grown to confluence at equal cell number and dorsal ruffles were 
examined by phase contrast microscopy in the focal plane slightly above the layer 
of cells, example ruffles indicated with red arrows. C) Dorsal ruffles were counted 
and are expressed as a percentage of the number of dorsal ruffles counted in 
empty vector infected cells. 
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Figure 4.14 - shRNA to P-Rex1 does not reduce 
growth of RPMI 8332 melanoma cells 
 
Growth of RPMI 8332 melanoma cells stably expressing 2 independent shRNA 
sequences for P-Rex1, a non-targeting control and an empty vector was measured 
by splitting cells into 12 well plates at equal cell number and making cell counts at 
24 hr periods. 
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Figure 4.15 – Dorsal ruffles in RPMI 8332 melanoma 
cells are dependent on serum, PI3 kinase and G-
protein signalling       
 
RPMI 8332 cells were grown to confluency in normal medium and either untreated, 
serum starved for 16 hrs, treated with 20 ng/ml pertussis toxin for 16 hrs or 200 nM 
wortmannin for 30 minutes. Dorsal ruffles were assessed by phase contrast 
microscopy. Planes of focus of the cell monolayer and slightly above, to visualise 
dorsal ruffles, are shown. Example ruffles are indicated with red arrows. 
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4.1.8 Inhibition of P-Rex1 reduces invasion of RPMI8332 
melanoma cells 
The invasiveness of RPMI8332 melanoma cells that had been retrovirally infected 
with either of 2 shRNA sequences to P-Rex1 or a non-targeting sequence or 
empty vector was measured by the inverse invasion assay. Stable knockdown of 
P-Rex1 reduced invasion towards 10 % serum by approximately 30 % (Fig. 4.16). 
P-Rex1 RNAi reduced both the number of invading cells and the distance to 
which they invaded, while increasing the number of non-invading cells remaining 
on the base of the transwell filter. Like the invasion of CHL-1 cells the 
morphology of the invading RPMI8332 cells was characterised by multiple 
protrusions emanating from the cell body into the matrigel, although the overall 
shape of RPMI8332 cells was more mesenchymal. The static morphology of cells 
invading matrigel was unaffected by reduction of P-Rex1 levels. Together with 
the data outlined in Section 4.1.6, these results show that P-Rex1 acts to control 
morphology and promote matrix invasion of multiple cell lines. 
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Figure 4.16 - shRNA to P-Rex1 reduces invasion of 
RPMI 8332 melanoma cells 
 
A) Invasion of RPMI 8332 melanoma cells stably expressing 2 independent 
shRNA sequences for P-Rex1, a non-targeting control and an empty vector. 
Sections represent 15 µm intervals. B) Invasion was measured by the inverse 
invasion assay and is expressed as a percentage of the invasion of empty vector 
containing RPMI 8332 cells. 
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4.2 Summary 
Experiments from Chapter 3 showed that P-Rex1 can induce cytoskeletal 
rearrangements and enhance 2D and 3D migration/invasion upon overexpression 
in human fibroblasts and investigated the signalling mechanisms involved in P-
Rex1 induced phenotypes. In this chapter, it is shown that P-Rex1 expression is 
elevated in a number of human melanoma derived cell lines and that ectopic 
overexpression of P-Rex1 can enhance their invasiveness. Furthermore, it is 
demonstrated that in some of these cell lines endogenous P-Rex1 is required for 
cytoskeletal mediated membrane protrusions and contributes to the extent of 
their invasion through 3D matrix. The regulation of P-Rex1 dependent 
morphologies by key signalling pathways was investigated and found to be 
consistent with the view that P-Rex1 is dependent on PIP3 and Gβγ signalling to 
function. Experiments to determine whether P-Rex1 promotes formation of 
membrane ruffles through Rac activity were inconclusive, and this warrants 
further examination. Together, these results further our understanding of the 
functional role of P-Rex1 and suggest that in some contexts it is an important 
regulator of tumour cell morphology and motility. 
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5 INVESTIGATING THE ROLE OF P-REX1 IN 
MELANOMA TUMOUR DEVELOPMENT 
Data presented in Chapter 4, supported by expression data external to this study 
(C. Der, personal communication, subsequently published (Shields, Thomas et al. 
2007)), suggested that P-Rex1 may have a role in melanoma tumour biology, 
specifically with regard to invasive progression. A potential in vivo role for P-
Rex1 in melanocyte migration was supported by the pigmentation phenotype of 
the P-Rex1-/- mouse, as described below. Therefore, the hypothesis that P-Rex1 
contributes to melanoma spread was tested using a genetic mouse model of 
metastatic melanoma. 
The model chosen was the Tyr::N-RasQ61K INK4a-/- model, in which activated N-
Ras is expressed under the promoter of tyrosinase, a melanocyte lineage specific 
gene involved in melanin biosynthesis, in an INK4a  locus deficient background. 
The model has been characterised as developing cutaneous melanoma with a 94 
% incidence within 6.8 months of age (+/- 1.3 months), with 64 % of mice 
displaying enlarged melanocyte laden lymph nodes and 36 % of mice developing 
lung or liver metastases (Ackermann, Frutschi et al. 2005). The lung and liver 
metastases present as solitary pigmented nodules, with 2 or 3 nodules commonly 
detected at autopsy. The progressive nature of melanoma development in this 
model makes it attractive for studying both melanoma formation and metastatic 
spread. In addition, data showing a positive correlation between MAP kinase 
activity and P-Rex1 expression as described in the previous chapters and 
elsewhere (C. Der, personal communication, subsequently published (Shields, 
Thomas et al. 2007)), supported the hypothesis that P-Rex1 expression would be 
increased following elevated Ras activity in this mouse cancer model. 
The P-Rex1-/- mouse has been generated and described as having no gross 
phenotypic abnormalities, other than overall body weight and liver weight being 
on average 14 % and 10 % lower, respectively, than wt mice at 10 weeks old. P-
Rex1-/- also had 61 % more peripheral leuckocytes than wt mice and their 
neutrophils had a migratory defect as described earlier (Welch, Condliffe et al. 
2005). 
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The aims of the studies in this chapter are to determine whether knockout of P-
Rex1 has any effect on tumour development in a genetic mouse model of 
melanoma. 
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5.1.1 THE P-REX1 KNOCKOUT MOUSE HAS A PIGMENTATION 
DEFECT 
P-Rex1+/+ and P-Rex1-/- mice were born at the expected Mendelian frequencies 
and it was noticed that all P-Rex1-/- had a distinctive white patch of hair and 
skin along their belly region and that they had white white hair and skin for a 
larger proportion of their feet tips (n=108) compared to P-Rex1+/+ mice (n=115) 
(Fig. 5.1). The size of the belly patch was variable, ranging from a thin line to 
approximately half the width of the mouse underside. Measuring the length of 
the unpigmented tips of the feet revealed that the phenotype displayed a gene 
dosage effect, as P-Rex1+/- mice had a slightly larger unpigmented area at the 
tips of their feet than wild type mice, but had no white belly (Fig. 5.1c). The 
pigmentation phenotype persisted after crossing to INK4A-/- mice and it was 
confirmed that P-Rex1-/- mice derived from 2 independent embryonic stem cell 
lines both displayed the same phenotype (H.Welch, personal communication), 
while P-Rex1 wt mice did not. Mice bearing activated N-RasQ61K under the 
tyrosinase promoter have much darkened skin and hair due to hyperproliferation 
of melanocytes. Crossing P-Rex1-/- mice with Tyr::N-RasQ61K mice had no effect 
on the pattern or colour of the areas of unpigmented skin and hair, despite 
hyperproliferation of melanocytes in the pigmented areas (n=98) (Fig. 5.2). 
Sectioning of skin and staining with H&E revealed that in Tyr::N-RasQ61K mice, 
melanocytes were increased in number and localised not only to the hair 
follicles, as melanocytes in normal C57BL/6J do, but were present in large 
number below the epidermis and also throughout the fat tissue (Fig. 5.2). The 
unpigmented skin areas in P-Rex1-/- mice, i.e. the belly and feet tips, were 
devoid of pigmented melanocytes (Fig. 5.3). Together, these results show that 
P-Rex1 deficiency causes a pigmentation defect in mice associated with a lack of 
melanocytes in areas distal to sources of melanocyte precursor migration and 
that this phenotype is not rescued by increased melanocyte proliferation. 
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Figure 5.1 - Pigmentation phenotype of P-Rex1-/- mice 
 
 
Mice shown are representative of P-Rex1+/+ and P-Rex1-/- mice. A) White 
belly pigmentation phenotype of P-Rex1-/- mice. B) Pigmentation 
phenotype of feet of P-Rex1-/- mice. C) The lengths of the unpigmented 
areas from the feet tips of P-Rex1+/+, +/- and -/- were measured and 
quantified (n = ≥ 9 per genotype). 
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Figure 5.2 – Tyr::N-RasQ61K elevates melanocyte 
number in skin 
 
Shown are photos of mouse bellies and H&E stained sections of back skin 
from WT and N-RasQ61K mice, with and without P-Rex1. Pigmented cells are 
melanocytes, indicated with black arrows. 
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Figure 5.3 – White skin patches of P-Rex1-/- mice are 
devoid of pigmented melanocytes 
 
 
Shown are H&E stained sections of belly skin from N-RasQ61K mice with and 
without P-Rex1. Melanocytes are indicated with black arrows. White belly 
patch area of P-Rex1-/- mice corresponds to area devoid of pigmented 
melanocytes. 
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5.1.2 P-REX1 KNOCKOUT DOES NOT AFFECT ONSET OF 
MELANOMA FORMATION 
Since the proposed migratory defect of P-Rex1-/- melanocytes persisted after 
expression of activated N-RasQ61K, it was hypothesised that melanoma cells 
arising in N-RasQ61K INK4a+/- or -/- mice may also have a reduced capacity for 
migration/invasion. In order to assess in vivo whether P-Rex1 contributes to the 
formation or progression of melanoma, P-Rex1-/- mice were crossed to Tyr::N-
RasQ61K mice with either INK4a+/- or -/-. Mice were examined weekly for 
melanoma formation. Melanomas developed as roughly symmetrical tumours 
that were hairless and raised less than 1 mm from the skin surface, consistent 
with the original characterisation of this model (Fig. 5.4) (Ackermann, Frutschi 
et al. 2005). Mice that were INK4a-/- often had multiple small (less than 1 x 1 
mm) growths at approximately 3 months of age, but as many of these did not 
grow in size, melanomas were classed here as tumours that were at least 2 x 2 
mm in surface area. Tumours of this size invariably grew larger with time. 
Consistent with previous characterisation, homozygous loss of INK4a significantly 
accelerated onset of melanoma formation compared to INK4a heterozygotes 
from a median of 255 days (8.5 months) to 120 days (4 months) (Fig. 5.5). P-
Rex1 deficiency caused an insignificant delay in the median melanoma onset age 
from 255 days to 279 days in INK4a+/- mice and an insignificant delay from 120 
days to 141 days in INK4a-/- mice (Fig. 5.5). 
These results suggest that P-Rex1 does not affect the age of melanoma onset in 
this genetic model. 
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Figure 5.4 – Melanomas on N-RasQ61K INK4a-/- mice 
 
Example melanomas formed on N-RasQ61K INK4a -/- mice, indicated with 
red arrows (in this case P-Rex1-/-). Melanomas were defined as being at 
least 2x2 mm in surface area. 
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Figure 5.5 – Effect of P-Rex1 status on melanoma 
onset 
 
Melanoma onset was recorded in N-RasQ61K INK4a-/- P-Rex1+/+ (n = 16);           
N-RasQ61K INK4a-/-P-Rex1-/- (n = 24); N-RasQ61K INK4a+/- P-Rex1+/+ (n = 12);       
N-RasQ61K INK4a+/- P-Rex1-/- (n = 4) mice. Melanomas were recorded at an area 
of at least 2 x2 mm. 
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5.1.3 ACTIVE N-RAS EXPRESSING MELANOCYTES EXPRESS P-
REX1 
The pigmentation phenotype of P-Rex1+/- and -/- mice suggest that P-Rex1 is 
expressed in mouse melanocytes or their precursors. However, expression data 
presented in section 4.1.1 shows that P-Rex1 is barely expressed in human 
primary melanocytes compared to melanoma cell lines. To determine whether P-
Rex1 is expressed in mouse melanocytes with and without active N-RasQ61K, 
cultures were derived from the skin of N-RasQ61K positive and negative, and P-
Rex1+/+ and -/- pups, and protein expression was analysed by Western blot of cell 
lysates. It was not possible to detect P-Rex1 expression in lysates of skin tissue, 
presumably because melanocytes constitute such a small proportion of total 
cells and protein. Melanocyte cell lines derived from N-RasQ61K negative mice had 
relatively low levels of P-Rex1 protein, while P-Rex1-/- mice, predictably, had no 
expression. Expression of N-RasQ16K, meanwhile, elevated P-Rex1 levels (Fig. 
5.6), consistent with similar experiments in human fibroblasts as shown in 
section 3.1.1. The morphology of cell lines generated from mice was quite 
heterogeneous, even within the same genotype. Initial experiments also suggest 
that their migratory/invasive characteristics show great variability within 
genotypes and these investigations are ongoing. 
 
5.1.4 INVESTIGATING THE EFFECT OF P-REX1 KNOCKOUT ON 
MELANOMA METASTASIS 
Previous characterisation of the Tyr::N-RasQ61K INK4A-/- mouse melanoma model 
described 36 % of mice as having metastasis to the lungs or liver and that often 2 
or 3 small metastatic nodules were observable in the lungs at autopsy. At the 
time of writing, there have not been a sufficient number of P-Rex1-/- and P-Rex1-
/+ mice with melanoma that have undergone autopsy in order to draw 
statistically firm conclusions regarding prevalence of metastasis in the 
respective genotypes. This is because a high proportion of INK4a-/- mice 
developed fatal lymphomas, see below, reducing the number of mice in the 
cohorts. From the cohort analysed so far, a total of 4 N-RasQ61K INK4a-/- P-Rex1+/+ 
mice and a total of 12 N-RasQ61K INK4a-/- P-Rex1-/- mice with primary melanomas  
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Figure 5.6 – P-Rex1 expression in mouse 
melanocytes 
 
Melanocyte cultures were derived from the skin of 3 day old pups of N-RasQ61K 
positive and negative, and P-Rex1-/- and +/+ genotypes. A) Phase contrast and 
bright-field microscopy of early melanocyte cultures in order to visualise 
melanocyte pigmentation, higher (lower panel) and lower (upper panel) 
magnifications shown. Unpigmented cells are fibroblasts. B) P-Rex1 expression 
was analysed by Western blot of cell lysates using a P-Rex1 specific antibody. 
Blots were reprobed with an ERK2 specific antibody to ensure equal loading. 
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underwent autopsy. Of the P-Rex1-/- mice, there were no cases of observable 
lung or liver metastases or enlarged lymph nodes (0/12). Of the P-Rex1+/+ mice, 
1 had a dark spot in the lungs and 1 had dark spots in the spleen (2/4). These 
are currently undergoing histological examination. Given the reported incidence 
of metastasis in this model, these results tentatively suggest that P-Rex1 
deficiency may be suppressing metastatic progression. An extended cohort size 
and closer histological examination is required to confirm this. 
 
5.1.5 EFFECT OF P-REX1 ON OVERALL SURVIVAL IN N-RASQ61K 
INK4a-/- C57BL/6J MICE 
The C57BL/6J mouse strain is the most commonly used strain for studying 
melanocyte biology. For this reason, all experiments were performed on pure-
bred C57BL/6J mice. During the current investigation it was observed that a high 
proportion of INK4a-/- mice developed lymphomas and sarcomas, characterised 
by enlarged spleen and liver, that was not previously reported for this model 
(Ackermann, Frutschi et al. 2005), where the genetic background of mice was 
mixed 87 % C57BL/6J and 13 % DBA/2. Mice were culled if they developed 
lymphoma, sarcoma or advanced melanoma (where the melanoma became over 
8 x 8 mm in surface area and/or broken). Interestingly, the overall survival age 
was increased from a median of 148 days in N-RasQ61K INK4a+/+ mice (n= 22), to a 
median of 218 days in P-Rex1-/- mice (n= 11) (Fig. 5.7a) (p < 0.001). Mice were 
excluded from cohorts if they died of unknown causes, or if they were culled due 
to non-tumour related conditions including hydrocephaly, which a small 
proportion of P-Rex1-/- mice developed at an early age. Analysis of the cause of 
tumour related deaths showed that 100 % of P-Rex1+/+ mice died due to 
lymphoma, while 56 % of P-Rex1-/- mice died due to lymphoma/sarcoma and 44 % 
died due to advanced melanoma (Fig. 5.7b). P-Rex1-/- mice deaths were more 
frequently due to advanced melanoma most likely because they lived longer to 
develop larger tumours. 
Together, these results show that P-Rex1 deficiency significantly delays the 
onset of lymphoma in N-RasQ61K INK4a-/- mice. 
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Figure 5.7 – Effect of P-Rex1 status on overall 
survival 
Overall survival was recorded in N-RasQ61K INK4a-/- mice with P-Rex1+/+ (n= 
11) and P-Rex1-/- (n= 22). All deaths recorded were due to advanced 
melanoma, lymphoma or sarcoma. Mice suffering from other conditions, such 
as hydrocephaly, or deaths from unknown causes, were excluded. A) Kaplan-
Meier plot of survival. Statistical significance by Log-Rank, p = 0.000. B) 
Percentages of deaths caused by melanoma, lymphoma, and sarcoma. 
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5.2 Summary 
Following in vitro data from cell lines suggesting that P-Rex1 is involved in the 
regulation of cell morphology and migration/invasion, and expression data 
demonstrating an upregulation of P-Rex1 in melanoma, it was hypothesised that 
P-Rex1 may contribute to in vivo tumour progression. P-Rex1-/- mice were 
sourced and found to have a previously uncharacterised pigmentation phenotype 
associated with a defect in melanocyte migration to distant areas during 
development. Increased proliferation of melanocytes caused by N-RasQ61K 
expression did not rescue this phenotype. The onset of melanoma formation in 
the Tyr::N-RasQ61K INK4a +/- or -/- mouse model was not changed by P-Rex1 
deficiency, suggesting that P-Rex1 does not contribute to melanoma initiation. 
Data on metastatic spread of primary tumours is still forthcoming due to 
insufficient cohort numbers, but it is clear that the N-RasQ61K INK4a-/- P-Rex1-/- 
mice that have died due to melanoma have not had the level of metastasises 
previously reported in the characterisation of this model. The reason for the 
insufficient cohort numbers achieving an age at which they should develop 
advanced melanoma is that INK4a deficiency has resulted in a high incidence of 
fatal lymphoma and sarcoma. Unexpectedly, it was observed that P-Rex1 
deficiency resulted in a significant increase in overall survival in N-RasQ61K INK4a-
/- mice and that this was due to a delay in the age at which P-Rex1-/- developed 
lymphoma and sarcoma. A cohort of N-Ras WT, INK4a-/- mice with and without P-
Rex1 has now been generated to examine the delay in lymphoma onset in P-
Rex1-/- in a cleaner genetic background independent of N-RasQ61K. 
Together, these results suggest that while P-Rex1 deficiency does not affect the 
onset of melanoma formation, it may reduce the incidence of metastasises. 
Unexpectedly, it also appears that P-Rex1 deficiency delays the onset of 
lymphoma development, suggesting that P-Rex1 plays an oncogenic role in 
lymphoma.
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6 DISCUSSION 
Previous work in the lab has sought to identify genes that mediate cell invasion 
and identified P-Rex1 as a candidate. The data presented here characterise the 
ability of the Rac GEF P-Rex1 to control cell morphology and 2D and 3D motility 
in response to upstream signalling pathways, as determined by overexpression 
and RNAi experiments in a number of cell lines, and characterise its role in 
tumourigenesis using a mouse genetic model of melanoma.  
Chapter 3 showed that P-Rex1 induces membrane ruffling, sensitises cells to 
chemotactic gradients and confers an invasive phenotype upon overexpression in 
human fibroblasts, and that this is dependent on Rac1 activity, PIP3 and Gβγ 
signalling. 
Chapter 4 showed that P-Rex1 is upregulated in a number of human melanoma 
derived cell lines and that it can promote the formation of membrane ruffles 
and contribute to their invasiveness. 
Chapter 5 showed that the P-Rex1 knockout mouse has a pigmentation 
phenotype consistent with a developmental defect in melanocyte migration; 
that P-Rex1 expression does not affect melanoma initiation, but may contribute 
to metastatic progression; and unexpectedly, that P-Rex1 deficiency delays the 
onset of lymphoma in INK4a-/- mice. 
Since the discovery of P-Rex1 and the start of these investigations, a number of 
studies have been published further describing its biochemical regulation and 
cellular and physiological function. There is now compelling evidence to support 
a role for P-Rex1 in promoting cell migration in a broad range of cell types and 
situations. 
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6.1 P- Rex1 influences cell morphology 
6.1.1 Overexpression of P-Rex1 modifies cell morphology 
The present study shows that overexpression of P-Rex1 in human fibroblasts, 
human primary melanocytes, or A375 and WM266.4 melanoma cells induces a 
morphology characterised by lamellipodial extensions and active actin rich 
membrane ruffles. This is consistent with the phenotype observed by others 
upon P-Rex1 overexpression in PAE cells (Welch, Coadwell et al. 2002) and in 
PC12 cells (Yoshizawa, Kawauchi et al. 2005), indicating that numerous diverse 
cell types are similarly responsive to P-Rex1. Overexpression of Tiam1 induces a 
similar morphology, but unlike P-Rex1, enhances cell adhesiveness, in agreement 
with previous studies in other melanoma and epithelial cell lines (Hordijk, ten 
Klooster et al. 1997; Uhlenbrock, Eberth et al. 2004). This illustrates 2 important 
points - that different GEFs can have different functions within the same 
context, and that similar influences on cell morphology do not always correlate 
with similar influences on migratory behaviour. Tiam1 has been shown to bind 
IRSp53, a protein that interacts with the Arp2/3 complex via the scaffold protein 
WAVE2, and to enhance the affinity of IRSp53 for activated Rac1 (Connolly, Rice 
et al. 2005). Additionally, Tiam1 has been shown to associate directly with the 
p21-Arc subunit of the Arp2/3 complex (Ten Klooster, Evers et al. 2006). A 
model has therefore been proposed where Tiam1 acts to localise activated Rac 
to its effectors that mediate cytoskeletal rearrangements, ultimately through 
activation of the Arp2/3 complex. Clearly Tiam1 is not unique in its ability to 
induce membrane ruffling, and so it would be interesting to determine whether 
P-Rex1 undergoes similar interactions with the molecular scaffolds and 
machinery responsible for actin polymerisation. In the current study it is shown 
that P-Rex1 induced ruffles in fibroblasts are dependent on Rac1, as siRNA 
towards Rac1, but not related GTPases, reverts the ruffling phenotype. In mouse 
neutrophils, P-Rex1 acts mainly on the haematopoietic isoform Rac2 (Dong, Mo 
et al. 2005; Welch, Condliffe et al. 2005), while in PC12 cells it acts primarily on 
the Rac3 isoform which is highly expressed in neural tissues (Waters, Astle et al. 
2008). The different Rac isoforms share 92 % homology in their amino acid 
sequences and comparative in vitro analysis has revealed they are highly similar 
in their biochemical properties such as effector interactions and nucleotide 
hydrolysis, although Rac2 displays much slower nucleotide association and 
149 
increased activation by Tiam1 (Haeusler, Blumenstein et al. 2003). Differences 
within the switch domain of GTPases confer a degree of selectivity towards 
binding to DH domains of different GEFs and mutation of the respective 
interaction regions of GEFs and GTPases has been shown to dramatically and 
specifically modulate their binding and activity (Wennerberg, Ellerbroek et al. 
2002). Perhaps the major difference between Rac isoforms lies in their cell and 
tissue distribution (Wherlock and Mellor 2002). P-Rex1 likely signals through Rac1 
in fibroblasts simply because this is the predominantly expressed isoform in 
these cells, with Rac2 being mostly restricted to haematopoietic cells. 
 
6.1.2 Inhibition of P-Rex1 modifies cell morphology 
The studies described so far have involved overexpression of GEFs, which could 
result in their aberrant localisation and hence the aberrant localisation and 
activity of their effectors. A quantitative difference in expression level could 
cause a qualitative difference in function. To study the function of endogenous 
levels of P-Rex1, it was knocked down using RNAi in melanoma cell lines that 
express it. In both CHL-1 and RPMI8332 melanoma cells, reducing P-Rex1 protein 
levels by either transient or stable RNAi is shown here to dramatically reduce 
actin rich protrusions, both peripheral and dorsal membrane ruffles. Considering 
that there are so many Rac GEFs, with the potential for functional redundancy, 
it is remarkable that inhibition of a single GEF, P-Rex1, is able to cause such a 
strong phenotype in these cells. In P-Rex1-/- neutrophils, levels of F-actin 
following fMLP stimulation are mildly reduced, but with no effect on gross cell 
morphology (Dong, Mo et al. 2005; Welch, Condliffe et al. 2005). In PC12 cells, it 
was observed that although P-Rex1 overexpression enhances ruffling, 
endogenous levels of NGF-induced ruffling are promoted by another Rac GEF, 
the Elmo/Dock180 complex, and not by P-Rex1 (Yoshizawa, Kawauchi et al. 
2005). However, recently it has been shown that RNAi of P-Rex1 in 
differentiating PC12 cells causes an increase in beta-tubulin rich projections 
with a concomitant loss of peripheral lamellipodial extensions, suggesting that in 
certain circumstances endogenous P-Rex1 does influence neuronal cell 
morphology (Waters, Astle et al. 2008). Experiments in which P-Rex1 was 
knocked down in highly ruffling HT1080 fibrosarcoma cells did not result in a 
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reduction in ruffles and similarly, P-Rex1 knockdown in H-RasV12 overexpressing 
fibroblasts did not reduce their ruffling. It is worth noting that in contrast to 
these 2 cell lines, the 2 melanoma cell lines in which P-Rex1 RNAi was observed 
to cause such a dramatic phenotype are both wild-type for isoforms of Ras. It is 
certain that different cell types have a different array of GEFs and that these 
have varying relative contributions to the control of the cytoskeleton. P-Rex1 
likely functions as a key regulator of cell morphology in other cell types, but 
certainly not universally.  
Unexpectedly, the ruffles of CHL-1 melanoma cells were not sensitive to siRNA 
to Rac1, Rac2, Rac3 or Cdc42. This is in contrast to the loss of ruffling observed 
upon treatment with the Rac inhibitor NSC23766. There are a number of possible 
explanations for this result. Firstly, the effectiveness of the RNAi knockdown 
may not be great enough to elicit an effect, despite appearing very robust by 
Western blot analysis. Secondly, there could be compensation between the 
GTPases, and a simultaneous knockdown of all 3 Rac isoforms could be required. 
It is possible that only a relatively small amount of Rac1 or Rac3 is sufficient for 
the membrane ruffles of CHL-1 cells. Thirdly, there could be other effects of 
using the chemical inhibitor and Rac itself is not required for the formation of 
these cellular protrusions. Interestingly, it has been reported that RhoG, a 
GTPase closely related to Rac that mediates some of its activity through 
downstream activation of Rac, is able to stimulate ruffling in a Rac independent 
manner. Active RhoG is able to stimulate ruffle formation in Rac1-/- MEFs, and 
TAT-mediated transduction of RacN17 or expression of a dominant negative PAK 
mutant is able to block Tiam1 C1199 and active Rac induced ruffling, but not 
RhoG induced ruffling (Wennerberg, Ellerbroek et al. 2002; Meller, Vidali et al. 
2008). Rac GEFs such as Trio and Vav2 are also able to activate RhoG (Blangy, 
Vignal et al. 2000; Wennerberg, Ellerbroek et al. 2002), and interestingly RhoG 
has been implicated in NGF induced neurite differentiation, as has P-Rex1 
(Katoh, Yasui et al. 2000; Waters, Astle et al. 2008). It is an intriguing possibility 
that P-Rex1 could act as a GEF for RhoG to induce membrane ruffling in CHL-1 
cells independently of Rac. The Rho Kinase dependency of CHL-1 cell ruffling 
was tested here by application of inhibitor Y-27632, which caused a dramatic 
retraction of the cell periphery, but did not inhibit ruffling at the remaining 
extensions. Peripheral ruffles are likely the result of the same kind of actin 
polymerisation responsible for lamellipodia formation, but with reduced 
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adherence to the substratum causing the polymerised actin to fall back into the 
cell. It would be interesting to see if CHL-1 cells have more prominent adhesive 
structures upon P-Rex1 knockdown. 
Attempts to investigate the subcellular localisation of endogenous P-Rex1 in 
CHL-1 and RPMI8332 melanoma cells were unsuccessful. Two P-Rex1 antibodies 
were used for immunofluorescence studies and both resulted in a diffuse 
speckled cytoplasmic staining that did not reduce upon siRNA treatment (data 
not shown, some experiments performed by Dr. L. McGarry). It would be 
interesting to see where endogenous P-Rex1 is localised in these cells, a 
reasonable prediction being in the membrane ruffles. Immunofluorescence 
examination of P-Rex1 localisation show it to be present in the shafts of neurites 
and the adjacent cytoplasmic regions of primary cultured neurons from E14 
embryonic cortices (Yoshizawa, Kawauchi et al. 2005) and in the shafts and 
distal tips of PC12 cell growth cones (Waters, Astle et al. 2008). A combination 
of cellular fractionation and immunofluorescence experiments in neutrophils has 
shown that P-Rex1 translocates to the membrane upon simultaneous activation 
by its membrane bound activators, PIP3 and Gβγ subunits (Barber, Donald et al. 
2007; Zhao, Nalbant et al. 2007). This translocation does not require GEF 
activity, as the GEF-dead P-Rex1 mutant behaves similarly in this respect to WT 
P-Rex1. The minimal region of P-Rex1 that displays significant membrane 
translocation is the iDHPH mutant, which also shows higher basal membrane 
localisation than WT P-Rex1 when expressed in sf9 cells. Upon stimulation with 
C5a, neutrophils form a leading edge of polymerised actin at which P-Rex1 has 
been shown to localise, and treatment with latrunculin shows that actin 
polymerisation itself is not required for P-Rex1 membrane translocation. In 
suspended neutrophils, the translocation of P-Rex1 to sites of polarisastion and 
actin polymerisation is observed to occur over a matter of seconds and minutes, 
while in adherent neutrophils, this event takes closer to an hour. This correlates 
well with the timecourse over which lamelipodia and membrane ruffles form 
upon serum stimulation of P-Rex1 overexpressing adherent fibroblasts shown in 
the current study. 
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6.2 P-Rex1 influences 2D and 3D migration 
6.2.1 Overexpression of P-Rex1 modifies migration 
In fibroblasts, P-Rex1 overexpression leads to an increase in cell speed but a 
reduction in persistence of movement across a 2D surface. These results are in 
general agreement with the work of Pankov et. al. who showed conversely that 
lowering levels of Rac in fibroblasts leads to a more persistent, slower motility 
(Pankov, Endo et al. 2005). Yoshizawa et. al. have described a role for P-Rex1 in 
promoting neuronal cell migration in response to neutrophin-derived growth 
factor stimulation (Yoshizawa, Kawauchi et al. 2005). Consistent with the data 
presented here, they also observed an increase in cell speed with P-Rex1 
overexpression in PC12 cells, but no reduction in persistence, although this is 
likely to be due to the immotile state of untreated PC12 cells. When given a 
directional cue, either chemically by a growth factor gradient in a Dunn chamber 
or physically by scratching a ‘wound’ in a confluent cell monolayer, P-Rex1 
overexpressing fibroblasts move both faster and with greater directionality. 
Overexpression of P-Rex1 in the absence of a stimulatory gradient likely causes 
Rac activation and Arp2/3 mediated actin polymerisation across the entire 
periphery of the cell. A number of self-sustaining positive and negative feedback 
mechanisms exist to localise protrusive actin polymerisation to the direction of 
movement (Ridley, Schwartz et al. 2003), but the excess of P-Rex1 mediated Rac 
activation likely overcomes these so that opposing regions of the periphery 
compete to drive the cell forward, resulting in swift but erratic movement. 
In response to serum, TIFF fibroblasts are capable of migrating across a transwell 
filter but unable to travel through matrigel, but overexpression of P-Rex1 
endows TIFFs with this ability. Compared to TIFF-P-Rex1 cells, the almost total 
inability of TIFFs to invade matrigel in response to serum is striking, but they do 
possess a capacity to invade, as evidenced from the use of 50 ng/ml PDGF as a 
chemoattractant. It is therefore likely that P-Rex1 overexpression simply 
sensitises cells to chemoattractants rather than conferring upon them some 
totally novel characteristic such as matrix degrading capability. It has been 
suggested that structures termed invadopodia promote invasion by focusing 
matrix degradation at points of actin protrusion, although how this relates to 3D 
migration/invasion is not clear (Gimona, Buccione et al. 2008). Attempts to 
153 
measure invapodia in TIFF and TIFF-P-Rex1 cells by a commonly used assay were 
unsuccessful as the cells contorted and ripped apart the gelatin matrix into 
which invadopodia forming cells are reported to send their small localised 
protrusions. 
The invasion induced by P-Rex1 overexpression in TIFFs is dependent on Rac1 
activity as RNAi to Rac1, but not related GTPases, reduces both the number of 
invading cells and the distance to which they invade. Surprisingly, the 
morphology of the TIFF-P-Rex1 cells that do invade following Rac1 siRNA is the 
same as that of untreated cells. Due to the plasticity of invasion mechanisms 
observed in many cell types, it may have been expected that the cells would 
appear rounder with fewer protrusive extensions. This result suggests that 
fibroblasts are not able to modulate their invasion phenotype as other cell types 
have been reported to. Either there is a threshold level of Rac below which 
these cells cannot invade, with some cells retaining levels above this threshold 
(with knockdown levels variable among the cell population), or reducing Rac 
levels slows the rate of invasion (with knockdown levels equal among the 
population). 
A375mm melanoma cells express endogenous levels of P-Rex1 to a similar degree 
as CHL-1 and RPMI8332 cells. However, RNAi of P-Rex1 in A375mm cells does not 
cause any morphological phenotype or migratory defect. Ectopic overexpression 
of P-Rex1 in these cells induces peripheral ruffling and enhances their 
invasiveness, while overexpression of Tiam1 enhances cell adhesiveness and 
inhibits invasion. Furthermore, P-Rex1 overexpression changes the mode of 
matrigel invasion from invading as amoeboid round cells to invading as elongated 
mesenchymal cells, consistent with the role of Rac in promoting this form of 
invasion (Friedl and Wolf 2003). While the effect of Tiam1 overexpression is cell 
and matrix type dependent, it appears that P-Rex1 overexpression enhances 
migration and invasion in a range of cell types and in 2D and 3D contexts. Other 
than the cell types used in this study, a direct comparison of Tiam1 and P-Rex1 
function has also been made in MDCK cells, where Tiam1 inhibits migration and 
P-Rex1 promotes it (A. Malliri, personal communication). Together, these results 
suggest that P-Rex1 may be a more promising candidate for an invasion inducing 
GEF in a broad range of cell types than Tiam1. 
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6.2.2 Inhibition of P-Rex1 reduces migration 
Athough overexpression experiments are informative, the study of protein 
functions at the endogenous level is far more relevant to physiological 
situations. In addition to its previously discussed role in neutrophil migration, a 
number of studies have now shown endogenous P-Rex1 levels to be important in 
promoting motility and regulating morphology of different cell types. RNAi of P-
Rex1 in PC12 cells reduces transwell migration towards NGF, while expression of 
a GEF-dead P-Rex1 mutant acts as a dominant negative to reduce transwell 
migration of cultured cortical neurons towards BDNF or EGF (Yoshizawa, 
Kawauchi et al. 2005). RNAi of P-Rex2b in endothelial cells reduces their 
migration towards sphingosine-1-phosphate (Li, Paik et al. 2005), and similarly 
reducing P-Rex1 expression levels in Hela cells reduces their migration in 
response to leucine (Hernandez-Negrete, Carretero-Ortega et al. 2007), and 
macrophages from P-Rex1 knockout mice show strongly impaired in vitro 
chemotaxis (Wang, Dong et al. 2008).  
In the current study, it is shown that RNAi towards P-Rex1 reduces the 3D 
migration of two melanoma derived cell lines. In the case of CHL-1 melanoma 
cells, the inhibition of matrigel invasion is a result of reduced migration across 
the transwell filter and reduced subsequent invasion into the matrigel. In the 
case of RPMI8332 melanoma cells, the migration across the transwell filter 
appears unaffected but subsequent 3D invasion is reduced. The relationship 
between 2D and 3D migration is not always clear and this is the first 
demonstration that P-Rex1 promotes the 3D migration of tumour cells. P-Rex1 
likely promotes chemotactic migration by the transduction of extracellular 
signalling events to protrusive actin polymerisation. P-Rex1 RNAi in RPMI8332 
melanoma cells seems to selectively inhibit 3D migration. One explanation for 
this could be that the actin remodelling regulated by P-Rex1 in these cells, 
perhaps related to the ruffling observed on 2D surfaces, is especially useful for 
3D migration. The morphology of CHL-1 and RPMI8332 cells following P-Rex1 
RNAi is dramatically altered on 2D surfaces but appears unchanged as they 
invade matrigel. Timelapse microscopy of invading cells may reveal differences 
in the dynamics of their movement and morphology not observable from static 
images. Attempts to assess the formation of invadopodia, by CHL-1 and 
RPMI8332 melanoma cell lines were unsuccessful.  
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Knockdown of P-Rex1 in H-RasV12 fibroblasts did not reduce their matrigel 
invasion. Ras is a central signalling molecule, linked to a large number of 
pathways involved in migration (Campbell and Der 2004). Overexpression of 
active Ras has multiple ramifications, both in immediate signalling events such 
as PI3 kinase and RalGEF activation and in transcriptional responses via 
activation of Raf-MEK-ERK pathway. Ras activates numerous effectors of 
migration including other RhoGTPase family GEFs such as Vav and Sos via PI3 
kinase driven PIP3 generation and also activates Tiam1 directly, although Tiam1 
activation is unlikely to account for TIFF-H-RasV12 cell invasion. It is likely that if 
P-Rex1 does contribute to the migratory capacity of TIFF-H-RasV12 cells, other 
GEFs compensate for its loss upon RNAi knockdown. A375mm melanoma cells 
were also refractory to P-Rex1 loss with regard to their invasion through 
matrigel. This is not entirely unexpected as A375mm cells use an amoeboid 
mode of invasion that is classically quite independent of Rac activity (Sahai and 
Marshall 2003). Initial experiments with P-Rex1 knockdown in WM266.4 
melanoma cells, which invade in a mix of amoeboid and mesenchymal modes, 
suggested that P-Rex1 may have a role in promoting mesenchymal invasion, but 
the sensitivity of these cells to transfection procedures and their intriguing 
response in invasive morphology to the density at which they are seeded, made 
these experiments difficult to interpret and inconclusive as previously discussed. 
Although stable knockdown of P-Rex1 levels did not affect the degree or nature 
of WM266.4 melanoma cell invasion, P-Rex1 protein levels were not totally 
reduced by the shRNA sequences and this could conceivably account for the lack 
of phenotype. Alternative methods of RNAi to reduce protein levels in WM266.4 
cells with greater effectiveness without detrimental effects on viability warrants 
further investigation. 
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6.3 P-Rex1 regulation 
6.3.1 Extracellular signals regulate P-Rex1 
P-Rex1 function has been shown in various systems to be regulated by a range of 
specific upstream signalling events. Most well characterised is its regulation in 
neutrophils and neutrophil-like cell lines. These cells express PI3 kinase γ, which 
allows for simultaneous accumulation of PIP3 and Gβγ subunits following 
activation of a single GPCR. P-Rex1 has also been shown to function downstream 
of PDGF in PAE cells; NGF, BDGF and EGF in PC12 glioblastoma cells; 
sphingosine-1-phosphate in endothelial cells; and leucine in HeLa cells.  
In the current study it is shown that P-Rex1 functions in fibroblasts specifically in 
response to serum and PDGF and not to EGF, HGF or LPA. Analysis of pAkt levels 
suggests that this is likely to be due to the higher PI3 kinase activity levels 
elicited by serum and PDGF over the other growth factors at the concentrations 
used. In contrast to fibroblasts, in RPMI8332 and CHL-1 melanoma cells P-Rex1 
mediates responses to serum and HGF, but these cells do not respond to PDGF. 
Where tested, P-Rex1-induced cell responses i.e. morphology or motility, have 
all been shown to be sensitive to PI3 kinase inhibition by use of the chemical 
inhibitor wortmannin. This is consistent with the notion that PIP3 is crucial for P-
Rex1 activity. Serum contains a multitude of ligands that bind both tyrosine 
kinase receptors and GPCRs leading to PIP3 and Gβγ accumulation, respectively. 
Although single ligands such as PDGF and NGF are classically thought to mediate 
all their effects through their direct tyrosinse kinase receptors, there is growing 
evidence that a degree of cross-talk exists between RTKs and GPCRs (Delcourt, 
Bockaert et al. 2007).  
 
6.3.2 Domain mutations affect P-Rex1 function 
GEFs function to co-ordinate a number different of input signals from an array of 
interacting proteins and intracellular locations to both activate their respective 
GTPases in a specific situation and influence the nature of the GTPase output. 
GEFs are generally very large proteins, and the Rho family GTPases are very 
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small. The physical independence of these proteins, as opposed to adding on 
what would actually be a relatively small ‘GTPase domain’ on to the GEF, likely 
enhances the potential for complex and co-ordinated GTPase regulation, both 
spatially and temporally.  
The functional contributions of the various domains of P-Rex1 were tested here 
by the expression of domain mutants in fibroblasts and subsequent analysis of 
morphology and invasion. Removal of the DEP or PH domains has been shown 
previously to elevate basal P-Rex1 activity in cell free assays, while removal of 
the IP4P domain results in similar basal activity to the full length protein (Hill, 
Krugmann et al. 2005). In fibroblasts, however, the ΔDEP and ΔIP4P mutants 
showed no ability to induce ruffling or invasion. This is consistent with similar 
overexpression studies in PC12 cells, where no morphology change was observed 
upon overexpression of these mutants, although their affect on the migratory 
behaviour of these cells was not tested (Yoshizawa, Kawauchi et al. 2005). 
Recently, it has been demonstrated that an intramolecular interaction occurs 
between the second DEP/first PDZ domain region and the ΔIP4P domain, and 
that this is required for Gβγ induced activity (Urano, Nakata et al. 2008). 
Interestingly, Urano et.al. have shown that overexpression of either the ΔIP4P 
domain mutant or the isolated IP4P domain does not cause lamellipodia 
formation in NIH3T3 fibroblasts, but that their co-expression does, and this is 
enhanced by additional expression of Gβγ subunits.  
While it seems clear that the DEP domain region of P-Rex1 is an important 
structural component of intramolecular interactions required for P-Rex1 activity, 
it is also likely that it is required for intermolecular protein interactions. For 
example, it has been shown that P-Rex1 binds to the MTORC complexes MTORC1 
and MTORC2 via its DEP domains. MTORC2 has been linked to Rac activation and 
cytoskeletal rearrangements (Jacinto, Loewith et al. 2004; Sarbassov, Ali et al. 
2004), and P-Rex1 has been shown to be important in mediating Rac activation 
and cell migration in HeLa cells in response to mTOR stimulation by leucine 
(Hernandez-Negrete, Carretero-Ortega et al. 2007). There is also evidence that 
DEP domains can mediate direct binding to GPCRs (Ballon, Flanary et al. 2006). 
Given the association of P-Rex1 with Gβγ subunits downstream of GPCRs, it 
would be extremely interesting if P-Rex1 were also shown to interact with 
specific membrane receptors via its tandem DEP domains.  
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Evidence from cell free systems also implicates the IP4P domain of P-Rex1 in 
regulating intramolecular interactions. Whether this domain interacts with other 
proteins in the cell is not currently known. Although it has not been observed to 
possess phosphatase activity, it could potentially recruit a functional 
phosphatase, which would be interesting given the role of IP4P in phosphatidyl 
inositol phosphate biochemistry and the activation of P-Rex1 by PIP3. Given the 
demonstrated importance of the IP4P domain in mediating Gβγ signalling in P-
Rex1 (Urano, Nakata et al. 2008), it is surprising that the splice variant 
homologue P-Rex2b that lacks the IP4P domain has been shown to respond to 
Gβγ signalling in cells (Li, Paik et al. 2005). It is possible that another protein in 
the cell takes on the role of the IP4P domain and interacts with P-Rex2b.  
The ΔPH mutant has constitutive activity in vitro but, as shown in the current 
study, the lamellipodia and ruffling of cells expressing the ΔPH mutant are just 
as dependent on serum as WT P-Rex1 TIFFs. It is interesting that the morphology 
induced by the ΔPH mutant is not as sensitive to PI3 kinase inhibition as that 
induced by WT P-Rex1, but that they are equally sensitive to Gβγ signalling 
inhibition. This is a logical extension of observations made in cell-free systems 
and shows that in cells, the ΔPH mutant does not require PIP3 stimulation for its 
activity, but does respond to G-protein signalling. As the ΔPH mutant has been 
shown to be unresponsive to PIP3 (at least in cell-free in vitro assays), this 
implies that serum and PDGF act to stimulate Gβγ mediated P-Rex1 activation in 
TIFF-P-Rex1 and TIFF-P-Rex1ΔPH cells. There is a possibility of an additional PIP3 
binding site outside the PH domain as the ΔPH mutant is still able to bind PIP3, 
albeit to much lesser degree (Hill, Krugmann et al. 2005). Although cell free 
assays do not support the idea, it is possible that this alternative binding site 
could be stimulatory to P-Rex1 function in cells. It remains to be seen if a single 
ligand for a GPCR could activate P-Rex1 in fibroblasts. 
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6.4 P-Rex1 expression and cancer 
Data from the cancer genome anatomy project indicates a consistently high 
expression of P-Rex1 mRNA in melanoma derived cell lines. Data presented here 
shows that indeed P-Rex1 protein levels are far higher in a number of melanoma 
cell lines than in normal melanocytes. Additionally, it is demonstrated that MAP 
kinase inhibition mildly reduces P-Rex1 expression levels, while stimulating MAP 
Kinase activity by H-RasV12 expression in fibroblasts or N-RasQ61K expression in 
mouse melanocytes is able to elevate expression levels. This is supported by 
microarray analysis that has identified P-Rex1 to be among a set of genes whose 
expression levels correlate with pERK levels and can be manipulated by UO126 
treatment in melanoma cells (Shields, Thomas et al. 2007). Since the current 
study has shown P-Rex1 expression to also be elevated in cell lines with low 
reported pERK levels i.e. CHL-1 and RPMI8332 cells, it is clear that high pERK is 
not always required for P-Rex1 expression in melanoma cells, and the 
mechanism by which P-Rex1 protein levels are controlled has not been fully 
investigated. The fact that it is elevated following v-Fos expression suggests that 
the transcription factor AP-1 is involved and this could be further examined by 
correlating P-Rex1 expression and AP-1 activity with reporter assays in a much 
larger panel of cell lines, or by measuring P-Rex1 expression following expression 
of dominant negative AP-1 components such as a-Fos and TAM67.  
Limited immunohistochemistry analysis of human tissue samples has shown 
positive P-Rex1 expression in 2 of 7 primary melanomas, 1 of 4 metastases, but 0 
of 5 melanoma in situ and 0 of 15 moles (C. Der, personal communication), 
suggesting a possible upregulation with progression from the benign state in 
human tumours. In addition to its potential role in melanoma, P-Rex1 has been 
identified as a candidate gene to promote glioblastoma progression through a 
method involving tagging of genes by an MMLV virus encoding the PDGF B-chain 
(Johansson, Brodd et al. 2004). In this model, the viral induced gliomas have a 
selective growth advantage if the virus integrates into the promoter regions of 
genes which co-operate in PDGF-B driven tumourigenesis.  A subsequent study 
confirmed that P-Rex1 was transcriptionally upregulated in gliomas following 
retroviral insertion (Johansson, Goransson et al. 2005). These studies suggest P-
Rex1 synergises with PDGF signalling in tumour growth and this is consistent with 
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data presented here showing that PDGF, at least in some cell types, is a major 
activator of P-Rex1 function. 
 
6.5 P-Rex1 knockout causes a pigmentation defect 
The P-Rex1 knockout mouse has been generated and characterised as having no 
gross phenotypic abnormalities(Dong, Mo et al. 2005; Welch, Condliffe et al. 
2005). However, during the current study it was observed that P-Rex1-/- mice 
have a pigmentation phenotype characterised by a white patch of varying size 
along the belly region and unpigmented feet tips, with 100 % penetrance. 
Interestingly, the phenotype showed some degree of gene dosage effects, as P-
Rex1+/- mice had normal belly pigmentation, but slightly less pigmented feet. 
Melanocytes are derived from melanoblasts, which in turn are derived from 
highly migratory neural crest progenitor cells. The unpigmented areas in P-Rex1-
/- mice are at the extremities of melanocyte precursor migration, suggesting that 
this phenotype is caused by a defect in cell migration. This is consistent with the 
incidence of exencephaly and hydrocephaly in P-Rex1-/- mice noted here, caused 
by a failure of the neural tube to close, and with the reported role of P-Rex1 in 
neural cell migration during development (Yoshizawa, Kawauchi et al. 2005). 
Such a phenotype is not without precedent, indeed there are numerous 
instances of gene disruption causing changes in mouse pigmentation. It is 
particularly intriguing that the c-Kit-/- mouse has a similar phenotype, Kit being a 
member of the PDGFR family of RTKs. The role of Kit in melanocyte biology is 
complex, but it is thought that the spotted phenotype of c-Kit mutant mice is in 
part due to a migratory defect of melanocyte precursors (Yoshida, Kunisada et 
al. 1996) and increasing Kit activity by mutation is motogenic for melanocytes, 
both in vitro and in vivo (Alexeev and Yoon 2006). Interestingly, mutation of 
Sparse, the zebrafish equivalent of Kit, causes a similar in vivo migratory defect 
of melanoblasts (Parichy, Rawls et al. 1999). It is an interesting possibility that 
P-Rex1 may signal downstream of Kit to mediate its migratory effects, especially 
considering the role of PDGF signalling in promoting P-Rex1 activity. In 
investigating the role of P-Rex1 in melanoma formation and development in the 
current study, P-Rex1-/- mice were crossed to mice with activated N-Ras under 
the control of the melanocyte specific tyrosinase promoter, which results in 
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hyperproliferation of melanocytes. This was unable to rescue the pigmentation 
defect, suggesting that the phenotype is not due to a proliferative defect. There 
remains a possible but unlikely explanation that the unpigmented areas of the P-
Rex1-/- mouse are due to a localised lack of melanin production rather than an 
absence of melanocytes. Rac signalling has been implicated in the formation of 
melanocyte dendrites, structures that transfer melanosomes from melanocytes 
to keratinocytes (Scott and Cassidy 1998). However, it is difficult to envisage 
why a defect in these processes would result in such a distinct patterned 
phenotype, specifically in areas distal to the sources of melanocyte migration. 
Immunostaining with melanocyte markers in non-pigmented areas would 
determine whether the non-pigmented areas are truly devoid of melanocytes. 
 
6.6 Investigating P-Rex1 function in a mouse model of 
melanoma 
The Tyr::NRasQ61K INK4a-/- mouse has been previously characterised as 
developing melanoma with high incidence around 6 months of age and 
developing enlarged melanocyte laden lymph nodes with a 64 % incidence and 
liver or lung metastases with a 36 % incidence. 
Having characterised a role for a gene in an in vitro situation, it is not always 
straightforward to predict its physiological function within an in vivo context. P-
Rex1 is no exception and multiple hypotheses can be made to predict its 
potential roles, both positive and negative, in mouse melanoma development. 
From a melanoma cell autonomous perspective, it would be reasonably 
predicted from in vitro cell line data and the proposed in vivo melanocyte 
precursor migratory defect phenotype, that melanomas developing in P-Rex1-/- 
mice would initiate and develop as normal but show a reduced capacity to 
migrate and invade from primary tumours, resulting in fewer metastases. 
However, given the characterised phenotype of P-Rex1-/- mice displaying a 
reduction in the speed of migration of neutrophils and macrophages, and a 
strong impairment in neutrophil recruitment to sites of inflammation and ROS 
production (Welch, Condliffe et al. 2005), there could also be an immune cell 
infiltrate aspect to tumour development in P-Rex1-/- mice. While there is 
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overwhelming evidence showing the immune system to be critical in the body’s 
defence against tumourigenesis by clearing mutated immunogenic cells, 
inflammation is heavily associated with promoting cancer progression 
(Mantovani, Allavena et al. 2008). For example, macrophages have been 
described to partake in a paracrine signalling loop with carcinoma cells that 
stimulate tumour cell invasion to the vasculature.  
The current study has shown that P-Rex1 deficiency does not alter the onset of 
melanoma in the N-RasQ61K INK4a-/- mouse model, but that data on metastatic 
progression is not yet complete. As discussed above, mice carrying certain 
mutations to the RTK Kit phenocopy P-Rex1-/- mice with respect to their 
pigmentation pattern. The involvement of Kit signalling in melanoma is not fully 
understood, but its expression is commonly lost melanoma as it seems to 
promote apoptosis (Easty and Bennett 2000). While data on the effects of P-Rex1 
on melanoma metastasis in mice is pending, it is tempting to speculate that P-
Rex1 acts downstream of Kit signalling to mediate it’s pro-migratory properties, 
while not affecting those related to growth and survival. 
An unexpected finding from this investigation, incidental to the study of P-Rex1 
function in melanoma, is that P-Rex1 appears to have a role in lymphoma 
development. A full cohort of mice has now been generated to examine the 
effect of P-Rex1 loss on lymphoma in a cleaner genetic background independent 
of Tyr::N-RasQ61K expression. Northern blot analysis has shown high levels of P-
Rex1 expression in the spleen and lymph nodes, consistent with it being 
expressed in lymphocytes (Welch, Coadwell et al. 2002). Rac3 activity has been 
shown to be stimulatory to lymphoblastic leukaemia(Cho, Zhang et al. 2005). 
Also, the progression of T-lymphoma induced by Pten deficiency has been shown 
to be dependent on Rac activity through an as yet unidentified GEF (Strumane, 
Song et al. 2008). P-Rex1 is a promising candidate not only because of data 
presented here, but also because it acts downstream of PIP3, the levels of which 
are elevated following Pten loss. 
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6.7 Future work 
The work presented here clearly demonstrates that P-Rex1 has an important role 
in regulating cell morphology and motility. However, within the scope of this 
study there have so far been only two cell lines, both melanoma derived with 
wild type B-Raf and Ras isoforms, that have responded to knockdown of 
endogenous P-Rex1 with robust phenotypes. Work described in the literature 
shows that P-Rex1 has similar functions in other cell types. It would be 
interesting to screen a large number of melanoma derived cell lines for their 
dependence on P-Rex1 with respect to morphology and invasion and determine 
whether this correlates to other known genetic characteristics, Ras and Raf 
mutation status being an obvious choice. 
While the overexpression studies in fibroblasts have shown that P-Rex1 activates 
Rac1 and is dependent on Rac1 expression to induce phenotypes, such a 
mechanism in the two melanoma derived cell lines has not been demonstrated. 
Activation of a Rac isoform and subsequent activation of well characterised 
downstream targets leading to cytoskeletal rearrangement is clearly the most 
promising mechanism for P-Rex1 function. However, as discussed previously, the 
involvement of Rac GTPases in CHL-1 membrane ruffling is not clear and it would 
certainly be informative to provide definitive evidence of whether Rac proteins 
are acting downstream of P-Rex1 in this context. As discussed, there is a 
possibility that P-Rex1 could function through RhoG to induce Rac independent 
ruffling in CHL-1 melanoma cells, and this could be tested by use of RNAi to 
RhoG. 
The substrate upon which a cell is cultured can have a dramatic influence on its 
morphology and motile behaviour. During the current study it was noticed that 
the extent of membrane ruffling exhibited by CHL-1 and RPMI8332 cells was 
somewhat reduced when cells were transferred from tissue culture plastic to 
glass coverslips. It would be interesting to closely examine the morphology of 
these cells with and without P-Rex1 expression on different substrates, such as 
fibronectin, laminin and cell-derived matrices, especially by timelapse 
microscopy. Some morphological features observed on cells in 2D tissue culture 
are undoubtedly artefacts of this environment, but they likely represent 
structures or processes that do occur in the 3D tissue environment.  
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Rho family GTPase GEFs are a diverse group of proteins and each GEF functions 
in different situations using different molecular mechanisms. P-Rex1 is a large, 
multi domain protein, and so there seems great potential for it to be involved in 
numerous protein interactions. It would therefore be extremely illuminating to 
identify its interacting partners by means of proteomic approaches such as 
immunoprecipitation. The stable Myc-tagged P-Rex1 expressing fibroblasts 
generated for the current study would be an ideal platform from which to 
investigate this. Binding partners for P-Rex1 could be identified in conditions of 
serum starvation and serum stimulation, and use of the GEF-dead P-Rex1 
expressing fibroblasts would help differentiate which of the proteins identified 
were parts of a fully functional complex. Further verification that the identified 
proteins are important for endogenous P-Rex1 function could be drawn from 
confirmation of their status in CHL-1 and RPMI 8332 melanoma cells. 
The major role of P-Rex1 in neutrophils is the formation of ROS via Rac2 
activation of NADPH oxidase. Other cell types also utilise NADPH oxidase to 
produce ROS, including melanoma cells (Brar, Kennedy et al. 2002), and ROS 
have been implicated in promoting cell motility and invasion. Although initial 
experiments in this study to measure ROS following P-Rex1 overexpression and to 
assay cells following treatment with the NADPH oxidase inhibitor DPI did not 
imply a role for ROS in P-Rex1 mediated functions (data not shown), it would be 
worthwhile investigating this possibility more thoroughly.  
A long-standing interest in this lab, and one that initiated the current study, has 
been regulation of cell morphology, motility and invasion by transcription. Rho 
GTPases have been implicated in the regulation of transcription and so there is a 
possibility that P-Rex1 has a transcriptional element to its function and this 
could be tested by microarray, most suitably by comparing the transcriptional 
profiles of melanoma cells with and without RNAi mediated P-Rex1 inhibition. 
Investigating the effect of P-Rex1 expression on melanoma formation in mice is 
ongoing, but it is clear that the genetic model employed here was not the most 
suitable for this purpose. The high incidence of other fatal tumours including 
lymphoma and sarcoma in INK4a-/- mice on a pure C57BL/6J background has 
drastically reduced the number of mice surviving to an age at which they 
develop sizeable melanomas that are expected to metastasise. It would be 
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advantageous to the study of melanoma development to make the INK4a 
deficiency specific to the melanocytic lineage, by flanking the INK4a locus with 
loxP sites and crossing with a Tyrosinase Cre strain. As discussed previously, the 
human melanoma cell lines that have responded to P-Rex1 knockdown with a 
reduction in invasion both have wild type Ras and Raf isoforms, and P-Rex1 does 
not contribute to the invasiveness of H-RasV12 fibroblasts, at least under the 
conditions tested and with the levels of RNAi mediated knockdown achieved. It 
would therefore perhaps be more appropriate to employ a different genetic 
melanoma model, the HGF driven model for example (Otsuka, Takayama et al. 
1998). Regardless of this, the pigmentation defect of the P-Rex1-/- mouse 
persisted when crossed to N-RasQ61K mice, suggesting that P-Rex1 does still 
contribute to melanocyte physiology in this background. The developmental 
basis for the pigmentation phenotype is currently under investigation. P-Rex1-/- 
mice have been crossed to Dct::LacZ mice, which bear LacZ under the promoter 
of Dct, a E9.5 to E14 and this allows visualisation of the location of melanoblasts 
throughout development (example, Fig. 6.1).  
Investigations are continuing as to whether P-Rex1 deficiency impairs the 
metastatic spread of primary tumours in the genetic mouse model. Early 
indications are that the incidence of macroscopically detected metastasis is not 
as high as previously reported and that so far there have not been any cases of 
such metastasis in the P-Rex1-/- mice, while there have been 3 possible 
metastasises (subject to closer histological examination) in the P-Rex1+/+ mice. 
Very early examination of histological tissue sections also suggests that 
micrometastasise may be fewer in organs such as liver and lung in P-Rex1-/- 
mice. 
As mentioned above, limited IHC analysis of human melanoma and benign naevi 
and cell line expression data suggests that P-Rex1 expression may be elevated in 
melanoma. It would be useful to examine this more thoroughly, perhaps by 
means of a melanoma tissue array. 
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Figure 6.1 – Melanoblast staining 
 
Example of X-gal staining of a WT (E14.5) and dct::lacZ embryo 
(E13.5), allowing visualisation of melanoblasts throughout embryonic 
development. Black scale bars are 1 mm. 
 
 
 
 
WT Dct::LacZ
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6.8 Conclusions 
The work presented here has further characterised the regulation of the Rac GEF 
P-Rex1 and has identified novel functional roles for this protein in the control of 
actin mediated membrane ruffling and motility. Furthermore, this study has 
demonstrated that P-Rex1 expression is elevated in a number of melanoma 
derived cell lines compared to normal melanocytes and that P-Rex1 has an in 
vivo function related to melanocyte localisation during development. P-Rex1 
deficiency may reduce metastatic progression of melanoma, and contribute to 
lymphoma tumourigenesis. Together, these results add to the convincing body of 
evidence implying a significant role for Rho family GTPase signalling in the 
regulation of cell morphology, motility and tumour cell invasion, and 
tumourigenesis
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